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Abstract

Mechanism and Development of Peptide-based Inhibitors to Human Islet
Amyloid Polypeptide (hIAPP) Self-assembly
by
Jayson Vedad
Advisor: Ruel Z. B. Desamero
Amyloid fibrils formed by of hIAPP1-37 (also known as amylin) has been linked to type-II
diabetes mortalities and its formation was found to be related to the three aromatic residues in
hIAPP1-37. In this dissertation, the role of aromatic amino acids, particularly that of Phe-23, and its
various interactions to the self-assembly of human islet amyloid polypeptide (hIAPP)22-29 were
investigated. Using a variety of spectroscopic techniques with emphasis to vibrational
spectroscopy (FT-IR and Raman spectroscopies) in conjunction with computational methods,
different factors leading to aggregation as well as its inhibition were identified. Among the driving
forces identified are aromatic-π stacking between Phe residues which upon disruption by utilizing
specially designed peptide-based inhibitors can lead to the abolition of aggregation propensity of
hIAPP. In this work, three classes of peptide-based inhibitors were developed. The first group of
inhibitors take advantage of the aromaticity of the Phe-23 residue of the hIAPP22-29 fragment that
undergoes π-stacking upon aggregation. These peptides disrupt the aromaticity by introducing
electron donating group (EDG) on Phe-23. Although these peptides showed no inherent
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amyloidogenic properties, their effectivity towards inhibition of full-length hIAPP aggregation
was weak. The second batch of inhibitors, also based on hIAPP22-29 where benzenecarboxylic acid
groups were conjugated to the N-terminus of the peptide fragment, showed a more promising
inhibitory property towards full-length hIAPP aggregation. These peptides were designed to
inhibit aggregation by interfering with the formation of the β-turn intermediate during the amyloid
formation and at the same time providing electrostatic repulsion between amylin monomers.
Although some of the conjugates showed inhibition, others showed promotion of amyloid
formation. The third batch of peptide-based inhibitors were designed to exploit cationic-π
interactions, a common interaction between aromatic and charged amino acid residues in
polypeptides and proteins. In this batch of peptides, some inhibition was achieved primarily on the
basis of increased solubility brought about by the peptide inhibitors binding to hIAPP via
hydrophobic interactions.
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1. Background

J. Vedad1
1

Department of Chemistry, York College, Institute for Macromolecular Assemblies, Jamaica,
New York, 11451 and PhD Program in Chemistry, The Graduate Center of The City University
of New York, New York, New York, 10016 USA

1.1. Human Islet Amyloid Polypeptide (hIAPP)
The human islet amyloid polypeptide (hIAPP or amylin) is a 37-amino acid polypeptide
with an amidated C-terminal that is co-secreted with insulin by pancreatic β-cells. It has a disulfide
bridge between the two cysteine residues 2 and 7. Amylin is originally secreted by β-cell granules
as ProIAPP, a 67-amino acid polypeptide, which undergoes post-translational modification (PTM)
with the removal of the C- and N- terminal flanking peptides by prohormone convertase 2 (PC2)
to produce the mature 37 amino acid polypeptide.1 The amino acid sequence of hIAPP suggests a
relative hydrophobicity with very few charged residues such as Lys-1, Arg-11, and His-18. At or
below the physiological conditions, hIAPP exhibits a net positive 2 - 4 charge depending on the
pKa of the N-terminus and His-18 as well as the environmental pH. Amylin also contains a
relatively large amount of Asn, Ser and Thr residues. It is also noteworthy to mention the presence
of several aromatic residues with the conserved Phe-15 and Tyr-37 as well as Phe-23 which is
replaced by a Leu-23 in rats and mice.2
Similar to the other pancreatic hormone insulin, amylin, is also believed to play a role in
carbohydrate homeostasis. Both are released in response to nutrient ingestion.3 Amylin is also
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involved in the regulation of glucagon secretion. Figure 1.1 summarizes the roles of the three
hormones involved in glucose metabolism.

Figure 1.1. Overview of the metabolic function of amylin in comparison with that of insulin
and glucagon. Amylin primarily influences the intake of glucose into the body by restricting
gastric emptying and inhibiting glucagon activity.

Early animal studies also suggested that amylin is a potent inhibitor to gastric emptying by
binding to the area postrema of the brain which is responsible for the control of the digestive
tract.4,
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Due to its ability to slow down nutrient intake in the gut, amylin analogs such as

pramlintide and davalintide have been developed and are being studied as therapeutics to bind on
the same binding site in the area postrema which results in decreased glucagon secretion that
thereby results in slowing down gastric emptying.6, 7 This slowing down of nutrient intake in the
2

intestine may as well explain amylin’s ability to affect food intake in mice. 8 Several studies in
mice have shown that central amylin administration resulted to reduced food intake and reduced
body weight and its effect is reversed in the presence of amylin antagonists.9, 10
Historically, the earliest description of amylin and its relation to diabetes goes back to the
beginning of the 20th century when Opie, Weichselbaum and Stangl reported the presence of
amyloid deposits in the pancreas which they referred to as amyloidosis or hyaloidosis. 11, 12 It was
predominantly observed in patients suffering from diabetes. In 1987, a more detailed description
of the peptide was published by Cooper, et al. in the post-mortem analysis of type 2 diabetes
patients.13 A similar polypeptide was reported by Westermark, et al. to be related in amyloid
deposits diabetic cats.14 In 1997, Goldsbury, et al. provided morphological description of human
amylin deposits as polymorphic fibrillar amyloid between pancreatic islet cells.15,

16

The

prevalence of amyloid deposits in the pancreata of more than 90% of type 2 diabetes mortality
cases as well as its localization in areas where there is pronounced cellular degeneration made
amylin a main suspect in the progression of the disease associated with β-cell dysfunction.14, 17-19
Amyloid deposits have been found in humans and cats but not on mice and rats. A
comparison of IAPP from these species revealed that amylin is highly conserved across species
even though rat and mice don’t develop amyloid deposits. The N- and C- termini of the ProIAPP
showed minimal conservation across species suggesting that these regions that were removed in
the post-translational modification do not represent additional bioactive compounds focusing the
blame to the mature IAPP as compared to ProIAPP. On IAPP, it was noted that the few interspecies variations, particularly the replacement of aromatic amino acids around residues 20-29, in
the amylin sequence among the tested mammals may account for the absence of amyloid deposits
in rats and mice.20, 21

3

1.2. Morphology and Structure of hIAPP Amyloid
The detailed molecular three-dimensional structure of amyloid fibrils that consist the
amyloid deposits in the pancreas is yet to be completely elucidated. Models of hIAPP fibril
structure has been developed throughout the years by combining data from different biophysical
techniques such as circular dichroism (CD), Fourier transform infrared (FT-IR) and electron
paramagnetic resonance (EPR) spectroscopies coupled with electron microscopy (EM) and hIAPP
fragment X-ray crystallography. Early studies involving these techniques have concluded the
presence of extensive β-sheet structures.22, 23 X-ray and electron diffraction data indicated the
presence of cross-β strands that are 4.7 Å apart perpendicular to the fibril axis.24 EM images of the
amyloid fibrils showed twisted fibril morphologies with strands arranged in a parallel, stacked
orientation.16, 25 Models from solid-state NMR and x-ray crystal structure data suggested that
residues 18-27 of hIAPP forms a loop between two β-strands.26, 27 Also, the presence of three βstrands with residues 8-26, 20-27 and 30-37 assuming an S-shaped orientation has been proposed
from a number of theoretical studies.28 A more recent EPR study by Bedrood, et al. suggested that
the two β-strands (residues 8-26 and 20-27) of individual hIAPP monomers has an out-of-plane
stagger of about 15 Å which stacks in a left-handed helical twist.29 Some minor differences of the
different models that has been presented in hIAPP fibril structure is the orientation of some of the
amino acid residues such as Arg-11, Ala-13 and most importantly Phe-15 which some studies
report to be solvent exposed while some report to be in the core of the amyloid structure.26, 27 These
differences in the different models may be detrimental in the understanding of amyloid structure
since some of these residues may play major roles in the mechanism of fibril formation. On the
other hand, since these models have been constructed from different sets of empirical and
theoretical data, the similarities that they possess gives a reassurance as well as the fact that
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amyloid also exhibit some degree of polymorphism which can be a reason for the small differences
between these models.2

1.3. Models of Amyloid Fibril Formation
Table 1.1. Summary of the different amyloidogenic fragments and nucleation sites that has
been observed and predicted since the first report in 1990.2
Amyloidogenic region
20-29
17-34, 24-37 and 30-37
20-29
23-27 and 22-27
22-29
8-20
14-18, 14-22, 14-20, 15-20 and 15-19
22-27
12-17 and15-20
12-17, 22-27 and 31-37
13-18
8-17 and 28-37
12-18, 15-20 and 28
8, 13, 17, 25, 27, 32*
*nucleation sites

Reported by
Westermark, et al.
Nilsson and Raleigh
Goldsbury, Goldie and Pellaud
Tenidis, et al.
Azreil and Gazit
Jaikaran, Higham and Serpell
Mazor, et al.
Scrocchi, et al.
Scrocchi, et al.
Kajava, Aebi and Steven
Galzitskaya, Garbuzynskiy and Lobanov
Luca, et al.
Zhang, Chen and Lai
Shim, et al

Year
1990
1999
2000
2000
2001
2001
2002
2002
2003
2005
2006
2007
2007
2009

The complete mechanism by which the amyloid fibrils form, similar to its complete
molecular structure is yet to be elucidated. An early theory on the amyloidogenicity of amylin is
from the comparison of amylin to its analog, CGRP or calcitonin gene related peptide. Amylin is
a member of the calcitonin gene peptide superfamily together with calcitonin (CT) and CGRP. The
gene found in chromosome 12 that is responsible for the expression of amylin in humans are
believed to be an evolutionary duplicate of the gene responsible for the expression of CT and
CGRP found in chromosome 11. Having been expressed by evolutionary duplicate genes, they
share almost similar sequence with amylin having 46% homology of amino acid sequence with
5

CGRP and 20% with CT.30 CGRP, however is not amyloidogenetic and a striking difference in
their sequence is the region 20-29 which became a suspect for their difference in properties.31, 32
A comparison of human IAPP and rat amylin (rIAPP) which does not form amyloid also showed
major differences along the same region of the peptide with notable replacement of proline residues
on positions 25, 28 and 29. This proline residues disfavor the formation of β-sheets prevalent in
amyloid fibrils, and they have been used to explain the inability of rIAPP to form amyloid fibrils.21
Fragmentation studies have revealed that other segments of hIAPP may also contribute to
its amyloidogenicity. It has been shown that aside from fragment 20-29, other fragments as small
as five residues also exhibit amyloidogenicity. Akter, et al. has summarized the discovery and
prediction of these amyloid forming regions of hIAPP in Table 1.12

1.4. Cytotoxicity and Pathology of Amylin
Association of amyloid fibrils to type II diabetes arose from observations that β-cell
degeneration is often colocalized on sites with amyloid deposits.14, 17, 18 The debate whether the
presence of these deposits is the cause or effect of type II diabetes is still ongoing. Another question
that needs to be answered is the cytotoxic form of hIAPP. Different schools of thought suggest
that mature fibrils, oligomers as well as pre-fibrillar states can be the most cytotoxic species.
On a publication by Lorenzo et al, it was suggested that insoluble fibrils are more cytotoxic
than soluble pre-fibrillar forms.33, 34 This is supported by studies on rIAPP which does not exhibit
cytotoxic properties since it does not form aggregates. A follow up study by Lorenzo’s research
group on the interaction of amylin with Congo red (CR), which has been shown to bind with hIAPP
fibrils, completely abolished cytotoxicity. However, it was not able to stop the conversion of
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soluble hIAPP to mature fibrils. This further supports the case for the greater role of mature fibrils
on the cytotoxic nature of amylin.
In contrast to the conclusions by Lorenzo et al., studies by Meier et al. on the potential
inhibitory properties of rifampicin on amyloid formation and toxicity of amylin showed that
rifampicin was successful in eliminating fibril formation without eliminating cytotoxicity. They
concluded that rifampicin may be able to stop the formation of insoluble amyloid but it was unable
to stop the proliferation of amylin oligomers which they attribute the toxicity of amylin to. Another
study supported this claim by showing that there is positive correlation between the presence of
fibrillar species and cell longevity of transgenic mice.
As the debate on the cytotoxic form of amylin goes on, its cytotoxic mechanism has been
proposed in several models. Amylin cytotoxic mechanism can be summarized into three major
hypotheses. The most studied of them is the disruption of the cell membrane leading to disruption
of cell homeostasis which eventually results to cell death.35 Several studies have confirmed the
interaction of amylin with the lipid bilayer including its ability to form pores on the cell membrane.
This has been confirmed by conductance measurements that revealed an influx of Ca2+ and efflux
of Na+ and K+ when hIAPP fibrils were introduced exogenously. Similarly, intracellular hIAPP
amyloid expressed in transfected COS-1 cells also showed similar results.36 Studies by Jayasinghe
and Knight also showed increased fibril formation in the presence of anionic lipid membranes
which suggests that interaction between amylin and the negatively charged lipids are responsible
for amyloid fibril formation.37 It has also been found that amylin can insert through the lipid bilayer
and incorporate lipid molecules in the growing fibril structure.
Another hypothesis on the mode of cytotoxicity of amylin is the generation of reactive
oxygen species (ROS) like hydrogen peroxide (H2O2). Schubert et al., has demonstrated that the
7

presence of amyloid fibrils increased the levels of H2O2 in β12 cells.38 Studies on rat cortical
neurons treated with hIAPP showed increased expression of oxidative stress related genes such as
cox-2 and IκB-α.39 This mechanism of toxicity can also be observed in other amyloidogenic
peptides.40
The third proposed mechanism of toxicity is through apoptosis which are characterized by
cell shrinkage, detachment of cell membrane from the cytoskeleton, perturbations on the nuclear
architecture and breakage of DNA into fragments. This hypothesis is supported by the studies done
by Lorenzo et al. where they demonstrated that the toxicity of amyloid fibrils was significantly
reduced in the presence of aurintricarboxylic acid which is an inhibitor to apoptosis.33 A study on
the effect of the presence of amylin in RINm5F cells showed amylin-induced DNA
fragmentation.41 This study suggested that amylin also causes overexpression of p21 and p35
tumor suppressor genes. These genes encode for proteins that arrest cell proliferation which causes
apoptosis in RINm5F cells.41

1.5. Inhibition Models of Amylin Fibril Formation
A complete understanding of the pathogenesis of IAPP is important in the development of
potential therapeutics. Several studies including this current work focused on the prevention of
self-association of IAPP by developing potent inhibitors. These models have evolved from the
observed pathology of hIAPP.
Prior to the development of therapeutics based on the inhibition hIAPP aggregation, some
potential therapeutics focused on the scavenging of ROS caused by increased presence of amyloid
fibrils in the pancreas. This was done by evaluating free-radical scavengers such as quinone
derivatives in their ability to prevent cell death in the presence of amyloid fibrils. Among these
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scavengers, rifampicin, p-benzoquinone and hydroquinone were found to be effective in the
reduction of the toxic effects of hIAPP amyloid.42 Other antioxidants failed to do the same. This
observed reduction in amyloid cytotoxity was attributed to the ability of rifampicin to bind with
amylin aggregates thus inhibiting its ability to bind to the cell surface in addition to its ability to
scavenge ROS. This is true also for other amyloidogenic polypeptides such as Aβ.43 The rifampicin
inhibition is the first reported study of inhibitor binding to amylin. Since then, other ROS related
inhibitors that has been reported including N-acetyl-L-cysteine and dithiothreitol.44, 45 This method
of inhibition, although effective in reducing cell mortality, does not address the formation of
cytotoxic peptide species. As a result, more strategies have been developed to address the issue of
cytotoxic oligomers and mature fibrils.
Among the first strategies for apoptosis prevention involving the actual inhibition of hIAPP
fibril formation involved small molecule binding, like polycyclic compounds, aimed to introduce
geometric constraints to fibril formation.46 Among the molecules studies that were able to inhibit
fibril growth are Congo red, acridine orange, phenol red, tetracycline and resveratrol. 46-48 These
compounds also demonstrated reduced amylin-mediated cytotoxicity and judging from the
structures of these small molecules, they have highlighted the potential significance of
heteroaromatic interactions in the inhibition of amyloid formation.49 These generation of inhibitors
are promising when it comes to their inhibition ability but one major hurdle in their use as potential
therapeutics are their inherent cytotoxicity. Among these small molecules that have been studied,
only a few are not inherently cytotoxic. Rosiglitazone and Metformin are compounds with low
cytotoxity and posed as promising therapeutics for amyloid induced cell death. These compounds
have undergone in vivo studies and has been found to be effective in increasing insulin sensitivity.
A higher insulin sensitivity would result to lower insulin production and since amylin is co-
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secreted with insulin, this would result to lower amylin production and eventually lower degree of
aggregation. Results of experiments in mice models supported this theory which then highlighted
the possibility of developing therapeutics targeting amylin production or amylin aggregation.50
The disadvantages of using small molecules as therapeutics opened the avenue for a new
generation of inhibitors based on biopolymers, particularly short peptide fragments which can offer
higher specificity and lower inherent toxicity. Initial development of peptide-based inhibitor to
amylin aggregation began with the study of rat IAPP. rIAPP possesses an abundance of proline
residues and does not have amyloidogenic properties. These observations ushered the synthesis of
peptide inhibitors with proline substitution. Among the very first of these peptides is the synthesis
of a proline substituted full length amylin at position 26 replacing a serine moiety.51 This mutation
converted the hIAPP into an inhibitor potent enough to prevent fibril formation by binding to the
native hIAPP. Aggregation inhibition is achieved by disrupting the free stacking of β-sheet amylin
monomers by introducing the mutated proline-substituted hIAPP in a β-turn conformation.52 The
success of this model of inhibition has led to the development of more versions of prolinesubstituted inhibitors including one that contains three proline mutations at positions 25, 28 and
29. This amylin derivative has undergone clinical trials and is now marketed as Pramlintide
currently used with insulin to manage type-II diabetes.53
Peptide-based inhibitors based on the full length hIAPP, though they may be effective in
regulating type-II diabetes, pose a different drawback. The difficulty of synthesizing a 37-amino
acid long peptide ushered the exploitation of using a shorter peptide-based inhibition. Among the
first short peptide fragment that showed successful inhibition of amyloid formation is in
development of depsipeptides where N-alkylated amino acids and/or ester functionalities where
introduced to amylin based peptide fragments.54 The mode of inhibition is based on the binding of
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the depsipeptide fragments to the amylin monomer forming a β-sheet structure with the amylin
monomer which disallows the further attachment of another amylin monomer by disrupting the Hbonding capability of amylin as well by introducing steric hindrance.55 Cyclic versions of these
peptide inhibitors were also utilized, increasing the stability of the peptide and peptide-amylin
binding resulting in increased activity.56
The further search for potent inhibitors to amylin aggregation have led to the study of other
small molecules and metal ions for their potential inhibitory effects. Research has been published
on the inhibitory effects of copper (II) and zinc (II). The inhibition model proposed for these ions
is based on the electrostatic repulsion between amylin monomers upon binding of the positively
charged ions to histidine residues of amylin.57 These effects were found to be concentration
dependent and the inhibitory effect reverses when the ratio of ion to amylin falls below unity.58, 59
Heme molecules and epigallocatechin gallate (EGCG, a green tea component) have also been
recently evaluated for their inhibitory property and have shown significant ability to reduce
aggregation of hIAPP. Their mode of inhibition is also based on amylin binding and owing to the
inhibitor molecules’ size, these molecules prevent the amylin from assuming the necessary
conformation towards fibrillogenesis.60, 61
All these modes of inhibition have shown promising leads in the search for a potent
inhibitor of amyloid fibril formation. However, only Pramlintide has reached clinical trials and
even then, is unable to completely eliminate the amyloid aspect of type-II diabetes symptoms. This
highlights the importance of further research in to the mechanism of inhibition of amyloid
formation towards the goal of developing inhibitors with sufficient potency, efficiency and
specificity.
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2. Biophysical Methods in the Study of Amylin Aggregation

J. Vedad1
1

Department of Chemistry, York College, Institute for Macromolecular Assemblies, Jamaica,
New York, 11451 and PhD Program in Chemistry, The Graduate Center of The City University
of New York, New York, New York, 10016 USA

2.1. Solid-Phase Peptide Synthesis
The use of peptides as potential therapeutics was ushered in by the development of solidphase peptide synthesis (SPPS) that offered fast and simple synthesis of peptide sequences. For
hIAPP, peptide synthesis has allowed site-specific mechanistic studies of hIAPP aggregation.
These studies have resulted in significant advancement in the current understanding of the factors
leading to amyloid formation.
SPPS is often performed using 9-fluoromethoxycarbonyl (Fmoc) chemistry over tbutoxycarbonyl (tBOC) chemistry. A typical procedure involves the coupling of α-hydroxy acids
to

resin-bound

peptide

using

N-hydroxybenzotriazole/2-[H-benzotriazole-1-yl]-1,1,3,3-

tetramethyluronium hexafluoridate (HOBT/HBTU) as activating agents.62 Figure 2.1. outlines a
typical synthesis procedure using Fmoc SPPS chemistry. Here, it is represented by the synthesis
of the amyloidogenic NFGAILSS (hIAPP22-29) sequence of hIAPP using Wang resin as the solid
support. Typically, synthesis procedures are now simplified with the first amino acid already
attached in commercially available resins. Deprotection or the removal of the base-labile Fmoc
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Figure 2.1. Typical Fmoc-chemistry SPPS procedure represented here with the synthesis of
the hIAPP amyloidogenic sequence NFGAILSS.

protecting group to prepare for the coupling of the second amino acid residue is done by 20%
piperidine in dimethylformamide (DMF) followed by subsequent coupling with HOBT/HBTU.
This procedure is repeated until all amino acid residues are added to form the peptide sequence.
Cleavage of the peptide fragment from the solid resin support is achieved in acidic environment
using trifluoroacetic acid (TFA). Peptides are then ready for purification prior to use. These
methods in peptide synthesis are generally simple although some peptides are difficult to
synthesize especially on the large scale.
The use of peptides as therapeutics has pros and cons. Among the disadvantages include
possible proteolysis and unfavorable pharmacokinetics.62 The advantages, on the other hand,
13

outweighs these disadvantages with the great potential for rational design, specificity, and welldeveloped methods of peptide analysis.
Common approaches in the study of peptides as potential therapeutics particularly as
inhibitors to fibrillogenesis includes the rational peptide design based on specific targets in the
amyloidogenic polypeptide.63, 64 In the case of hIAPP, where aggregation promoting sites have
been identified, much of the potential peptide inhibitors that have since been designed are based
on these known aggregation sites.65, 66 In other amyloid forming proteins, unmodified peptide
fragments derived from the amyloidogenic peptides have served as fibrillogenesis inhibitors.
Improved inhibition from these peptide fragments has been demonstrated with amino acid
substitution or side chain modification. Side chain modification can offer greater inhibition by
improving the affinity of these peptides to target sequence or by altering the hydrophobic character
of the peptide target. Modifications can also help overcome the proteolytic vulnerability of these
peptide inhibitors.62
Other peptide modifications that have been applied in the development of peptide
therapeutics aside from side chain or amino acid mutation are modifications of the N and C termini
and peptide backbone, N-methylation, α-C modification, peptide cyclization, use of ester bonds in
lieu of amide bonds and N-substitution of polyglycine (peptoids).62
Modern advances in SPPS instrumentation has led to even more efficient synthesis
methods with the development of microwave-assisted techniques that are now equipped with
automation. A lot of research has also been done towards the synthesis of “difficult” sequences
which has paved the way towards even more peptide varieties.67-69
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2.2. Kinetic Turbidity Assay

Figure 2.2. Schematic representation of a turbidity assay showing the measurement of light
scattered by the peptide aggregates.

A quick and simple method of measuring amyloid formation and growth is needed in the
study of amyloid formation. The most common method employed today is based on the intrinsic
light scattering property of polypeptide aggregates which can be monitored using a simple UVVis set up (Figure 2.1). This method has first been established by Andreu and Timasheff in 1986
and subsequently used by Moody, et al in 1996 until it became a standard technique in measuring
protein association.70, 71 These turbidimetric measurements can give insight into the rate and degree
of aggregation of peptide fragments or whole hIAPP sequences under different conditions.
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The measured turbidity is described as the attenuation of incident light through lightscattering.72 This light scattering can be measured either directly or indirectly via transmission
measurements or angle-dependent measurements.73, 74 The former is the more common one which
can be done with a conventional spectrophotometer or a plate reader. The simplicity of this
technique has made this type of assay a standard in monitoring protein aggregation kinetics. 75 To
date, turbidity has been applied in the monitoring of the formation of cytoskeletal fibers, virus
capsid formation, and the aggregation of sickle-cell hemoglobin other amyloid forming
polypeptides.71, 76-83

Figure 2.3. Schematic of amyloid formation kinetics showing the three characteristic features
of nucleation-growth kinetics.
Amylin has a characteristic nucleation-growth polymerization kinetics characterized by a
lag (or nucleation) phase, a steep growth phase and an asymptotic endpoint (Figure 2.2). The
turbidity plot can be divided into three parameters with the growth phase represented by the kinetic
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tenth-time (t10) or the time it took for the aggregation to reach 10% of maximum. The time between
the kinetic half-time (t50) and the t10 represents the growth phase; and the asymptotic phase is
characterized by the time-independent value of monomer incorporation to amyloid, (Camyloid)t→∞.75
The interpretation of turbidity data is usually straightforward. Complications arise when
the monomer associating to form aggregates lack positional order, they rather form amorphous
aggregates.84,

85

The formation of amorphous aggregates presents major drawback on the

measurement of the kinetics of amyloid formation. Studies involving simulations of amyloid
association against amorphous aggregation have shown that even with the assumption of higher
thermodynamic stability on the side of amyloid formation, the presence of relatively small amounts
of amorphous aggregates can dramatically alter the turbidimetric kinetic profile.75
Alternatives to turbidimetric measurements are available that offers more specific kinetic
measurements that are less susceptible to competition with amorphous aggregate formation.
Among these kinetic measurements that are specific to the ordered amyloid formation are induced
fluorescence from thioflavin-T binding and spectral shift from Congo Red dye binding.86-90

2.3. Secondary Structure Analysis During Amyloid Formation
The measurement of amyloid aggregation kinetics using thioflavin-T is based on the
change on the secondary structure happening on the peptide during aggregation. The model of
amyloid aggregate detection is based on ThT binding to β-sheet rich structures which induces a
blue shift in the emission spectrum of ThT from 510 nm in its free form to 480 nm in the bound
form.91, 92 This binding is highly specific even in the presence of amorphous aggregates or partially
folded proteins. This inherent selectivity has led to ThT becoming the “gold standard” in amyloid
detection and analysis based on its secondary structure changes.93
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The earliest quantified use of ThT in amyloid studies was done by Naiki et al. in 1989
where they have demonstrated a linear relationship between amyloid fibril concentration and ThT
fluorescence emission intensity.91 In hIAPP kinetics measurements, ThT monitoring yields a
similar kinetic profile as that of turbidity kinetics in support of the nucleation growth
polymerization kinetics. Similarly, the ThT aggregation kinetic profile can be divided into three
regions: the lag, growth (or elongation) phase and a plateau indicating the end of further amyloid
formation.

Figure 2.4. Molecular structure of ThT (top) demonstrating the rotation of its two planar
segments which upon immobilization by amyloid fibrils yields to enhanced fluorescence
emission.
ThT exhibits strong interaction with mature amyloid fibrils. Models of ThT-amyloid
binding suggest ThT binds by intercalating to the repeating side-chain interactions running along
β-strands within the β-sheet layer.94, 95 Contributing to the intensity of ThT emission is the length
and rigidity of the fibrils that restricts the mobility of the ThT molecule. It is believed that the
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molecular structure of ThT allows it to act as a molecular rotor with a low energy barrier to rotation
between its benzylamine and benzathiol rings (Figure 2.3).96 The free rotation along the shared
carbon-carbon bond quenches excited states leading to lower fluorescence emission. Amyloid
biding locks and immobilizes ThT leading to enhancement of fluorescence emission.97
This model of ThT binding means that ThT does not necessarily identify amyloid fibrils
but rather molecular grooves that form when the amylin monomers form the signature β-sheet
structures found in amyloid fibrils. This means that ThT fluorescence can also be activated by
similar structures including that of DNA, certain micelles and cyclodextrin.98,

99

Particular

attention therefore must be put in designing a ThT experiment so as to avoid interference from
these similar biochemical structures. Also, corollary to the mechanism of ThT fluorescence
emission enhancement, ThT is unable to bind with early forms of amyloid aggregates such as
protofibers and oligomers.100-103 These species usually form during the lag phase of a ThT kinetics
profile. The protocol for a ThT experiment set forth by Porat et al. has been the standard procedure
used in the study of hIAPP aggregation.49 When incubated with potential inhibitors to aggregation,
this technique can be used to see the progress of β-sheet formation in the presence or absence of
aggregation inhibitors. A typical ThT experiment would comprise of 1:10 hIAPP to inhibitor
mixture in a buffer solution with ThT at 3 µM with fluorescence excitation set at the wavelength
of ThT absorption at 450 nm and emission wavelength set at 480 nm (Figure 2.4). The hIAPP lag
phase usually take around 5 hrs to reach t10 and an additional 2.5 hrs to reach t50. At 10 hrs, amyloid
formation starts to taper-off and begins to establish the asymptotic stage of the aggregation kinetics
as equilibrium is achieved between free and aggregated peptides.
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Figure 2.5. Schematic diagram of a ThT binding assay.

Complementary to the ThT fluorescence assay, circular dichroism (CD) spectroscopy can
also be used as evidence of amyloid fibril formation based on the changes in the secondary
structure involved in the process. CD spectroscopy has been particularly useful in the study of
protein and polypeptide secondary structures due to the fact that the far ultraviolet (UV) spectra of
these molecules are dominated by n → π* (220 nm) and π → π* (190 nm) transitions of amide I
group.104, 105 Amide I groups are susceptible to the influence of the molecular geometries of the
peptide backbone that reflect their secondary structures. The chirality of peptides is key to the use
CD spectra in analyzing secondary structures. Like any other chiral molecule, polypeptides
differentially absorb the two components of plane polarized light, one rotating counter-clockwise
(left-handed, L) and the other clockwise (right-handed, R). CD spectropolarimeters measures the
difference in the absorption of L and R circularly polarized component over the far UV spectrum.
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The difference (ΔA=AL – AR) is often reported in terms of ellipticity (θ) in degrees (θ = 32.98
ΔA).106, 107 The CD spectra is obtained by plotting θ versus the wavelength.
Algorithms have been developed to deconvolute the contribution of the different secondary
structures of polypeptides and proteins to the CD spectra. These algorithms are based on a library

Figure 2.6. Schematic diagram of a CD experiment showing a component of a plane
polarized light being absorbed by a peptide sample.
of reference spectra of proteins with known crystal structures and relies heavily on the assumption
that the contribution of each structural component of the protein are independent and at the same
time additive. Services are now available online that offers deconvolution of CD spectra based on
different algorithms, among them are DICHROWEB, Bestsel and K2D2.105,

108, 109

Software

developed for this purpose are also available, namely CDPro, DICROPROT and many more.110
These algorithms often provide the most accurate results for helical secondary structures
due to the fact that helices often have very regular and well-defined ϕ and ψ angles which results
to fairly consistent CD spectra with intense CD signals. A purely α-helical polypeptide/protein
would yield a spectrum with distinct minima at 208 and 222 nm. β-sheets, on the contrary, tend to
be more variable with parallel and anti-parallel orientations as well as different twists that vary the
ϕ and ψ angles of the amide bonds. Compared to helices, β-sheets have less intense CD signals. A
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protein with majority β-sheet secondary structure will exhibit a weaker but distinct minimum at
ca. 215 nm. Although distinct from α-helices, in most proteins that contain a mixture of β-sheets
and helices with considerable bias towards helices, estimates of β-sheets tends to have less
accuracy with CD signals of helices overwhelming that of β-sheets. Estimation of less common
secondary structures also has limited accuracy in most deconvolution algorithms. Estimation of
intrinsically disordered secondary structures (also known as random coils) is also limited due to
the wide range of ϕ and ψ angles that these structures can assume.105, 111
For amyloid forming peptides, the aggregation process often involves a decrease in the
initial ordered structures forming disordered structures followed by an increase in β-sheet rich
features. In the CD spectra these changes can be seen as a shift from the initial minima at 208 and
222 nm (indicative of α-helical content) to an eventual β-rich structure characterized by a minimum
between 222 and 218 nm. Parallel ThT assay and CD analysis will confirm the formation of βsheets which is characteristic of amyloid fibrils.49

2.4. Vibrational Spectroscopic Study of Peptide Aggregation

Figure 2.7. Jablonski diagram of the different spectroscopic techniques.
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Another useful method in the study of protein aggregation is the use of vibrational
spectroscopy. Fourier transform infrared spectroscopy (FT-IR), for instance, can provide useful
insights on the mechanism of amyloid formation that cannot be easily obtained from other
techniques.112 An IR spectrum is obtained from the absorption of energy by vibrating chemical
bonds primarily stretching and bending modes that change the inherent dipole moment of the
molecule. Complementary to FT-IR is Raman spectroscopy. Similar to IR, Raman is also based
on the vibration of covalent bonds, however, it follows a different set of selection rules which
allows weak bands in the IR spectrum to appear more intense in the Raman spectrum and vice
versa.113 IR is based on perturbations on the dipole moment upon vibration while Raman is based
on perturbations on the molecule’s polarizability. A strongly polarized bond undergoing a small
change in its length upon vibration will only have small change in polarization. This means that
polar bonds usually scatter Raman radiation weakly. Those polar bonds, however, carry their
charge during vibrational motion which results to a large change in the net dipole moment and
results in strong IR absorption bands.114 Aside from the selection rules, the energy required to
induce IR absorption and Raman scattering are also different. The energy diagram (Jablonski
diagram) in Figure 2.6. illustrates these differences. Raman spectroscopy will require a more
energetic light source to raise the energy level to a virtual state (usually a monochromatic beam or
laser in the visible or near-IR or near-UV range). In IR, vibrational/rotational transition requires a
light source in that scans the IR range to observe all the absorption lines within the IR region. The
resulting spectra in a Raman scattering experiment will mostly be comprised of elastic Rayleigh
scattered light (later filtered off) and two equally distanced Stokes and anti-Stokes scattering
bands.
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Figure 2.8. Atomic displacements involved in the amide I, II and III vibrational modes.
Vibrational spectroscopy, in terms of the study of amyloid proteins is mainly focused on
the amide backbone bands. There is a total of nine normal modes for the amide group of
polypeptides (amide A, B and amide I - VII). The most important vibrational modes for peptide
conformational study are amide I, II and III. Figure 2.7 shows these motions on a Nmethylacetamide model compound with their respective approximate frequencies. The frequencies
of amide I, II and III are affected by factors including the ψ and ϕ angles, hydrogen bonding and
other interactions. Based on the study of the geometry of the model compound N-acetyl-L-alanineN-methylamide, various ψ and ϕ angles corresponding from α-helical to β-sheet conformations
shift the amide I frequency from 1653 to 1664 cm-1. The high degree of order in these structures
resulted in narrow line-widths as narrow as 2 cm-1. Disordered structures resulted to greater linewidths due to the wider distribution of ψ and ϕ values. Amide III has been found to be most
sensitive to changes ψ and ϕ angles. There was an observed 11 cm-1 shift in frequency of amide III
in α-helices with a corresponding 10⁰ change in ψ and a 6 cm-1 change shift for a 10⁰ change in
either ψ and ϕ in β-sheet conformation.115 The sensitivity of these amide bands based on the peptide
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backbone dihedral angles demonstrates their usefulness in the study of polypeptide
conformation.116
Hydrogen bonding also affects the amide bands with an expected decrease in amide I
frequency and increase in amide II and III bands. These observations are based on the study of the
amide bands for phenylacetoamidoacetate which showed a 30 cm-1 redshift in its amide I band in
the presence of hydrogen bonding. Amide II exhibited an increase in frequency by 40 cm-1.117, 118
These observations support the potential of the amide bands as indication of hydrogen bonding in
polypeptides. 116
In practice, the amide I and III have reasonable intensities in the Raman spectra with visible
light excitation. Together with the amide I band in the IR spectra, these markers can be used to
assign secondary structures on proteins and polypeptides. By a combination of an extensive library
of homo-polypeptides with predominantly α-helical or β-sheet structures, theoretical calculations,
synthetic peptides and proteins with known crystal structures, it is possible to assign secondary
structures by identifying specific vibrational frequencies.113
Proteins known to adopt a predominant α-helical secondary structure exhibit strong amide
I bands between 1650 and 1655 cm-1. In contrast, proteins rich in β-sheets, with variable H-bonding
strengths due to the structure’s tendency to twist and flex, would normally have a band between
1612 and 1640 cm-1 with a weaker band at around 1685 cm-1. Adding to the complexity of
assigning conformational structures are the presence of turns and disordered structures with
frequencies overlapping that of helices.113
Amide II, which is largely based on N-H bending can be studied with deuteration.
Deuteration studies involves the replacement of some or all 1H in the molecule with 2H (or D).
For the case of an amide bond, a deuterated N-D would shift the amide II band to lower frequency
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(ca.1460 cm-1). In the infrared spectra, a deuterated N-D would have amide II bands at around
1540 – 1550 cm-1 and 1510 – 1525 cm-1. Anti-parallel β-sheets usually have peaks between 1510
and 1530 cm-1 while parallel β-sheets have slightly higher frequencies. Amide III is also affected
by deuteration in the same manner in terms of peak shifts as amide II. In the IR spectra, amide III
appears in the same range as C-H modes but bands are inherently weak in intensity, while in the
Raman spectra, the amide III has a slightly stronger intensity but also appears in a region of many
unrelated bands.
Certain considerations must be taken into account in the actual FT-IR and Raman
measurements especially in the sampling method used. In FT-IR, interference by water which
exhibits a strong and broad band at 1650 cm-1, makes measurements in aqueous environment
impossible. To circumvent this, removal of water via evaporation or the use of deuterated water
(D2O) can be done. Water is less of a problem in Raman measurements since it only gives a
relatively weak Raman band. However, Raman spectroscopy is more susceptible to fluorescence
interference and sample degradation by the excitation laser source. Fluorescence interference can
be reduced by employing Drop Coat Deposition Technique (DCDT) which can significantly
reduce fluorescence interference and improve weak Raman signals from dilute sample solutions.
DCDT has first been developed by Ben-Amotz and has since been demonstrated to be
useful in analyzing proteins.119 In a DCDT experiment, peptide samples are deposited on a
polished stainless-steel surface coated with a thin hydrophobic substrate. The solvent is evaporated
to form a well-defined ring of peptide deposit in a phenomenon called the “coffee ring” effect,
where excess solvent molecules are evaporated leaving a layer of solvent molecules to surround
the analyte. The resulting Raman spectra of peptide/protein samples prepared using DCDT is very
similar to the Raman spectra of samples in solution.120 This technique permits Raman
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measurements of dilute concentrations up to the millimolar scale since DCDT minimizes spectral
interference from water.120 This technique has been applied to on the study of proteins and was
shown to generate identical Raman spectra to that of conventional Raman spectroscopy in solution
even at different pH’s.121
Another means of dealing with fluorescence interference in Raman measurements is by
using a UV laser beam source for excitation with a wavelength that falls within the electronic
absorption of the molecule, also known as UV resonance Raman spectroscopy (UVRR).114 This
allows selective excitation of chromophores within the peptide. With an excitation at 244 nm,
vibrations coupled with π - π* transition are selectively enhanced which can give focus on those
vibrations. Using a deep-UV excitation wavelength thus allows selective study of smaller subunits
in large biological assemblies such as amyloid fibrils. Fluorescence interference is greatly reduced
since fluorescence is energetically far from the scattered radiation frequency.114 This made UVRR
an ideal technique in the study of DNA, protein and peptide conformations, as well as in the
identification and differentiation of bacteria, fungi and algae. Both UVRR and DCDT also
addresses the main drawback associated with Raman spectroscopy, having low sensitivity.122

2.5. Transmission Electron Microscopy
In the nano-scale, amyloid fibrils can also give some information about amyloid formation.
The preferred technique for visualizing these nano-structures is transmission electron microscopy
(TEM). TEM is often done using negative uranyl acetate staning, which offers simple sample
preparation with minimal effect to the morphology of amyloid fibrils.123, 124 TEM can reveal
information on the aggregation state of amyloid polypeptides and discern amorphous aggregates
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from mature polypeprtides which can be used to complement turbidity assays that does not
discriminate between the two forms.125, 126

2.6. Biophysical Techniques on the Study of hIAPP Mechanism and SelfAssembly Inhibition
These biophysical techniques were used extensively in this dissertation to probe possible
interactions involved in the aggregation of hIAPP. In this dissertation, we aim to exploit these
interactions into developing hIAPP aggregation inhibitors which can potentially be further
developed into effective therapeutics for type-II diabetes.
To this end, we set our first specific aim to synthesize peptide constructs based on hIAPP2229

to determine the effects of different factors to aggregation rates, secondary structure changes in

amylin, β-sheet orientation and amyloid fibril morphology. The hIAPP22-29 fragment is known to
be involved in the aggregation process with particular attention given to Phe-23 as the key residue
to its aggregation propensity.
Our second specific aim is to determine the effects of perturbing π-stacking interactions
involving Phe-23 on the aggregation of hIAPP. Evidence in support of π-stacking interactions
being involved in full-length and fragment hIAPP aggregates has been previously published.127
From this, we hypothesize the significant role played by π-stacking interactions in the aggregation
mechanism. It is therefore imperative to look at interactions that can perturb this stabilizing force
in search of potent aggregation inhibitors.
Lastly, we set our third specific aim to take advantage of π-stacking interactions and factors
that can perturb this interaction in the design of peptide-based inhibitors to hIAPP aggregation.
Our experimental design follows a general flow starting with solid-phase peptide synthesis
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of different peptide constructs based on the hIAPP22-29 fragment. Purified peptides are subjected
to kinetic turbidity assay followed by TEM imaging to ascertain their aggregation propensities and
fibril morphology. Raman and IR spectroscopy experiments are then done to further characterize
the peptide fibrils formed by these peptides. Inherently non-aggregating peptides become
candidates for amylin inhibition and were subjected to ThT and CD assays.
In the following chapter, we present the spectroscopic basis of the amyloid characterization
discussed in the succeeding chapters of this dissertation. Chapter 4 looks into the aromaticity and
π-electron distribution of Phe-23 and the consequences of introducing electron-donating (EDG)
and withdrawing groups (EWG) to the aggregation propensity of the peptide fragment hIAPP22-29.
Chapter 5 investigates the aggregation behavior of benzenecarboxylic acid peptide conjugates
based on hIAPP22-29. Lastly, Chapter 6 probes into the possibility of exploiting cation-π
interactions involving Phe-23 in the development of potential aggregation inhibitors.

29

3. Conformational Consequences and Structural Details of the SelfAssembly of hIAPP22-29
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3.1. Abstract
The octapeptide NFGAILSS (hIAPP22-29), derived from human islet amyloid polypeptide,
has been extensively used as a model system to study amyloid formation. However, despite being
the target of numerous investigations, information describing specific molecular interactions and
conformational details are still lacking in regard to aggregates formed by this peptide. We
synthesized peptide analogs of hIAPP22-29 and employed turbidity measurements in conjunction
with FTIR, Raman and fluorescence spectroscopy along with computer modeling to investigate
and probe the structure of aggregates formed by the NFGAILSS sequence. Our findings
unambiguously indicate that, at neutral pH, hIAPP22-29 self-assembles into a parallel β-sheet
secondary structure in which the aromatic ring of Phe-23 engages in π-stacking interactions.

30

Computational modeling confirms that of the possible ring stacking motifs (sandwich, parallel
displaced, parallel staggered and T-shaped geometries) only a parallel displaced stacking
arrangement can account for the observed vibrational modes in the Raman spectra. The amide I
vibrational mode ca. 1655 cm-1 in the Raman spectra of aggregates from hIAPP22-29 indicates the
presence of a parallel β-sheet secondary structure. Fluorescence data also support these
observations and point to the formation of excimers due to ring stacking. These observations are
compared and contrasted to results obtained with amidated hIAPP20-29 (SNNFGAILSS-NH2)
analogs that are only capable of forming amyloid composed of antiparallel β-sheets in which πstacking interactions involving Phe-23 cannot occur. Consistent with this, the presence of an
electron donating substituent on the aromatic ring of Phe-23 was found not to abolish the
amyloidogenic potential of hIAPP20-29 as it has previously been shown with hIAPP22-29. Raman
spectra of aggregates formed from hIAPP20-29 were distinctly different from those of hIAPP22-29 in
the amide and ring mode vibrational regions and provide evidence of an antiparallel β-sheet
structure. Finally, results from these investigations reveal that the hIAPP22-29 sequence is sensitive
to its chemical environment and can undergo “conformational switching” between parallel and
antiparallel β-sheets in response to changes in pH. The ramifications of the above findings are
discussed in the context of other amyloidogenic systems and full-length hIAPP.

3.2. Introduction
Abnormal protein aggregation and the formation of amyloid deposits are the hallmark of
several pathological neurodegenerative disorders such as Alzheimer’s, Parkinson’s, Huntington’s
and Cruetzfeldt-Jacob diseases.128, 129 Amyloid formation has also been found to play a significant
role in the development of adult onset diabetes or Type 2 diabetes (diabetes mellitus).130 Amyloid
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deposits derived from polypeptides such as Aβ, tau, α-synuclein, human islet amyloid polypeptide
(hIAPP) as well as prions all share a common structural arrangement known as the “cross-β
motif”.131 In this type of structure, repeating units of extended polypeptides, in the β-sheet
conformation, run perpendicular to the long axis of the amyloid fibril. The repeating polypeptide
units are characterized by a “steric zipper” interface between opposing β-sheets in which amino
acid side chains interdigitate to form a hydrophobic core. While amyloid deposits often serve as
markers of disease pathology, it is believed that the cytotoxic effect of amyloid fibrils is actually
due to soluble oligomers. These soluble oligomers have been linked to cell membrane disruption
resulting in cell death.132-134
The inhibition of abnormal protein aggregation may represent an effective strategy for
potential therapeutic intervention through the design and application of novel chemical entities.
However, success in such endeavors may be more readily facilitated by a thorough understanding
of the molecular interactions that occur during the fibrillization process. While many of the details
pertaining to amyloid assembly have yet to be clarified on a molecular level, it is apparent that
electrostatic, hydrophobic and other non-covalent interactions are pivotal to the process.
Many amyloidogenic peptides and proteins contain aromatic amino acids. However, the exact
role aromatic amino acids play in the formation of amyloid is currently under debate and requires
clarification.
Human islet amyloid polypeptide is a 37-residue hormone that is the major component of
amyloid deposits found in the pancreas of over 95% of type 2 diabetes patients. Soluble oligomers
of hIAPP are believed to be the toxic agents responsible for the loss of insulin producing β-cells.135,
136

Full-length hIAPP contains three aromatic residues: Phe-15, Phe-23 and Tyr-37. The peptide

fragment, hIAPP22-29 (NFGAILSS) has been used extensively as a model system to study amyloid
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formation. Alanine scanning and other mutational studies have implicated Phe-23 as playing a key
role in the self-assembly of hIAPP22-29.137 Furthermore, replacement of Phe-23 with Tyr results in
a peptide incapable of forming aggregates. It has been postulated that the failure of NYGAILSS
to self-assemble may be attributed to the altered electronic structure of the aromatic ring of Tyr, in
comparison to phenylalanine, due to the electron donating phenolic hydroxyl.138 Molecular
dynamics simulations seem to support this hypothesis and have shown that Tyr - Tyr π-stacking
interactions likely involve a T shaped geometry that may not be as conducive to fibril formation
as the parallel displaced stacking geometry associated with Phe.139
These observations strongly suggest that π-stacking interactions play a role in the selfassembly of hIAPP22-29. Gazit has postulated that π-stacking interactions provide the driving force
for amyloid formation as well as the directional organization of the self-assembly process with the
structural order of fibrils being dictated by geometrical constraints associated π-stacking
interactions.140
In contrast to the above observations, Raleigh and co-workers have demonstrated that
aromatic amino acids are not an absolute requirement for amyloid formation by hIAPP.
Replacement of Phe-15 and Phe-23 with Leu in the amyloidogenic sequences LANFLVH
(hIAPP12-18) and hIAPP22-29 resulted in peptides still capable of undergoing fibrillization.141, 142
Furthermore, replacement of all three aromatic residues in full-length hIAPP failed to inhibit
amyloid formation.143 This triple mutant variant of hIAPP readily formed amyloid albeit with
altered kinetics. Similar mutational studies employing hIAPP20-29 and human muscle
acylphosphatase also corroborate this observation.144, 145 Taken together, these findings suggest
that it is the planar geometry and hydrophobic nature of aromatic residues along with their
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enhanced β-sheet forming propensity that are the relevant characteristics associated with amyloid
formation.
While mutational studies that replace Phe-23 with non-aromatic amino acids of varying or
similar hydrophobicity can provide meaningful insights into the requirements of amyloid
formation, such studies may not adequately address the contribution of aromaticity to the
fibrillization process. This is especially true in light of the polymorphism exhibited by many
amyloidogenic sequences that can tolerate the substitution of an amino acid at a specific position.
Under these circumstances, amyloid formation may not be disrupted as the peptide or protein may
adopt an alternative packing mode that still facilitates fibrillization. These mutational studies often
provide an “all or nothing” analysis of the role of aromatic amino acids in the formation of
aggregates. The aromatic amino acid is either required or not. Indeed, such studies may actually
reveal more information regarding the amino acid replacing the aromatic residue and its
contribution to the formation or disruption of amyloid than to the role of the aromatic amino acid.
Our laboratory has taken a more direct approach to investigate the contribution of
aromaticity to amyloid formation by preparing and characterizing analogs of peptide fragments
derived from hIAPP22-29 that contain phenylalanine derivatives with electron donating or
withdrawing groups on the aromatic ring. By directly altering the electronic structure of the
aromatic ring and observing changes in the amyloidogenic propensity, spectroscopic properties
and ultrastructure of aggregates, a more fundamental correlation between aromaticity and amyloid
formation may be established. Recent findings from our laboratory demonstrate that the electronic
nature of the aromatic ring of Phe-23 can have a profound effect on the amyloidogenic propensity
of hIAPP22-29.146 Electron donating groups universally inhibit the formation of amyloid whereas
EWGs facilitate aggregation. These findings clearly demonstrate that π-stacking interactions
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participate in the self-assembly of hIAPP22-29 and that it is not only the hydrophobic nature and
planar geometry of Phe-23 that is relevant in the formation of amyloid.
Having previously demonstrated that π-stacking interactions are involved in the
aggregation of hIAPP22-29, we now provide a detailed structural description of these interactions
and unambiguously assign the conformation of hIAPP22-29 in amyloid fibrils. Raman spectroscopic
studies on analogs of hIAPP22-29 and hIAPP20-29 (SNNFGAILSS), along with computational
modeling, have been employed to ascertain the function of π-stacking in hIAPP22-29 fibrillization.
In this communication, we also discuss the ramifications of these findings to the self-assembly of
full-length hIAPP and other amyloidogenic systems.

3.3. Experimental and Theoretical Methods
3.3.1. Reagents
Fmoc-Ser(tBu)-Wang resin and Fmoc-(CH3-O)Tyr-OH were purchased from EMD
Chemicals, Inc (Gibbstown, NJ). All other peptide synthesis reagents and Fmoc-protected amino
acids were obtained from Advanced ChemTech (Louisville, KY). N,N-dimethylformamide
(DMF), dichloromethane (DCM) and acetonitrile were purchased from Pharmco-AAPER
(Brookfield, CT). All other reagents were from Sigma-Aldrich Co. (St. Louis, MO).
3.2.2. Peptide Synthesis
Peptides based on hIAPP22-29 were synthesized as previously described.146 Peptides based
on hIAPP20-29 were synthesized manually using Rink amide resin (substitution level 0.59 mmol/g)
via a standard Fmoc-solid phase synthesis protocol using N,N,N’,N’-Tetramethyl-O-(1 Hbenzotriazol-1-yl)uranium hexafluorophosphate (HBTU), 1-Hydroxy-benzotriazole (HOBT) as
activating agents. Peptides were cleaved from the resin using 95% trifluoroacetic acid, 2.5% water
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and 2.5% triisopropylsilane (TFA/H2O/TIS) for 2.5 h. After concentration in vacuo, crude peptides
were precipitated with ice cold diethylether, filtered and dried under vacuum. Crude peptides were
solubilized in acetonitrile/water 1:1 and passed through a 0.25 µM filter just prior to being
subjected to preparative reverse phase HPLC (Varian ProStar, Palo Alto, CA) on a Vydac C18
column (22 × 250 mm) using a linear gradient of CH3CN/H2O containing 0.1 % TFA. Purified
peptides were lyophilized and their structure confirmed by matrix-assisted laser desorption
ionization time of flight (MALDI-TOF) mass spectrometry (Waters Corporation, Milford, MA).
Peptide purity was assessed by analytical HPLC on a reversed phase Vydac C18 column (4.6 ×
250 mm).
3.3.3. Kinetic Aggregation Assay
Lyophilized peptides were dissolved in 100% 1,1,1,3,3,3-hexafluoroisopropanol (HFIP) to
prepare concentrated stock solutions. Known molar absorptivities of Phe or its derivative,
whenever available, were used to determine concentrations of representative samples. The
concentrations determined using this method varied by 10 – 20 % to that based on mass hence the
final relative concentrations of each of the samples were similar. Stock solutions were sonicated
immediately prior to use. Aliquots of the concentrated stocks were diluted into 10 mM Tris-HCl
pH 7.5 to a final peptide concentration of 1 mM for peptide aggregation studies. The final
concentration of HFIP ranged from 2 to 4%. To assay aggregation, turbidity was measured at 405
nm at room temperature as a function of time on a Jasco V-670 spectrophotometer (Easton, MD).
The fluorescence emission profiles of the aggregated and unaggregated forms of the
peptides were also measured. Measurement of the unaggregated peptides was done by first
separating the fibrils from the aggregated mixture through centrifugation at 10,000 rpm for 30 min.
The supernatant obtained after centrifugation contains the dissolved peptide. All steady state
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fluorescence scans were made using a FluoroMax-4 Spectrofluorimeter (Horiba Jobin Yvon Inc.,
Edison, NJ) with excitation wavelengths set at the respective absorption max and monochromator
slit-widths of 2.5 and 10 nm for the excitation and emission, respectively.
3.3.4. Fourier-Transform Infrared (FTIR) Spectroscopy
FTIR spectra were collected using a Nicolet 8700 equipped with liquid N2 cooled mercuric
cadmium telluride (MCT) detector (Thermo Scientific, West Palm Beach, Fl). Aggregates were
collected, layered on to a CaF2 cells, allowed to dry and its spectra measured from 1100-4000 cm1

. Each spectrum is an average of 256 scans with a resolution of 0.5 cm-1. The reproducibility in

the band position measurements was better than ± 1 cm-1 based on sample to sample variations
observed in this study. To eliminate spectral contributions due to atmospheric water vapor and
CO2, the spectrometer was purged with CO2 free dry air from a ParkerBalston 75-62 Air Dryer &
CO2 remover (Haverhill, MA). Second derivative spectra were performed to more accurately
identify peaks using central difference differentiation algorithm with no smoothing function on
IGOR Pro 5 (WaveMetrics, Inc., Portland, OR).
3.3.5. Raman Spectroscopy
All Raman spectra were obtained on a Jasco NRS-3100 confocal dispersive Raman
spectrometer equipped with a macro-Raman measurement accessory (Easton, MD). Raman
scattering was induced by a 12 mW 488 nm laser and collected on a thermoelectrically cooled
CCD detector. The macro-Raman assembly permitted direct measurements of solution in quartz
cuvettes. Reproducibility in the band position measurements was better than ± 1 cm -1 based on
sample to sample variations. For samples too dilute for direct solution Raman measurement we
employed a drop coating deposition technique (DCDT) developed by Ben-Amotz’s group.147-150
The method essentially uses as sample the hydrated residue deposited (not a precipitate) on a
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commercially available teflon coated stainless steel (RamChip, Z & S Tech LLC, Starkville, MS).
A 5 – 10 µL sample of a 1 mM solution is deposited on to the matrix, allowed to form the hydrated
residue at ambient conditions and its spectra taken at room temperature. Samples prepared using
DCDT yielded stronger Raman signals with minimized interfering solvent signals.
3.3.6. Computational Work
To help analyze the Raman and FTIR data, computational studies were performed to aid in
the peak assignments and model the interactions occurring in the vicinity of the ring as the
aggregate forms. The geometry of each model compound was optimized in the gas phase and in
water. Peptide structures were generated using the Chem3D sub-structure library and the frequency
calculated using Gaussian 09W software.151 We also modeled different structural motifs to mimic
interactions with the ring moiety. All calculations were carried out using density functional theory
(DFT) approximation implementing the Becke’s three-parameter exchange functional in
combination with the Lee, Yang, and Parr correlation function (or B3LYP).151-153 As a compromise
between accuracy and applicability to large molecules, the 6-31G(d) basis set was used.154, 155
Smaller basis sets are enough in DFT based calculations because the basic functions do not have
to describe correlating orbitals. GaussView05 was used to prepare the input file and analyze the
results of the calculations.156

3.4. Results and Discussion
We recently provided experimental evidence implicating the involvement of π-stacking in
the self-assembly of hIAPP22-29.146 Our findings demonstrated that EDGs on Phe-23 inhibit
amyloid formation whereas EWGs do not and that the environment of the aromatic ring becomes
increasingly more hydrophobic and ordered upon aggregation. We also showed that the failure of
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NYGAILSS to form aggregates cannot solely be due to the more hydrophilic nature of Tyr and it
is not attributable to an alternate T-stacking geometry. Finally, downshifts in the –C=C– ring mode
(ca. 1600 cm-1) of the EWG peptides provided conclusive evidence of π-stacking interactions.
Here we explore the structural details of π-stacking interactions in the self-assembly of
hIAPP22-29. Specifics of the π-stacking in the aggregation of hIAPP22-29 were assessed by preparing
a series of peptides in which Phe-23 was replaced with phenylalanine analogs (Fig. 3.1A). The Phe
analogs incorporated into peptides were O-methyltyrosine [(CH3-O)Tyr], and nitrophenylalanine
[(NO2)Phe]. These hIAPP22-29 peptides (1 – 3) are thought to form aggregates with parallel β-sheets
conformation.146 A corresponding set of hIAPP20-29 peptides (4 – 6) amidated at the C-terminal
(Fig. 3.1B) were made to model aggregates that are known to form anti-parallel β-sheet.145, 157 We
also studied an hIAPP22-29 mutant containing Leu at position 23 (7), its corresponding hIAPP20-29
mutant does not form aggregates.145
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Figure 3.1. Structure of peptides based on hIAPP22-29 and hIAPP20-29.
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3.4.1. Aggregation Characteristics
Turbidity measurements were used to assess the propensity of the peptides to form
aggregates. This technique is a well-established protocol that allows for the direct observation of
peptide aggregates without the use of external dyes which may fail to detect, the ability short
peptides to self-assemble.49, 137, 138, 158, 159 The data shown in Figure 3.2 reveal that all hIAPP22-29
and hIAPP20-29 peptides, except for hIAPP22-29 with (CH3-O)Tyr at position 23 (3), formed
aggregates. The native Phe-containing hIAPP22-29 peptide (1) as well as the one with (NO2)Phe at
position 23 (2) displayed the fastest aggregation kinetics with amyloid formed in less than one
minute. Peptide 3 did not yield aggregates even after days of incubation. The difference in the
behavior of peptides 1 and 2 to peptide 3 is in keeping with our previous assessment that EDGs on
Phe-23 in hIAPP22-29 inhibit amyloid formation whereas EWGs do not.146

Figure 3.2. Turbidity (optical density reading at 405 nm) plots for the hIAPP22-29 (1 – 3, 7)
peptides and hIAPP20-29 (4 – 6) peptides. Peptides were incubated in cuvettes containing 1
mM peptide in 10 mM Tris-HCl (pH 7.5) and 2 - 4% HFIP.
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The native Phe-containing hIAPP20-29 peptide (4) as well as those with (NO2)Phe and (CH3O)Tyr derivatives (5 and 6, respectively), were capable of forming aggregates but with varying
rates and lag times. Amyloid formation reached equilibrium in approximately 4 hours for 4 and 5
and 2 hours for 6. Of the hIAPP20-29 analogs, peptide 6 displayed the highest aggregation rate
followed by peptide 5. Interestingly, both 5 and 6 were significantly more amyloidogenic than the
native hIAPP20-29 sequence.
The observed differences in aggregation rate for 4 – 6 may be attributed to the hydrophobic
and/or steric profile of the functional group on the aryl ring of Phe-23. It has previously been
shown that peptides based on hIAPP20-29 are particularly sensitive to the hydrophobic nature of the
residue at position 23. Replacement of Phe-23 with Tyr in hIAPP20-29 results in a peptide incapable
of forming aggregates.145 The observation that SNNYGAILSS-NH2 does not form amyloid cannot
be attributed to repulsion between the electron rich aromatic rings as in the case of NYGAILSS or
peptide 3 since SNNYGAILSS-NH2 can only potentially assemble into an antiparallel β-sheet.
Tyrosine is less hydrophobic than phenylalanine (Tyr Π = 0.96 and Phe Π = 1.76). 160 Hence, it is
most likely that the more hydrophilic nature of the Tyr residue is responsible for the failure of this
peptide to aggregate. The importance of the hydrophobic nature of the residue at position 23 in
peptides derived from hIAPP20-29 is further supported by analytic HPLC retention times. Peptides
5 and 6 have virtually identical reverse phase HPLC retention times (22.96 and 23.10 min
respectively) to that of the native SNNFGAILSS-NH2 sequence 4 (22.96 min) and all of these
peptides are capable of self-assembly. It appears that a minimum hydrophobicity threshold needs
to be overcome for amyloid formation to take place. Interestingly, of the hIAPP 20-29 analogs
investigated, 6 displays the greatest amyloidogenic potential. This may be due to the slightly higher
hydrophobocity of (CH3-O)Tyr when compared to that of (NO2)Phe and Phe. It is also plausible
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that, the increased aggregation rates of 5 and 6 may be due to the aryl substituents participating in
favorable hydrogen bonding or dipole-dipole interaction that enhance and facilitate the selfassembly process.
The disparity between the aggregation rates of hIAPP22-29 peptides (1 and 2) to that of
hIAPP20-29 peptides (4 – 6) may be accounted for by structural differences in the aggregates.
Previous work from our laboratory has demonstrated that the aggregation of hIAPP 22-29 is
influenced by π-π interactions, which can only occur in a parallel β-sheet conformation.146 In
contrast, C-terminal amidated peptides based on hIAPP20-29 are only capable of forming
antiparallel β-sheets and lack the ability to engage in π-stacking interactions. Thus, it appears that
π-stacking interactions are responsible for the enhanced aggregation kinetics and significantly
shorter lag times of peptides 1 and 2. Aromatic-aromatic interactions are believed to exert their
effects initially during the lag phase when oligomers form to provide the template for nucleation
and fibril growth.140 Such interactions have been hypothesized to provide the directional
component of the self-assembly process.
The fact that the electronic nature of the functional group appended to the aromatic ring of
Phe-23 in peptides 4 – 6 does not have as dramatic effect on the aggregation is in keeping with the
fact that Phe-23 does participate in aromatic–aromatic interactions in hIAPP20-29. The electron
donating methoxy group of peptide 6 does not abolish amyloidogenic propensity as in the case of
3. In stark contrast, the methoxy group actually enhances the aggregation rate of 6.
It is also abundantly clear that the steric demands associated with position 23 in hIAPP 2229 and hIAPP20-29 are significantly different

as the peptide SNNLGAILSS also fails to form amyloid

despite the fact that Leu ( = 1.70)160 is just as hydrophobic as Phe. In contrast, 7 (NLGAILSS)
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is still capable of undergoing self-assembly albeit with much slower kinetics than all of the
aggregating peptides. Peptide 7 took approximately 5 hours to aggregate.
The above findings compelled us to investigate further the structural nature of amyloid
fibrils formed by the aggregating peptides in an effort to obtain a more detailed understating of the
self-assembly process and the role of π-stacking interactions. This was accomplished through the
use of several spectroscopic techniques including FTIR, Raman and Fluorescence spectroscopy.
3.4.2. Evidence for Ring Stacking.
Figure 3.3 (top panel) displays the steady state fluorescence spectra of phenylalanine as
well as peptides 1 and 4. The spectra of unaggregated 1 and 4 were measured from the supernatant
obtained after a solution containing the aggregates was centrifuged at 10,000 rpm for 30 min.
Centrifugation effectively removes insoluble fibrils and leaves solvated peptides in solution. All
phenylalanine containing samples exhibit a characteristic emission at 278 nm when excited at the
absorption max (260 nm). While the emission spectra of 4 were not affected by aggregation and
were in complete agreement with that of phenylalanine by itself, that for 1 revealed sensitivity to
fibrillization. The spectrum of aggregated 1 is broader and appears to have another peak at 302
nm, red shifted by 24 nm from the emission peak of phenylalanine. Peptide 3 did not aggregate
and exhibited a peak at 300 nm when excited at its absorption max (275 nm), the same emission
profile as free (CH3-O)Tyr (Fig. 3.3, bottom panel). A comparison of the fluorescence spectra of
the aggregated and unaggregated forms of 6 does not display any spectral red shift. It is clear from
the fluorescence steady state data that there is a difference in the environment around position 23
in the aggregated and non-aggregated forms of 1. Peptides 4 and 6, on the other hand, form
aggregates where the environment around position 23 does not significantly differ from that of the
corresponding unaggregated form. We performed a similar set of experiments for peptides 2 and
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5 but their fluorescence are inherently weaker161 and definitive conclusion regarding the effect of
the aggregation on the emission peak is impossible (data not shown).

Figure 3.3. Steady state emission spectra of phenylalanine (Panel A) and O-methyltyrosine
(Panel B) containing compounds taken with excitation wavelengths set at the respective
absorption max and monochromator slit-widths of 2.5 and 10 nm for the excitation and
emission, respectively. Samples were incubated in cuvettes containing 1 mM peptide in 10 mM
Tris-HCl (pH 7.5) and 2 - 4% HFIP.

44

The steady state fluorescence data indicates that the aromatic rings in 1 are in close
proximity to one another. Stacked aromatic rings exhibit unique spectral properties which are
dependent upon their relative proximity to neighboring aromatic groups. An excited phenylalanine
ring monomer capable of emissions bands at 278 nm (when excited at 260 nm), can interact with
a suitably positioned ground-state phenylalanine ring to form excited-state dimers/complexes or
excimers.162, 163 Excimers occupy a lower energy excited state than an excited monomer, and give
rise to a characteristic fluorescence emission upon returning to the ground state. Compared to
monomer fluorescence, excimer emission is red-shifted and often lacks the fine structure
commonly attributed to vibrational transitions. Thus, excimer emission goes against the mirrorimage rule of excitation and emission spectra,164 and as in the case of 1 may appear as band
broadening. The observed steady state fluorescence spectrum of 1 is consistent with the formation
of a parallel -sheet conformation where the aromatic rings are stacked close to one another.165
Furthermore, when two aromatic ring moieties giving rise to excimer fluorescence are further apart
or, worse yet separated by aliphatic chains, excimer fluorescence is decreased or lost entirely. In
peptides 4 and 6, where no band broadening was observed, an antiparallel β-sheet conformation is
plausible. Such a conformation places the aromatic rings further apart with an intervening aliphatic
hydrocarbon chain.165 It is recognized that a change in monomer fluorescence could also influence
excimer fluorescence. Moreover, while excimer emission arises only from stacked rings, not every
stacked configuration leads to excimer emission.
While the fluorescence data suggests a possible parallel β-sheet conformation for peptides
1 and 2, the overall secondary structure could not be definitively ascertained using this
methodology. Hence, an alternative technique was needed to evaluate peptide conformations. This
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was particularly true in the case of peptide 7, which lacks intrinsic fluorescence, as well as peptides
2 and 5 which fluoresce only weakly.

Figure 3.4. Raman spectra of hIAPP20-29 (broken line plots) and hIAPP22-29 (solid line plots)
peptides taken in the spectral region 1000-1700 cm-1. The spectrum of 1 is overlaid with that of
4 (Panel A) to display similar differences observed when spectra of 2 and 5 (Panel B) are
compared. Raman spectrum of 6 (Panel C) resembles that of 4 and 5, the set of hIAPP20-29
peptides. It also appears that the Raman spectrum of 7 (Panel D) is reflective of the set of
hIAPP22-29 peptides, 1 and 2. Evident are distinguishing characteristics between the hIAPP22-29
(1, 2 and 7) peptides and the longer amidated hIAPP20-29 (4 – 6) forms. Overlapping Raman
peaks were resolved by spectral curve fitting using Voigt functions (e. g. Fig. 3.5), a convolution
of Lorentian and Gaussian character, which best represent vibrational peaks of liquid samples.

To further unravel the structural details of π-stacking in aggregating peptides we employed
vibrational, both IR and Raman, spectroscopy. Figure 3.4 shows the Raman spectrum of peptides
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based on hIAAP22-29 peptides compared to their corresponding hIAPP20-29 counterparts and
highlights the major similarities and differences observed. The spectrum of 1 is overlaid with that
of 4 (Fig. 3.4, Panel A) to display similar differences observed when spectra of 2 and 5 (Fig. 3.4,
Panel B) are compared. Raman spectrum of 6 (Fig. 3.4, Panel C) resembles that of 4 and 5, the set
of hIAPP20-29 peptides. It also appears that the Raman spectrum of 7 (Fig. 3.4, Panel D) is reflective
of the set of hIAPP22-29 peptides, 1 and 2. Evident from Figure 3.4 are distinguishing characteristics
between the hIAPP22-29 (1, 2 and 7) peptides and the longer amidated hIAPP20-29 (4 – 6) forms.
Overlapping Raman peaks were resolved by spectral curve fitting using Voigt functions (e. g. Fig.
3.5), a convolution of Lorentian and Gaussian character, which best represent vibrational peaks of
liquid samples.166 The fitting function takes into consideration that the observed lineshape is the
sum of all molecules interacting with its environment each having characteristic absorption or
scattering. To validate and help assess the Raman data, the FTIR spectra of all the different
aggregates were measured. While peaks are not easily identifiable from the IR spectra (Fig. 3.6,
red dash lines), the corresponding double differential plot indicates them as minima (Fig. 3.6, blue
solid lines). When the IR spectra of the hIAPP22-29 and hIAPP20-29 peptides were compared, they
validated the structural differences implicated from the Raman measurements.
Computer simulation studies were executed using peptide structures generated from a
Chem3D (CambridgeSoft, Waltham, MA) sub-structure library. The simulated IR/Raman
frequencies of the generated peptide structures were then calculated using Gaussian 09W software
(Table 3.1). Identification of some important vibrational modes was facilitated by comparing the
spectra of 1 in H2O and in 2H2O as well as when dissolved in solutions of various pH. For contrast
we also measured the vibrational spectra of 4 in 2H2O. Rather than attempt to identify all modes
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we focused on a few structurally significant modes including those highlighted in Figures 3.4 –
3.6. A summary of these analyses is presented in Tables 3.2 and 3.3

Table 3.1. Some observed and calculated frequencies highlighting the differences between
hIAPP20-29 and hIAPP22-29 peptides.
Observed (cm-1)
Raman
IR
1037
1039
1042
1204
1214
1314
1390

Calculated (cm-1)*
Raman
IR
1066
1047
1053
1258
1269
1359
1444

1401

1441

1418

1488

1543

1644

1554

1648

1565
1605
1610
1619

1580
1688
1664
1670
1626

1674

1657
1690

1683
1685

1706
1706

1698
1738
3400

1762
1762
3520

Plausible Assignments#
ring –CH ib seen in 1 and 4
ring –CH ib seen in 6
ring –CH ib seen in 2 and 5
ring –CH ib seen in 1 and 2
ring –CH ib found in 1, 2, and 4 – 6
–NH– ib, –CαH– ib and –CH2– (Amide III)
found in 1 and 2
–CαH– ib and –C–Cα– st (Amide S) found in 1
and 2 as well as 4 – 6
–NH2 ob and –CH2– w found in 4 – 6
–NH– ib, –CαH– ib and –CH2– t (Amide III)
found in 4 – 6
–NH– ib, –CαH– ib and –CH2– (Amide II)
found in 1, 2, and 7
–NH– ib, –CαH– ib and –CH2– (Amide II)
found in 4 – 6
–CH2– sc found in 4 – 7
ring –C=C– st found in 2 and 5
ring –C=C– st found in 1 and 4
ring –C=C– st found in 6
–NH2 ib with –CN st (Amide I)
–NH2 ib with –CN st (Amide I)
–NH2 ib with –CN st (Amide I)
–NH2 ib with –CN st (Amide I)
C-terminal –C=O st with –OH ib for 1 and 2
C-terminal –C=O st with –OH ib for 1 and 2
terminal amide –NH2 ast for 4 – 6

*All calculations are based on DFT/B3LYP using 6-31g(d).
#

The following abbreviations applies: ib – in plane bending; ob – out of plane bending; tw –
twisting; r – rocking; sc – scissoring; st – stretch; ast – asymmetric stretch; w – wagging
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Table 3.2. Assignment, isotopic and pH dependencies of the observed modes for the native Phecontaining hIAPP22-29 (1).
Observed (cm-1)
Raman
IR
1037
1204
1214
1314

2

H substitution of
exchangeable H’s
unchanged

pH dependencies

Assignments#

none

ring –CH ib

unchanged

none

ring –CH ib

disappears with new
bands appearing at
975 and 1440 cm-1

none

–NH– ib, –CαH– ib and –CH2–
(Amide III)

1390
1408

shifted
shifts to 1402 cm-1

1453

unchanged

1543

disappears with new
bands appearing at
975 and 1440 cm-1

none
intensity increases
with decreasing pH
intensity increases
with increasing pH
none

1610

unchanged
shifted to 1623 cm-1
unchanged

–CαH– ib and –C–Cα– st (Amide S)
–COOH mode
–COO– mode
–NH– ib, –CαH– ib and –CH2–
(Amide II)

none
ring –C=C– st
1626
not measured
–NH2 ib with –CN st (Amide I)
1632
intensity increases
–COO– mode
with increasing pH
-1
1674
shifted to 1670 cm
none
–NH2 ib with –CN st (Amide I)
1698
shifted to 1690 cm-1
not measured
C-terminal –C=O st with –OH ib
-1
1738
shifted to 1720 cm
increases with
C-terminal –C=O st with –OH ib
decreasing pH
#
The following abbreviations applies: ib – in plane bending; ob – out of plane bending; tw – twisting; r –
rocking; sc – scissoring; st – stretch; ast – asymmetric stretch; w – wagging
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Table 3.3. Assignment and isotopic dependencies of the observed modes for the native Phecontaining hIAPP20-29 (4).
Observed (cm-1)
Raman
IR
1037
1204
1225
1390
1401
1418

1554

2

H substitution of
exchangeable H’s
unchanged
unchanged
disappears
shifted
unchanged

disappears with new
bands appearing at
975 and 1440 cm-1
disappears with new
bands appearing at
975 and 1440 cm-1

pH dependencies
none
none
disappears at very
high pH
none
none
none

none

Assignments#
ring –CH ib
ring –CH ib
–NH3+ r
–CαH– ib and –C–Cα– st (Amide S)
–CH2– mode
–NH– ib, –CαH– ib and –CH2–
(Amide III)
–NH– ib, –CαH– ib and –CH2–
(Amide II)

1565
1610

unchanged
none
–CH2– sc
unchanged
none
ring –C=C– st
-1
1626
shifted to 1623 cm
not measured
–NH2 ib with –CN st (Amide I)
-1
1674
shifted to 1670 cm
none
–NH2 ib with –CN st (Amide I)
1683
unchanged
not measured
–NH2 ib with –CN st (Amide I)
-1
1685
shifted to 1670 cm
none
–NH2 ib with –CN st (Amide I)
3400
shifted
not measured
terminal amide –NH2 ast
#
The following abbreviations applies: ib – in plane bending; ob – out of plane bending; tw – twisting; r –
rocking; sc – scissoring; st – stretch; ast – asymmetric stretch; w – wagging

There are several Raman marker bands that clearly distinguish the structure of the peptides
and reveal important conformational information. Ring stacking is evident from its effect on the
observed ring modes at ca. 1037, 1210 and 1610 cm-1, which are clearly absent in the spectrum of
7 (Fig. 3.4). The peaks at ca. 1037 cm-1 are ring –CH in-plane bending mode, with very little
motion coming from the –CH group para to the peptide backbone. The peak appears at ca. 1037
cm-1 for 1 and 4, at ca. 1039 for 6 and at ca. 1042 for 2 and 5. Another set of ring –CH in-plane
bending modes are observed in the region 1200 – 1210 cm-1 (Fig. 3.4). This mode is not sensitive
at all to para-substitution as vibrational motions mainly involve CH bonds at positions meta- or
ortho- to the peptide backbone. Peptides 1 and 2 appear to have two peaks in this region, at 1204
and 1214 cm-1, while peptides 4 – 6 displays a single peak at 1214 cm-1 (Fig. 3.4). This indicates,
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perhaps, that the nature of the environment around the aromatic groups at position 23 is different
in hIAPP22-29 than in hIAPP20-29 peptides. A ring –C=C– stretching mode, which is sensitive to
substitution at the para-position, occurs at ca. 1610 cm-1 in the Raman spectra (Figs. 3.4 and 3.5).
Peptides 1 and 4 exhibit a peak at 1610 cm-1, 2 and 5 at 1605 cm-1 and 6 at 1619 cm-1. It has
previously been noted that ring –C=C– stretching mode downshifts and narrows as aggregation
takes place.146 All ring modes are, as expected, insensitive to N-deuteration and pH changes
(Tables 3.2 and 3.3). Ring modes are not easily identifiable in the IR spectra for they are not only
weak, but also coincide with other more prominent modes.

A

B

C

D

E

F

Figure 3.5. Raman spectra of the hIAPP22-29 peptides, 1, 2 and 7 (Panels A, B and C,
respectively), and hIAPP20-29 peptides, 4, 5 and 6 (Panels D, E, and F, respectively), taken in
the spectral region 1560-1740 cm-1. Highlighted are the ring (ca. 1610 cm-1) and amide I (ca.
1675 and 1685 cm-1) modes. In red are Voigt curves obtained through a fitting-program
executed on IGOR Pro 5 (WaveMetrics, Inc., Portland, OR).
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Computer modeling studies confirmed assignment of each these modes to ring bands and
points to a parallel displaced ring conformation for the aromatic groups at position 23 of hIAPP2229.

Different ring stacking motifs ---sandwich, parallel displaced, parallel staggered, T-shaped, etc-

-- and ring-aliphatic chain interactions were modeled and their associated ring mode frequency
calculated (see Table S1). The characteristic single peaks at ca. 1037 and 1610 cm-1 as well as the
split modes, 1204 and 1214 cm-1, can only be replicated in parallel displaced ring stacking that
likely exist in the aggregated forms of 1 and 2. The modes at ca. 1210 cm-1 appear to be a coupling
of ring vibrational modes with the ring motion of one affecting the neighboring aromatic rings.
3.4.3. Peptide Conformations
Amide I, II and III modes as well as Cα-H bending bands (also referred to as amide S mode)
are sensitive to protein secondary structure and have been used to clarify the conformation of the
aggregated peptides.167-169 The amide I band consist of amide carbonyl –C=O stretching, with some
contributions from –C–N– stretching and –NH– bending. The amide II and III bands involve
significant –C–N– stretching, –NH– bending and –C–C– stretching. The Cα-H bending/amide S
band involves –Cα–H symmetric bending with a variable amount of –C–Cα– stretching. All of
these modes have been shown to be sensitive to N-deuteration, including the Cα-H bending/amide
S band.167, 168 While the Cα-H bending/amide S band does not have any direct contribution from
an –NH– mode, its existence depends sensitively to contribution from the –C–N–, –C=O, –C–C–
and –N–C– motions.167, 168
Consistent with published theoretical170-173 and experimental150,

167-169, 174, 175

data, the

amide III band for the aggregated peptides occur at ca. 1243 cm-1 in the Raman spectra. Clear
distinction between the hIAPP22-29 and hIAPP20-29 peptides can be observed in the amide III region.
While the Raman spectra of both types of peptide display amide III peak at ca.1243 cm-1, the

52

hIAPP20-29 peptides display an additional amide III mode at 1418 cm-1. An amide III band at 1401
cm-1 was also detected from the IR spectra of only the hIAPP20-29 peptides. These assignments
were confirmed when N-deuteration abolishes these peaks as well as the lack of pH dependencies
(Tables 2 and 3). The amide II bands, an N–H in-plane bending coupled to the C–N stretch mode,
appear in the Raman spectra at ca. 1543 cm-1 for hIAPP22-29 peptides and at ca. 1554 cm-1 in
hIAPP20-29 (Fig. 3.4). The assignment was again confirmed by peak shifts due to N-deuteration
and the lack of pH dependencies. N-deuteration abolishes the amide II and III modes as the
coupling between the C-N mode and the now N-D bending is non-existent leading to new peaks,
one at ca. 1440 cm-1, an isolated C-N stretch mode, and another at ca. 975 cm-1, an isolated N-D
bending mode. The amide S mode for both types of peptides is found at ca. 1390 cm-1. The amide
II, III and S bands point to a β-sheet conformation for both hIAPP22-29 and hIAPP20-29 peptides but
at the same time highlight some differences that may imply a variation in the nature of the β-sheets
formed. Krimm et al., using classical peptide normal mode analysis, computed substantial
wavenumber dispersion of amide II and III components in β-sheet conformations, with the spread
being more distinct in the anti-parallel arrangement than for the parallel β-sheet.170-172 Their normal
mode analysis also suggest that the conformational dependence of the amide band frequencies
results from the dependence of the amide bond force constants on the polypeptide geometry and
the differences in hydrogen bonding of the different secondary structure forms. These force
constant alterations change normal mode compositions, which result in amide band frequency
changes. Moreover, a –CH2 scissoring mode at ca. 1565 cm-1 is evident from the Raman spectra
of the hIAPP20-29 peptides but not for the set of hIAPP22-29. This is perhaps due to a perturbation
of the CH2 backbone being more distinct for the hIAPP20-29 peptides.
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Figure 3.6. Infrared (broken lines) and IR double derivative (solid lines) spectra of peptides 1 (A), 4
(B), 2 (C), 5 (D), 6 (E), and 7 (F). Highlighted are the –CH2– (ca. 1401 cm-1), amide II (ca. 1541 cm1
), and amide I (ca. 1626 and 1683 cm-1) modes. Also evident is the –COOH mode (ca. 1698 cm-1)
observed for the hIAPP22-29 peptides.

The amide I band, which occurs around the 1655 cm-1 region, leads to definitive assignment
of the hIAPP22-29 peptides to a parallel β-sheet structure and the hIAPP20-29 peptides to an
antiparallel β-sheet conformation. Theoretical170-173 and experimental150,

167-169, 174, 175

data

correlates the presence of peaks at ca. 1674 and 1685 cm-1 in the Raman as well as the ca. 1629
and 1685 cm-1 in the IR spectra to an antiparallel β-sheet conformation. Structure with parallel βsheet conformation only yields a 1674 cm-1 peak in the Raman and a 1629 cm-1 band in the IR.
Evident from the Raman spectra of the peptides (Fig. 3.5) that while the hIAPP22-29 peptides yield
a plot that fit nicely into a single Voigt curve centered at ca. 1674 cm-1, that for hIAPP20-29 peptides
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yielded two Voigt fitting apexes, ca. 1674 and 1685 cm-1. Moreover, the double derivative plots
of the IR spectra for hIAPP20-29 peptides (Fig. 3.6) presented two minima, 1629 and 1683 cm-1, in
the amide I region while that for the hAIPP22-29 peptides are missing the 1683 cm-1 band. The set
of Raman and IR spectra unequivocally leads to an assignment of a parallel β-sheet conformation
for the hIAPP22-29 peptides and an antiparallel structure for the set of hIAPP20-29 peptides.
The presence of a ring moiety at position 23 may at first appear to be irrelevant in
determining the secondary structure of peptides 1 and 2 as peptide 7 adopts a similar parallel βsheet conformation. These observations imply that, in the self-assembly of hIAPP22-29, π-stacking
interactions may not be responsible for providing the directional component of the aggregation
process as originally postulated by Gazit.140 However, the lag time and fibril growth rates for
peptide 7 are both considerably longer than those for 1 and 2. These observations provide critical
evidence that π-stacking interactions function to facilitate the nucleation and growth of amyloid
fibrils. Indeed, it may just be the polymorphic nature of the hIAPP22-29 sequence that allows
NLGAILSS to also form a parallel β-sheet. The steric demands in this system associated with
position 23 may be flexible enough to accommodate either an aromatic ring or the iso-butyl group
of Leu. The side chains of Phe and Leu are not only similar in hydrophobicity but they occupy
almost the same molecular volume (98.83 and 96.22 Å3 respectively).145 Both of these moieties
may satisfy the requirement for stabilizing the hydrophobic core. However, the presence of the
aromatic ring may serve to further enhance peptide-peptide interactions through π-stacking which
does appear to hasten the aggregation of 1 and 2 when compared to 4, 5, 6 and 7. These π-stacking
interactions may also serve to increase the thermodynamic stability of amyloid fibrils derived from
hIAPP22-29.
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These observations are consistent with more recent and extensive investigations that have
characterized all possible single, double and triple aromatic to leucine mutants of full-length
hIAPP.176 All mutants were found to be capable of self-assembling with varying rates and lag
times. Furthermore, all mutants self-assembled more slowly than the wild-type protein with the
exception of a Phe-15 to Leu mutant that displayed more rapid amyloid formation. This approach
has allowed investigators to dissect the contribution of each aromatic residue to the kinetics of
hIAPP self-assembly and confirms that while aromatics are not required for amyloid formation,
they do contribute to the kinetics of fibrillization.
3.4.4. Protonation State of the C- and N-terminals
Modes associated with the amino and carboxyl-terminals are a significant part of the
Raman/IR spectra and leads to the identification of the overall protonation state of the peptide as
the amino acids in the sequences do not have acidic or basic residues. The hIAPP 20-29 peptides,
besides being longer by two amino acid residues than the hIAPP22-29 peptides, have an amidated
C-terminal. The additional free amide NH2 group appears as a peak in the 3400 cm-1 region
reported in the IR spectra of hIAPP20-29 peptides only. N-deuteration and protonation shifts this
mode. Because of the amidation the –COOH and –COO– modes do not appear in the Raman or the
IR spectra of the hIAPP20-29 peptides. A strong Raman band at ca. 1620 cm-1 detected more
pronouncedly in the hIAPP20-29 peptides is assigned to an –NH3+ rock mode that disappears on Ndeuteration and on deprotonation of the group to –NH2.
The hIAPP22-29 peptides are expected to exist in their zwitterionic form in solution at
neutral pH. However, spectroscopic evidence indicates that, in the aggregates, this is not the case.
While no –COO– mode was detected in either the Raman or IR spectra of the solid aggregates, a
peak for the –COOH mode is clearly visible at 1408 and 1730 cm-1 from the Raman spectrum and
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at 1698 cm-1 in the FTIR measurement. Moreover, no evidence for a protonated amino-terminal
exists as no –NH3+ rock mode was detected. Assignment of the carboxy- and amino-terminal peaks
was confirmed from the sensitivity of the associated peaks to pH variations. Figure 3.7 depicts the
Raman and IR spectra of 1 incubated in solutions of different pH. The lower pH the more
prominent are the –COOH peaks identified above and less distinct are the –COO– mode at ca.
1458 and 1630 cm-1 (Table 2, Fig. 3.7). Concomitantly, the Raman intensity of the –NH3+ rock
mode at 1620 cm-1 is more evident at lower pH.
3.4.5. Conformational Sensitivity to pH

Figure 3.7. pH dependence of the Raman spectra of peptide 1. Distinct are the appearance of a
second Amide I peak (ca. 1685 cm-1) at pH 8.6 and the –COOH peak (ca. 1735 cm-1) at pH 4.0.

It is also clear from Figure 3.7 that the amide I mode appears as single peak at pH 5.9 or
lower implicating that the aggregates have parallel β-sheet structure. At higher pH, say 8.5, the
secondary structure appears to shift to antiparallel β-sheet as indicated by the appearance of a peak
at 1685 cm-1 (see above for the significance of the amide I mode). At lower pH, say 3.3, the parallel
β-sheet structure is favored indicating that a protonated amine group is not enough to shift the
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structure. As the pH goes up the carboxyl group deprotonates thus increasing the negative charge
at the C-terminal. Because of the repulsion between the negative moieties the molecule tends to
take an antiparallel conformation so as to have the negative charges separated. Also in this
conformation, the C- and N-terminals of adjacent strand can form stabilizing ionic interactions
(salt bridges). It should, however, be noted that at high pH some amount of parallel β-sheet
conformation may exist but the peak (ca. 1674 cm-1) attributed to this coincides with that of the
antiparallel configuration.
The above data clearly indicates that the pH of the environment affects the conformation
of hIAPP22-29 in amyloid fibrils, and through the course of this study we observed three
conformational packing modes. At neutral/physiological pH, hIAPP22-29 in amyloid fibrils adopts
a parallel β-sheet conformation with neutral N- and C-terminals. In this conformation π-stacking
occurs and likely contributes to fibril stability. At higher pH values, aggregates of the hIAPP 22-29
sequence adopt an antiparallel β-sheet conformation composed of extended peptide chains are in
their zwitterionic form with charged N- and C-terminals. Aromatic-aromatic interactions in this
conformation are not permitted. This indicates that the charge stabilization that occurs through ion
pairing between the N- and C-terminals of adjacent peptide strands in the antiparallel conformation
out-weighs the contribution of π-stacking associated with a parallel conformation and therefore
must be more energetically favorable.
In contrast, below neutral pH, hIAPP22-29 in fibrils assumes a parallel β-sheet conformation
with a neutral C-terminal and a positively charged N-terminal. This conformation is perhaps the
most interesting and revealing in that it indicates that there is not enough charge repulsion between
adjacent protonated amino terminals to counteract the thermodynamically stabilizing effects that
π-stacking imparts onto this conformation. This is especially intriguing when compared to the C-
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terminally amidated hIAPP20-29 peptide that is only capable of forming antiparallel β-sheets
(presumably due to charge repulsion between adjacent N-terminals). Caution should be taken when
making and interpreting such observations however, as peptide sequences differing in length by as
little as a single amino acid may exhibit significantly different morphologies.158 Hence other
factors may be at play with the longer hIAPP20-29 sequence.
In any case, the revelation of these three conformational packing modes provides valuable
insight as to the relative energies and influence that ionic and π-stacking interactions exert on
hIAPP22-29 self-assembly process.

3.5. Conclusions
Previously our laboratory demonstrated that π-stacking interactions influence the selfassembly of hIAPP22-29. In this communication we have: i) provided a detailed structural
description of these π-stacking interactions, ii) provided spectroscopic and structural evidence that
unambiguously demonstrates that hIAPP20-29 exists in an antiparallel β-sheet conformation in
amyloid fibrils formed at neutral pH, iii) that the conformation of hIAPP22-29 in fibrils is sensitive
to the protonation state of the N- and C-terminus, iv) that π-stacking interactions serve to enhance
peptide – peptide interactions and likely provide the directional and organization component of the
self-assembly process, and v) that the electronic nature of the aromatic ring of Phe-23 in peptides
based on SNNFGAILSS-NH2 has no effect on self-assembly.
The results presented in this study indicate that amyloid formation by hIAPP 22-29 involves
a delicate balance of intermolecular forces that include aromatic – aromatic interactions. A
chemical environment that alters one or more of these interactions may disrupt amyloid formation
completely or the system may be able to adapt and change its conformation/packing mode to retain
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the ability to form fibrils. How robust a particular sequence is to these changes likely will
determine its polymorphic capability. The pH data presented here is an excellent example and
demonstrates conformational switching by the hIAPP22-29 sequence. These findings illustrate how
changes in the environment are compensated for in a polymorphic amyloidogenic system. At
neutral pH, aromatic interactions are favorable and enhance peptide self-assembly. However, at
different pH values, ionic interactions become more dominant and counteract π-stacking
interactions making them virtually irrelevant.
The kinetics of amyloid formation by full-length hIAPP has been shown to be sensitive to
small changes in pH. This is mainly due to the protonation state of His-18 and the amino
terminus.177 The conformational effects observed in this study may be specific to the hIAPP 22-29
and may not apply to other larger amyloidogenic sequences. Indeed short peptides may not always
be representative of their larger counterparts. The 20-29 region of hIAPP has been shown to be
particularly important in controlling the amyloidogenic propensity of the native protein. Structural
models indicate that hIAPP fibrils are composed of U-shaped monomers that assemble into parallel
β-sheets. Strikingly, residues 20-29 are not part of a β-sheet but form a partially ordered loop that
connects the two β-stands of each U-shaped monomer.178-180 In stark contrast, peptides derived
from this region competently form β-sheet rich amyloid structures. These findings imply that the
observed behavior and structure of short peptide sequences may not necessarily correlate with the
structural role they play in the native protein. However, exploitation of the knowledge gained from
studying short amyloidogenic sequences may ultimately lead to the identification and development
of novel compounds and peptide scaffolds capable of modulating or inhibiting amyloid formation.
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4. Aromaticity and Amyloid Formation: Effect of π-Electron
Distribution and Aryl Substituent Geometry on the Self-Assembly of
Peptides Derived from hIAPP22-29

Profit, A. A., Vedad, J., Saleh, M., and Desamero, R. Z. (2015) Aromaticity and amyloid formation:
Effect of π-electron distribution and aryl substituent geometry on the self-assembly of peptides derived
from hIAPP 22–29, Archives of biochemistry and biophysics 567, 46-58.

4.1. Abstract

A comprehensive investigation of peptides derived from the 22-29 region of human islet
amyloid polypeptide (hIAPP) that contain phenylalanine analogs at position 23 with a variety of
electron donating and withdrawing groups, along with heteroaromatic surrogates, has been
employed to interrogate how π-electron distribution effects amyloid formation. Kinetic
aggregation studies using turbidity measurements indicate that electron rich aromatic ring systems
consistently abolish the amyloidogenic propensity of hIAPP22-29. Electron poor systems modulate
the rate of aggregation. Raman and Fourier transform infrared spectroscopy confirm the parallel
β-sheet secondary structure of aggregates derived from peptides containing electron poor
phenylalanine analogs and provide direct evidence of ring stacking. Transmission electron
microscopy confirms the presence of amyloid fibrils. The effect of aryl substituent geometry on
peptide self-assembly reveals that the electronic nature of substituents and not their steric profile
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is responsible for failure of the electron donating group peptides to aggregate. Non-aggregating
hIAPP22-29 peptides were found to inhibit the self-assembly of full-length hIAPP1-37. The most
potent inhibitory peptides contain phenylalanine with the p-amino and p-formamido
functionalities. These novel peptides may serve as leads for the development of future aggregation
inhibitors. A potential mechanism for inhibition of amylin self-assembly by electron rich hIAPP2229

peptides is proposed.

4.2. Introduction
Aberrant protein aggregation and the formation of amyloid deposits is the cornerstone of
as many as twenty pathological neurodegenerative disorders in humans including Alzheimer’s,
Parkinson’s, Huntington’s, and Cruetzfeld-Jacob diseases.128, 129, 181 Amyloid deposits also play a
role in Adult Onset Diabetes also known as Type II diabetes or diabetes mellitus.130, 136, 182 Despite
originating from different proteins, these insoluble amyloid deposits all display a common
molecular architecture, known as the cross β-motif, in which extended polypeptide chains
assemble into parallel or antiparallel β-sheets that run perpendicular to the long axis of the amyloid
fibrils.131
Human islet amyloid polypeptide (hIAPP or amylin) is a 37 residue hormone that is cosecreted with insulin.183-185 The polypeptide has been shown to be involved in the regulation of
metabolic acitivities such as glucose homeostasis and appetite suppression.186-188 Amyloid deposits
composed of hIAPP have been found in the pancreas of over 95% of Type II diabetes patients
upon post mortem examination.185, 189 These insoluble amyloid deposits were initially thought to
be responsible for β-cell death and subsequent loss of insulin production. However, more recent
investigations have demonstrated that β-cell loss can be attributed to soluble hIAPP oligomers and
not insoluble fibers.132, 133 It has been hypothesized that the cytotoxic effects of hIAPP oligomers
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are due to disruption of the cell membrane either by the formation of ion channels or through
nonspecific rupturing of the lipid bilayer.

In addition, it has been observed that anionic

phospholipids enhance the aggregation rate of hIAPP.190-192
Studies using fragments of hIAPP have identified the N-terminal region encompassing
residues 1-19 as being responsible for the interation of hIAPP with membranes containing
negatively charged phospholipids.193 This observation is consistent with the fact that all three
positively charged residues in the polypeptide reside in the 1-19 region. His-18 appears to be
particularly important for the interaction of hIAPP with membranes. NMR studies have revealed
that rat IAPP1-19 (rIAPP1-19), which lacks His-18, orients itself differently on membrane surfaces
than hIAPP1-19.191 The hIAPP1-19 fragment is equally potent as the full-length polypeptide in its
ability to disrupt model membranes but does not form amyloid fibrils.193
The kinetics of membrane disruption by hIAPP is biphasic indicating a two step process.194,
195

In the first phase, channels are formed producing membrane leakage. The second phase is

characterized by amyloid fibril growth on the membrane which produces additional membrane
damage and leakage. Rat IAPP, which is incapable of forming amyliod, does not display this
biphasic kinetic profile but is still capable of inducing membrane damage.195
Although in vitro studies employing model membranes seem to indicate that the cytotoxic
effects of hIAPP may be due to plasma membrane disruption, this may not necessarily be the case
in vivo. Cao et al. have demonstrated that there is no direct correlation between hIAPP cytotoxicity
and the ability to disrupt model membranes.195 For example, 60
membrane damage similar to 10

M rIAPP is capable of inflicting

M hIAPP but is not cytotoxic. Furthermore, other hIAPP point

mutants along with N-methylated derivatives and pramlintide were all able to cause membrane
damage whitout being cytotoxic. Finally, studies conducted with model membranes often do not
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accuratly replicate the plasma membrane phospholipid composition of β-cells. Clearly more work
needs to be done to clarify the exact mechanism of hIAPP cytotoxicity and it is likely that in vivo
multiple mechansisms may be at work including oxidative stress, ER stress, exposure to proinflammatory cytokines as well as membrane leakage and loss of ion homeostasis.182, 196
While insoluble hIAPP exists in the cross-β motif, soluble hIAPP is largely disordered with
a small amount of helical content.197, 198 In contrast, the structure of full-length hIAPP in detergent
micelles, has shown the polypeptide to adopt what has been described as a kinked helix motif with
residues 7-17 and 21-28 existing in an α-helical conformation and residues 33-35 in a 310 helix.191
The 20-29 region of hIAPP is often referred to as the “amylodogenic core” although other
amylodogenic fragments have been described. This hIAPP20-29 fragment is highly amyloidogenic
but is significantly less cytotoxic and displays a drastically reduced affinity for phospholipids when
compared to full-legth hIAPP.158,

199

Thus it appears that the fibril forming and membrane

disrupting capabilities of hIAPP lie in two distinct regions of the polypeptide.193 Peptides derived
from hIAPP20-29 have been used extensively as models for studying hIAPP fibrillization.
Many polypeptides involved in amyloid formation contain aromatic amino acids. For
example, A, βis pivotal in Alzheimer’s disease, contains the minimum amyloidogenic sequence
KLVFF.200-202 hIAPP contains two phenylalanines along with a single tyrosine residue. Phe-15
and Phe-23 appear to be involved in the amyloidogenic process. However, the exact role that these
amino acids play in the formation of amyloid is not well understood and is under debate.
Two schools of thought have emerged on the function aromatic residues play in the
amyloidogenic process. One suggests that aromatic amino acids contribute to peptide selfassembly through π-stacking interactions.140, 203, 204 Such interactions may serve to do one or more
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of the following: enhance the kinetics of fibril formation, increase the thermodynamic stability of
fibrils and/or provide the directional component to fibril growth and elongation.
Alternatively, it has been postulated that it is not the aromatic nature of these residues that
contributes to the formation of amyloid but it is their hydrophobic nature, high β-sheet propensity
along with their planar geometry that are the most relevant factors in self-assembly. Raleigh and
co-workers have demonstrated that aromatic amino acids are not an absolute requirement for
amyloid formation by both full-length and peptide fragments derived from hIAPP. Replacement
of Phe-15 and 23 in the peptide fragments hIAPP12-19 (LANVFLVH) and hIAPP22-29 (NFGAILSS)
respectively with leucine resulted in peptides still capable of forming amyloid. 141, 142 Likewise,
substitution of all three aromatic amino acids in full-length hIAPP with Leu did not inhibit the
polypeptide from forming aggregates.143 Leu and Phe are known to have similar molecular volume,
hydrophobicity and β-sheet forming propensity.205
Further investigations involving all possible single, double and triple aromatic to Leu
mutants of full-length hIAPP revealed that such substitutions altered the kinetics of fibril
formation.176 In all cases, except one, mutants self-assembled more slowly than the native
polypeptide. In the case of Phe-15 to Leu mutation, amyloid formation was actually enhanced.
It is important to note that aromatic amino acids also appear not to be a strict requirement
for membrane disruption. The hIAPP Leu triple mutant mentioned above demonstrated the ability
to induce membrane leakage as effectively as the native polypeptide.195 However, since fibril
growth is known to contribute to membrane leakage, the fact that aromatic amino acids affect selfassembly kinetics does imply an indirect role for these residues in the ability of hIAPP to impart
membrane damage.
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Until recently, direct evidence that the electronic nature of the aromatic π-system is a
relevant factor in the amyloidogenic process has been lacking. Much of this evidence, although
well-reasoned, has been speculative and has come from the observation that many compounds
capable of inhibiting amyloid formation are aromatic in nature, many of which are derivatives of
or contain polyphenols.206-209 Gazit et al. reported that replacement of Phe with Tyr in the hIAPP2229 lead

to a peptide with drastically reduced amyloidogenic propensity.49, 138 Gazit and co-workers

speculated that the lack of amyloid formation by NYGAILSS could be attributed to the electron
donating phenolic hydroxyl which would alter the electronic nature of the π-system.
In an effort to directly interrogate the role that aromaticity plays in the formation of
amyloid, our laboratory has adopted the strategy of altering the electronic nature of the π-system
of Phe-23 in hIAPP22-29 through the use of electron donating or withdrawing substituents. By
altering the electronic nature of the aromatic ring and observing changes in the kinetic and
spectroscopic properties of peptides along with the ultrastructure of aggregates, a more direct
correlation between amyloid formation and aromaticity can be established.
We recently demonstrated that electron donating group (EDG) substituents on Phe-23 can
eliminate the amyloidogenic propensity of hIAPP22-29. In contrast, electron withdrawing groups
(EWGs) do not have as drastic effect.146 Furthermore, our findings indicate that peptides
containing EDGs fail to form any type of π-stacking interactions. These results rule out the
possibility that a T-shaped geometry is responsible for the lack of amyloid formation by
NYGAILSS, as was previously proposed.49, 138 On the basis of these observations, we concluded,
while π-stacking interactions are not an absolute requirement, they do play a role in the selfassembly of hIAPP22-29 peptides.
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Although these studies provide compelling evidence of π-stacking, we could not rule out
the possibility that the geometry and steric profile of the functional group on the aromatic ring may
perturb the kinetics of peptide self-assembly. Therefore, we have expanded our investigations in
order to deconvolute the role that electronics and functional group geometry play in the selfassembly of peptides derived from hIAPP22-29. Toward this end we have: i) prepared peptides
containing EDGs and EWGs with similar geometries and ii) prepared peptide analogs which
contain heteroaromatic rings of varying electron density to probe the role of π-electron distribution
without the use of bulky external substituents on the aromatic ring. We now report the results of
these investigations and closely examine how these peptides interact with full-length hIAPP.

4.3. Materials and Methods
Fmoc-Ser(t-Bu)-Wang

resin,

Fmoc-(CH3-O)Tyr-OH,

and

Fmoc-2-Thi-OH

were

purchased from EMD Chemicals, Inc (Gibbstown, NJ). Fmoc-(C≡N)Phe-OH was purchased from
Bachem Americas, Inc (Torrance, CA). All other peptide synthesis reagents and Fmoc-protected
amino acids were obtained from Advanced ChemTech (Louisville, KY). N,N-dimethylformamide
(DMF), dichloromethane (DCM) and acetonitrile were purchased from Pharmco-AAPER
(Brookfield, CT). All other reagents were from Sigma-Aldrich Co. (St. Louis, MO).
4.3.1. Synthesis of Fmoc-(4-formyl-NH)Phe-OH
The preparation Fmoc-(4-formyl-NH)Phe-OH is illustrated in Figure 4.1. Fmoc-(4BocNH)Phe -OH (0.801 g, 1.59 mmol) was dissolved in 10 mL trifluoroacetic acid (TFA) and
stirred at room temperature for 50 min. The TFA was evaporated under reduced pressure to yield
brown foam. The residue was dissolved in 10 mL dry tetrahydrofuran (THF) and N,Ndiisopropylethylamine (1.10 mL, 0.822 g, 6.36 mmol) added followed by 2,2,2-
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trifluoroethylformate (170

L 0.224 g 1.75 mmol) and formylation allowed to proceed for 48 h

with stirring at room temperature. Then, the solvent was removed and the crude product purified
by chromatography on SiO2 gel using CHCl3/MeOH/AcOH (90:8:2) as eluant. Appropriate
fractions were pooled and evaporated. Residual AcOH was removed by the addition and
evaporation of hexanes (3×) to afford the desired product as an orange/yellow solid.
4.3.2. Peptide Synthesis
O
O
Fmoc-HN

1. TFA
OH

O
Fmoc-HN

2. DIEA
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O
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OH
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Figure 4.1. Synthesis of Fmoc-(4-formamido)phenylalanine.
Peptides based on hIAPP22-29 were synthesized as previously described.146 Peptides based
on hIAPP20-29 were synthesized manually using Rink amide resin (substitution level 0.59 mmol/g)
via a standard Fmoc-solid phase synthesis protocol using N,N,N’,N’-Tetramethyl-O-(1 Hbenzotriazol-1-yl)uranium hexafluorophosphate (HBTU), 1-Hydroxy-benzotriazole (HOBT) as
activating agents. Peptides were cleaved from the resin using 95 % trifluoroacetic acid, 2.5 %
water and 2.5 % triisopropylsilane (TFA/H2O/TIS) for 2.5 h. After concentration in vacuo, crude
peptides were precipitated with ice cold diethyl ether, filtered and dried under vacuum. Crude
peptides were solubilized in acetonitrile/water 1:1 and passed through a 0.25 µm filter just prior to
being subjected to preparative reverse phase HPLC (Varian ProStar, Palo Alto, CA) on a Vydac
C18 column (22 × 250 mm) using a linear gradient of CH3CN/H2O containing 0.1 % TFA. Purified
peptides were lyophilized and their structure confirmed by matrix-assisted laser desorption
ionization time of flight (MALDI-TOF) mass spectrometry (Waters Corporation, Milford, MA).
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Peptide purity was assessed by analytical HPLC on a reversed phase Vydac C18 column (4.6 ×
250 mm).
4.3.3. Characterization of Peptides and Aggregates
4.3.3.1. Kinetic Aggregation Assays. The amyloidogenic propensity of peptides was
determined through the use of turbidity measurements. Turbidity measurement is a wellestablished protocol used to monitor the self-assembly of amyloid.49, 138, 158, 204, 210 Lyophilized
peptides were dissolved in 100% 1,1,1,3,3,3-hexafluoroisopropanol (HFIP) to prepare
concentrated stock solutions. Known molar absorptivities of Phe or its derivative, whenever
available, were used to determine concentrations of representative samples. The concentrations
determined using this method varied by 10 – 20 % to that based on mass hence the final relative
concentrations of each of the samples were similar. Stock solutions were sonicated immediately
prior to use. Aliquots of the concentrated stocks were diluted into 10 mM Tris-HCl buffer (pH 7.5)
to a final peptide concentration of 1 mM. The final concentration of HFIP ranged from 2 to 4%.
Turbidity of samples was monitored at 405 nm at room temperature as a function of time on a
Jasco V-570 spectrophotometer (Easton, MD). The data obtained were analyzed and compared to
the appropriate control sequence.
4.3.3.2. Raman Spectroscopy. Raman spectroscopy was employed to investigate the nature
of the aromatic ring interactions during aggregation as well as to provide evidence of -sheet
formation. Raman spectra of the aggregated peptides were measured using a Jasco NRS-3100
Raman Spectrometer (Easton, MD) with 12 mW 488 nm laser stimulation and a peak
reproducibility of  0.5 cm-1. In order to minimize fluorescence interference and maximize Raman
peak intensities, samples were prepared using drop coat deposition technique (DCDT) employing
RamChip (Z & S Tech, LLC, Starkville, MS) slides.150 Samples (5 – 10 μL) were deposited onto
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Teflon coated stainless steel surface and allowed to set for 30 minutes or until excess moisture had
evaporated leaving a more concentrated sample coated with a thin film of solvent or “drop coats”.
Raman spectra of the “drop coats” were obtained at room temperature with slit size of 0.2 × 6 mm
using a 100× objective lens. Exposure times and number scans varied from sample to sample.
4.3.3.3. Transmission Electron Microscopy (TEM). To ascertain the effects of the various
phenylalanine derivatives on amyloid structure, aliquots of aged peptide solutions were visualized.
Samples were prepared as follows, 5 μL of a solution containing aggregates from either turbidity
or ThT assays were deposited onto 300 mesh copper grids with Formvar carbon film (Electron
Microscopy Sciences, Hatfield, PA). Solutions were allowed to set for two minutes before blotting
excess liquid. Grids were then negatively stained with 5 μL of 2 % aqueous solution of uranyl
acetate. Excess staining solution was blotted out immediately to avoid over staining. TEM images
were taken using ZEISS Libra 120 Plus 120kV Electron Microscope (Carl Zeiss Microscopy, LLC,
Thornwood, NY) equipped with an Olympus Megaview G2 CCD camera with resolution of 1376
 1032 pixels with pixel size of 6.45  6.45 μm2 for viewing samples at low magnification. Images
at 12500 magnification were taken using the bottom mounted Cantega G2 Soft Imaging Solutions
CCD TEM camera with resolution up to 2048  2048 pixels.
4.3.4. Assessing the Influence of hIAPP22-29 Peptides on the Self-Assembly of full-length
Amylin (hIAPP1-37)
4.3.4.1. Thioflavin T (ThT) Fluorescence Assay. To assess the influence of peptides,
which did not aggregate on their own, on the self-assembly of amylin we performed ThT
fluorescence assays.49,

211

For the ThT assay, lyophilized peptides were dissolved in 100 %

1,1,1,3,3,3-HFIP to prepare concentrated stock solutions. Stock solutions were sonicated
immediately prior to use. Aliquots of the concentrated stocks were diluted into 10 mM Tris-HCl
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buffer (pH 7.5) containing ThT to a final peptide and ThT concentration of 40 and 3 µM,
respectively. To this mixture amylin (Bachem, Torrance, CA) was added to a final concentration
of 4 µM. The solutions were mixed slowly by inverting the cuvette. The ThT chromophore was
excited at 450 nm and the emission monitored at 482 nm as a function of time on a FluoroMax-4
Spectrofluorimeter (Horiba Jobin Yvon Inc., Edison, NJ). Monochromator slits were set to 2.5 and
10 nm, respectively, for excitation and emission. Fluorescence was monitored every 30 minutes
for at least 20 hours at 25oC.
4.3.4.2. Circular Dichroism (CD) Spectroscopy. To quickly assess changes in the
secondary structure of amylin in the presence of hIAPP22-29 peptides, the CD spectra of amylinpeptide mixtures were obtained as a function of time. A similar protocol was followed as that for
the ThT assay except no ThT was added to the mixture. Solutions were mixed by cuvette inversion
and the CD spectra measured using a Jasco J-810 spectropolarimeter (Easton, MD) every 30
minutes for 24 hours. All CD spectra were baseline corrected by subtracting the spectrum of the
solution containing buffer and peptide.
4.3.4.3. TEM. To validate fibril formation and ascertain morphology changes, TEM was
used to visualize the amyloid structure in the various amylin-peptide mixtures. A similar protocol
was used as stated above.

4.4. Results and Discussion
4.4.1. Peptide Design and Synthesis.
To date, the majority of efforts aimed at determining the role of aromatic amino acids in
the formation of amyloid have focused on replacing these residues with non-aromatic amino acids
of similar or varying hydrophobicity and observing the effects on amyloid formation. While this
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approach can provide meaningful insight into the requirements of amyloid formation, such studies
may not adequately address the contribution of aromaticity to the fibrillization process. This is
especially true in light of the polymorphism exhibited by many amyloidogenic sequences that can
tolerate the substitution of an amino acid at a specific position. Under these circumstances, amyloid
formation may not be disrupted as the peptide or protein may adopt an alternative packing mode
that still facilitates fibrillization. Such studies often provide an “all or nothing” analysis of the role
of aromatic amino acids in the formation of aggregates. The aromatic amino acid is either required
or not. Even if the aromatic amino acid is not a strict requirement, this does not mean that its
aromatic character does not contribute to amyloid formation in some manner. Indeed, mutational
studies such as these may actually reveal more information regarding the amino acid replacing the
aromatic residue and its contribution to the formation or disruption of amyloid than to the role of
the aromatic amino acid. Determining the contribution of aromaticity to amyloid formation is not
only important for a more complete understanding of the amyloidogenic process but may also be
useful for the rational design of potential amyloid inhibitors.
To more effectively probe the role aromaticity plays in the self-assembly of hIAPP22-29, a
library of peptides was constructed containing phenylalanine derivatives in which the electron
distribution of the aromatic ring was altered (Figure 4.1). This was accomplished by incorporating
phenylalanine derivatives with EDGs or EWGs at the para position of Phe-23. The phenylalanine
analogs employed containing EDGs were tyrosine, O-methyltyrosine, [(CH3-O)Tyr], 4aminophenylalanine [(NH2)Phe] and 4-formamido phenylalanine [(HCONH)Phe]. The relative
strengths of these electron donating groups are -NH2 > -OH > -OCH3 > -NHCOH.
The phenylalanine derivatives containing EWGs incorporated into peptides were
pentafluorophenylalanine [(F5)Phe], 4-carboxyphenylalanine [(COOH)Phe], 4-nitrophenyl-
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alanine [(NO2)Phe], 4-cyanophenylalanine [(C≡N)Phe] and 4-fluorophenylalanine. [(F)Phe].
While (F5)Phe contains a highly deactivated and electron poor aromatic ring, the enhanced
hydrophobicity and β-sheet forming propensity of this residue may complicate the ability to
ascertain the role electronic factors play in the self-assembly process. Therefore, we relied on the
remaining EWGs to more accurately examine how aromaticity affects aggregation. The relative
strengths of the EWGs are NO2 > C≡N > F > COOH.
The 4-nitro, formamido and carboxyl phenylalanine derivatives employed in this study
specifically provide the ability to investigate the role of functional group geometry in the selfassembly process. All of these functional groups possess a planar geometry yet their electron
donating and withdrawing abilities vary. Through the use of these variants, we hoped to accurately
dissect how electronic factors influence self-assembly under the circumstances of a fixed
functional group geometry.
We also investigated the effect of EDGs and EWGs on peptides derived from the hIAPP2029

sequence (SNNFGAILSS-NH2). C-terminal amidated hIAPP20-29 has been shown to assemble

exclusively into antiparallel β-sheets. This antiparallel conformation precludes π-stacking
interactions as it places phenylalanine residues at opposing ends of adjacent peptide strands.212
Peptides containing phenylalanine surrogates with heteroaromatic rings were also
employed in this study. The Phe surrogates incorporated into peptides were 4-pyridyl
phenylalanine (4-Pal) 2-thienylphenylalanine (2-Thi), and histidine (Figure 4.2). The use of
heteroaromatic surrogates enables the ability to examine the role of π-electron density without the
use of external substituents that may introduce nonproductive steric interactions. Aromatic
heterocycles are typically classified as electron rich or electron poor. This definition focuses on
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the electron density, or the electron to nuclei ratio of the aromatic system, and as to whether the
heteroatom donates or withdraws electrons to or from the ring carbons.
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Figure 4.2. Structure of hIAPP22-29 and hIAPP20-29 peptide analogs.
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The pyridine ring in 4-Pal is an electron poor aromatic system compared to that of
phenylalanine. This is due to the presence of the electronegative nitrogen atom which inductively
withdraws electron density from the π-system. The thiophene ring of 2-Thi is an electron rich
system in which six π-electrons (two donated by sulfur) are delocalized over five nuclei. In
contrast, Phe has six π-electrons delocalized over six nuclei. 2-Thi has been used previously as a
surrogate for Phe and has been shown to participate in π-stacking interactions and impart unique
electron transfer properties to peptide-based nanomaterials.213, 214 The imidazole π-system of His
is also classified as electron rich and is isoelectronic to that of thiophene but is more polarized due
to the additional nitrogen atom.
The synthesis of all hIAPP22-29 peptides was conducted on Wang resin while those derived
from the hIAPP20-29 sequence were prepared on Rink amide resin using standard Fmoc chemistry.
The incorporation of the Fmoc-(4-HCONH)Phe-OH derivative into peptide 10 was accomplished
using standard activating agents and proceeded smoothly without incident. Reverse phase HPLC
chromatographic analysis of 10 revealed two closely eluting peaks. Both peaks were subjected to
MALDI-TOF mass spectrometry and found to contain molecular ions of 851.25 ([M + H]+) in
agreement with the calculated mass. Due to the ability of the formamide moiety to exist as both
cis and trans stereoisomers,215-217 the two peaks observed by HPLC are likely diastereomeric
peptides.
4.4.2. Effect of EDGs and EWGs on Amyloidogenic Potential of hIAPP22-29.
Turbidity measurements were used to determine the amyloidogenic propensity of hIAPP2229 analogs

and were compared to that of the native phenylalanine sequence (1). Turbidity is a well-

established protocol employed for assessing the self-assembly kinetics of the NFGAILSS
sequence. The protocol does not involve the use of external dyes such as ThT which may fail to

75

bind amyloid produced by short peptide sequences. Figures 4.2 – 4.4 illustrates the results of
turbidity measurements. The amyloidogenic propensities of some of these peptides have
previously been characterized but are included for comparison purposes.146 From the turbidity data
it is abundantly clear that peptides 2, 3, 4, 5 and 10 which contain EDGs are universally incapable
of forming amyloid (Figure 4.3). The Phe analogs incorporated into the majority of these peptides
all possess extended π-systems in which the lone pair of electrons on the oxygen or nitrogen atoms
of the aryl substituents can be delocalized to the aromatic ring. In the case of peptide 5, electron
donation to the aryl system can occur through hyperconjugation. These EDG peptides were found
not to form aggregates even after an extended incubation period of up to seven days.

Figure 4.3. Turbidity at 405 nm of hIAPP22-29 peptides containing electron donating and
withdrawing groups. Peptides 1, 6, 7 and 9 showed very fast aggregation rates occurring at the
first few minutes of introducing the peptides into a 10 mM Tris-buffer solution at room
temperature with a final peptide concentration of 1 mM. Peptides 8 and 11 aggregated slower
showing increased turbidity after about 120 hours of incubation. Peptides 2, 3, 4, 5 and 10 did
not show any significant turbidity after prolonged incubation indicating complete abolishment
of aggregation propensities of the modified peptide constructs.
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Figure 4.4. Measured time dependent turbidity of hIAPP22-29 peptides containing
heteroaromatic phenylalanine surrogates at 405 nm from a solution of peptides at 1 mM final
peptide concentration in 10 mM Tris-buffer (pH 7.21) at room temperature. Peptide 14
showed an immediate increase in absorbance at 405 nm after the first few minutes of
introduction to Tris-Buffer solution indicating the formation of aggregates. Peptide 12 showed
a slower rate of aggregation with significant increase in turbidity monitored after 336 hours of
incubation. Comparison of the low and high concentration mixtures of peptide 12 in Trisbuffer indicates a direct relationship between concentration of peptides and rate of
aggregation. Peptide 13 did not show any signs of aggregation after the incubation period.

In contrast, peptides containing EWGs were all completely capable of forming aggregates,
albeit at differing rates (Figure 4.3). The EWG peptides with the greatest amyloidogenic potential
are 7 and 9. Both of these forms amyloid extremely rapidly. In the case of 7 this is as expected due
to the high β-sheet propensity and increased hydrophobicity of the (F5) Phe residue. The kinetic
profile of 7 reaches a maximum and then drops off sharply. This is due to the formation of large
aggregates that quickly precipitate out of solution. This behavior is in contrast to that of the other
EWG aggregating peptides (1, 6, 8, 9, 11) in which there is a gradual decrease in turbidity as
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aggregates slowly settle out of solution. Since peptide 7 and 9 form amyloid rapidly, it is difficult
to determine which peptide displays faster kinetics. However, based on previous hydrogelation
studies using fluorinated phenylalanine derivatives, it is expected the (F5)Phe containing peptide
should aggregate more rapidly.218

Figure 4.5. Turbidity of peptides based on hIAPP20-29 measured at 405 nm. Peptides were
diluted to a final concentration of 1 mM in 10 mM Tris-buffer (pH 7.21) at room temperature.
All peptide constructs based on hIAPP20-29 (peptides 15, 16, and 17) showed significant
increase in absorbance at 405 nm. Peptide 17 showed fastest aggregation rate. Unmodified
hIAPP20-29 (peptide 15) showed only a small increase in turbidity since the aggregates formed
were observed to be clear and gelatinous in appearance, different from the other peptides that
formed solid white aggregates.

Peptides 6, 7 and 9 are significantly more amyloidogenic than the native NFGAILSS
sequence (1) while peptide 8 displays a dramatically extended lag-phase. The aggregation of 8 was
found to be complete after five days. The (COOH)Phe peptide (11) was also found to aggregate
quite slowly. TEM has previously shown that peptides 1, 6, 8, and 9 form amyloid fibrils whereas
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7 was found to form helical tapes.146 TEM imaging of aggregates produced by peptide 11 reveal
fibril morphology similar to that of the other aggregating peptides (Figure 4.6). It should also be
noted that peptide 9 formed flaky aggregates which may be due amorphous β-sheets assemblies
that may form prior to fibril formation.219-221

Table 4.1. Summary of selected Raman modes for aggregated peptides from the kinetic turbidity
assay taken from samples prepared using drop coat deposition technique and run using a 488nm
laser. Parallel β-sheets were observed for peptides 1, 6, 7, 8, 9, 11, 12, and 14 with characteristic
split modes for the –CH in plane bending appearing at ca. 1204 and 1214 cm-1 and single peak for
the amide I mode at ca. 1676 cm-1. Anti-parallel β-sheets were formed by peptides 15, 16, and 17
having two peaks for the amide I mode.
Raman modes
Peptide

1
6
7
8
9
11
12
14
15
16
17

Ring -CH in
plane bending
mode 1 (cm-1)
1036

Ring -CH in
plane bending
mode 2 (cm-1)

Ring -C=Cstretching (cm-1)

Amide I mode
(cm-1)

1037
1032
1039
1034
1034
1033
1037
1040

1204, 1211
1119, 1214
1197, 1217
1200, 1216
1200, 1212
1189, 1216
1190, 1219
1196, 1214
1213
1213

1611
1607
1616
1618
1608
1617
1609
1611
1065

1676
1676
1676
1675
1676
1676
1676
1676
1674, 1685
1675, 1688

1039

1215

1618

1674, 1685

Raman spectroscopy was employed to examine the conformational properties of
aggregates derived from peptides 1, 6, 7, 8, 9 and 11 (Table 3.1). The amide I vibrational mode
ca. 1674 cm-1 in the Raman spectra of these aggregates indicates the presence of a parallel β-sheet
secondary structure. Parallel ring stacking is evident from its effect on the observed ring modes
exhibiting single peaks at ca. 1037 and 1610 cm-1 and split modes at ca. 1204 and 1214 cm-1 (Table
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3.1). This is consistent with a structural model in which hIAPP22-29 self-assembles into a parallel
β-sheet secondary structure in which π-stacking interactions occur between Phe residues on
adjacent strands.222 The parallel arrangement of 1 and the EWG peptides observed by vibrational
spectroscopy is consistent with the reported crystal structure of hIAPP21-27 (NNFGAIL) which
displays a parallel β-sheet structure.179
Based on this structural model, we postulate that failure of the EDG containing peptides to
self-assemble may be attributed to repulsion between electron rich aromatic rings in accordance
with the Hunter-Sanders rules of aromatic-aromatic interactions.223, 224 The behavior of the EWG
containing peptides is consistent with this and is likely due to attraction between electron deficient
aromatic rings.
4.4.3. Probing Electronic and Steric Effects.
The electron donating and withdrawing groups employed in this study alter the steric
profile of phenylalanine. In addition, these functional groups display a broad range of shapes
including linear, tetrahedral, planar and bent geometries. These factors may influence selfassembly by impeding the ability of peptides to form aggregates as adverse steric interactions
between functional groups may hamper efficient ring stacking. While the turbidity data obtained
with EDG containing peptides derived from hIAPP22-29 strongly suggests that electronic factors are
responsible for their lack of amyloid formation, we cannot completely rule out that steric
constraints associated with the geometry of aryl substituents may also contribute to the inability
of these peptides to aggregate. Data, involving hIAPP22-29 peptides with EWGs, also implies that
steric demands associated with the functional groups on the aromatic ring may be responsible for
the different aggregation rates. Therefore, it is essential to deconvolute electronic effects from
steric effects.
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Figure 4.6. TEM images of aggregated peptides after the turbidity measurements. Samples
were deposited on Formvar coated TEM grids, negatively stained by 2 % aqueous uranyl
acetate. Images were taken after 14 days of incubation. Images showed fibrils on all
aggregated samples except for peptide 9 where aggregates appeared to be of flaky
morphology. Presence of these aggregates conforms to the results of the kinetic turbidity
assay. The solid bar represents 500 nm.
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Peptide analogs containing phenylalanine derivatives with the formamide (10), nitro (6)
and carboxyl (11) groups at the para- position of Phe-23 are especially useful for deciphering how
the steric and electronic properties of aryl substituents affect aggregation. These functional groups
all have similar planar geometry, yet the nitro and carboxyl groups are electron withdrawing
whereas the formamide group is electron donating. The fact that these groups are planar in
geometry should make ring stacking in a parallel displaced arrangement more conducive as
opposed to other functional group geometries. Thus, by constraining the geometry of the functional
group, it is possible to more accurately assess how electronic factors contribute to the selfassembly process.
In the case of peptides 6, 10 and 11, only the peptide containing the planar electron donating
formamide group (10) is incapable of forming aggregates (Figure 4.6). This is consistent with
turbidity data obtained with the other EDG containing peptides. Peptides, 6 and 11 which contain
the planar electron withdrawing nitro and carboxyl groups respectively are still capable of
undergoing self-assembly. These observations further indicate that it is indeed the electronic
character of the aromatic ring and not substituent geometry that is relevant to the self-assembly
process.
The formation of amyloid by peptide 11 is particularly interesting when one considers the
ionization of the benzoic acid moiety. At neutral pH the carboxyl functionality should exist
primarily as the carboxylate. One might expect that charge repulsion between ring stacked, ionized
carboxyl groups on adjacent parallel β-strands would prevent fibril formation but this is clearly
not the case. However, the slower aggregation kinetics of 11 compared to that of the (NO2)Phe
containing compound 6 may be due to this charge repulsion. Whether or not this is actually the
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case, it is clear that charge repulsion between adjacent carboxylates is not destabilizing enough to
abolish amyloid formation.
4.4.4. Effect of Heteroaromatic Substitutions on hIAPP22-29 Self-Assembly.
Turbidity data for those peptides containing heteroaromatic phenylalanine surrogates are
presented in Figure 4.4. From the data it can be seen that peptide 14 with the 2-Thienyl moiety
forms amyloid rapidly. This is not surprising as 2-Thi has been substituted for Phe in peptides
derived from Aβ and has been shown to participate in π-stacking interactions.213, 214 In contrast,
the NHGAILSS peptide (13) fails to form aggregates even after extended incubation times.
Interestingly, the 4-Pal containing peptide (12) aggregates quite slowly with extended lag times at
both 1 and 2 mM concentrations. The amyloidogenic propensity of this peptide is similar to that
of 8 which contains the electron withdrawing cyano group. Both the aromatic rings in (C≡N)Phe
and 4-Pal are strongly polarized and electron deficient. Overall, the behavior of 12 and 13 appears
to corroborate the data obtained with the EDG and EWG peptides.
Raman spectroscopic data again confirms the presence of a parallel β-sheet secondary
structure in amyloid derived from peptides 12 and 14 (Table 3.1).
4.4.5. Effect of EDGs and EWGs on Amyloidogenic Potential of hIAPP20-29.
To further illustrate that the electronic nature of Phe-23 is important for the self-assembly
of hIAPP22-29, we prepared peptides based on C-terminal amidated hIAPP20-29. Amyloid derived
from C-terminal amidated hIAPP20-29 has been shown by solid state NMR to exist exclusively in
an antiparallel β-sheet conformation which does not permit π-stacking interactions between Phe
residues on adjacent β-strands.212 We postulated that under these circumstances the electronic
nature of the aromatic ring of Phe-23 should not have a drastic effect on the ability of the hIAPP2029 sequence

to form aggregates. Turbidity data in Figure 4.4 confirms this to be the case. Peptides
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16 and 17 contain nitro and methoxy groups respectively. Significantly both peptides readily form
aggregates (Figure 4.6). The electron donating methoxy group does not inhibit amyloid formation
as it does in the case of the hIAPP22-29 derivative 3. In fact, peptide 16 displays an even greater
amyloidogenic potential than its NO2 containing counterpart. These findings are the exact opposite
of what was observed with the corresponding hIAPP22-29 analogs (3 & 6). We speculate that the
enhanced amyloidogenic propensity of 17 may be due to favorable hydrogen bonding or dipoledipole interactions involving the methoxy group. It is possible that differences in the
hydrophobicity of the phenylalanine derivative at position 23 may influence self-assembly but this
is unlikely as both 16 and 17 have identical analytical HPLC retention times. Unmodified hIAPP2029

(peptide 15) showed only a small increase in turbidity since the aggregates formed were

observed to be clear and gelatinous in appearance (Figure 4.5), different from the other peptides
that formed solid white aggregates. TEM confirms the presence of amyloid fibers produced by 15
(Figure 4.6).
Raman data confirms that peptides 15 – 17 all self-assemble into an anti-parallel β-sheet
as evidenced by the two Raman peaks in the amide I region, 1674 and 1689 cm-1 (Figure 4.7) and
the presence of only a single peak for the ring –CH in plane bending at ca. 1204 cm-1 (Table 3.1).
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Figure 4.7. Representative Raman spectra of parallel (peptide 1) and anti-parallel β-sheet
forming (peptide 15) peptides showing distinguishing features such as the split peaks for the –
CH in-plane bending mode of the aromatic ring at around 1204 and 1211 cm-1 and single
peaks for the amide I mode at around 1675 cm-1 which are exhibited by parallel β-sheets.
Raman spectra were taken from samples prepared by drop coat deposition technique using a
488 nm laser. Peak positions were determined by curve fitting using Voigt peaks fitted
through IGOR Pro 6 (WaveMetrics, Inc. Portland, OR).

4.4.6. Effect of hIAPP22-29 peptides on Amylin aggregation.
Having screened the amyloidogenic properties of the various peptides synthesized, we
contemplated that non-aggregating sequences may have potential as modulators or inhibitors of
amylin self-assembly. For example, Porat et al. demonstrated that the non-aggregating peptide
NYGAILSS reduced the amyloidogenic propensity of hIAPP1-37.49 Likewise, Nilsson et al. showed
that SNNWGAILSS inhibited amyloid formation by full-length amylin.225 On the basis of this, we
investigated the effects of peptides 2, 3, 4, 10 and 13 on the self-assembly kinetics of hIAPP1-37.
This was accomplished using the standard ThT fluorescence assay employing 4
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M of hIAPP1-37

and 40

M peptide. The ThT data are presented in Figure 4.8 and reveals that all non-aggregating

peptides modulate the self-assembly of full-length amylin. The data obtained with NYGAILSS (2)
is consistent with results previously reported by Porat et al. Peptide 2 reduces the total amount of
amyloid formed by approximately 25 % while slightly increasing lag time.49 A slightly slower rate
of fibril growth is also observed in the presence of 2 (Table 3.2). The methoxy derivative 3 slows
the self-assembly rate of full-length hIAPP even more than 2 although the lag time is similar to
that of amylin alone.

Figure 4.8. ThT fluorescence assay monitoring the effects of non-aggregating hIAPP22-29
peptides on the amyloidogenic propensity of full-length amylin. Amylin incubated with
peptide 10 showed the greatest reduction in aggregation propensity with longer lag time,
reduced rate of aggregation and the least amount of amyloid formed.

The (NH2)Phe containing peptide 4 appears to be an effective modulator of amylin selfassembly. Peptide 4 reduces the total amount of amyloid produced by greater than 60 %. The lag
phase is lengthened and the rate of fibrillization slowed. However, the most effective inhibitor of
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amyloid formation by hIAPP1-37 is peptide 10 which contains the p-formamido functionality on
Phe-23. The addition of 10 reduces amyloid formation by greater than 80 %, significantly
extending the lag phase and dramatically slowing the growth phase. To ascertain the effect of
peptide on the formation of the amylin-ThT complex, amylin was incubated with various
concentrations of ThT in the presence or absence of 10. After incubation the ratio of bound and
unbound ThT was estimated (amylin-ThT complex was separated from the unbound ThT by
centrifugation at 14,000 rpm for 3 hours) and it is clear the formation of the amylin-ThT complex
is not affected by the presence of the peptide.
Structural similarities between 4 and 10 imply that the amine/amide functionality plays an
important role when interacting with full-length amylin. The amino group is a stronger EDG than
the amide moiety so it is unlikely that the dramatic effect of 10 on amylin fibrillization is solely
due to electronic factors. Other favorable interactions, perhaps due to the presence of the
formamido carbonyl group may be responsible for the enhanced potency of 10.
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Figure 4.9. Changes in the circular dichroism spectra of amylin alone (panel A) compared
with the CD spectra of peptides 4 and 10 (panel 4 and 10, respectively) incubated with
amylin. The amylin CD profile changes with respect to time indicated a shift from partial αhelical structure (negative peak at ca. 205 nm) to β-sheets during the aggregation process.
Peptide 4 also showed an increase in β-sheet structure after 10 hours of incubation (black
trace). Peptide 10 showed no significant changes in its CD profile which indicated that it
maintained its secondary structure during the monitoring period of 20 hours. CD
measurements were done at amylin peptide concentration of 4 and 40 μM, respectively, in
Tris-buffer at pH 7.21.
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Table 4.2. Comparison of the degree of aggregation from the relative ThT fluorescence assay and
change in observed secondary structure from circular dichroism spectroscopy of amylin (4 μM)
incubated with the different peptide constructs (40 μM). Peptide 10 showed the least formation of
aggregates with no significant change in amylin secondary structure observed.
Peptide

ThT fluorescence assay
relative intensity

Observed change in secondary structure based on CD
data

Amylin
2
3
4
10

1.00
0.73
0.72
0.49
0.20

partial helical character to β-sheets after 3 hours
partial helical character to β-sheets after 3 hours
partial helical character to β-sheets after 2 hours
partial helical character to β-sheets after 10 hours
no significant change

13

0.68

partial helical character to β-sheets after 3 hours

To correlate ThT assay results to the changes in the secondary structure of amylin,
incubation of peptide constructs with full-length hIAPP1-37 were made and their CD profiles
monitored on the same time scale as the ThT assay (Figure 4.9, Table 4.2). The control sample
containing only amylin and Tris-HCl buffer at pH 7.2 shows gradual disappearance of its partial
helical structure as the protein aggregates. Minima at approximately 208 and 222 nm at time zero
indicates the presence of α-helical secondary structure.226 Hourly monitoring shows these features
gradually disappear with most changes starting to occur at 5 hours. After 20 hours of monitoring,
the CD profile now resembles more of a β-sheet secondary structure with a minimum at around
216 nm which may differ due to the variability of β-sheet secondary structures.226-228 This is
consistent with the ThT fluorescence assay data showing aggregation starting at around 5 hours of
incubation. Gradual changes in the CD spectrum of peptides 4 and 10 with amylin were observed
(Figure 4.9). Peptide 10, which inhibited aggregation the most, only showed a decrease in the
intensity of peaks but not in the profile suggesting that its secondary structure remained unchanged
during the monitoring period. Peptide 4 showed a delayed shift to β-sheet secondary structure
which was found to occur after approximately 10 hours of incubation. Changes in the amylin
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secondary structure upon incubation with peptide 2, 3 and 13 showed a shift from partial α-helix
to β-sheet at approximately the same time as the amylin control (Table 3.2).

Figure 4.10. TEM images of amylin after incubation with the different non-aggregating
peptides. Images were taken from aged samples deposited on Formvar coated negatively
stained with 2 % uranyl acetate. The first panel shows the aggregates formed by incubating
amylin alone. Amylin incubated with peptide 2 formed very fine fibers in comparison with the
control. Amylin in the presence of peptide 10 did not form any fibers even after repeated
sampling. The solid bar represents 500 nm.
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TEM imaging of the incubated samples from the CD experiment confirmed the formation
of amyloid fibrils during protein aggregation to rule out the possibility of false positives and false
negatives. Similar fibers found in the amylin control are present for the amylin samples incubated
with peptides 2, 3, 4 and 13 which showed minimal inhibition of aggregation based on the ThT
assay. Fibrils found in the sample of amylin with peptide 2 have aggregates of different
morphology than those of 3, 4 and 13 which were much finer and tangle together to form large
clumps. TEM images (Figure 4.10) of the sample containing amylin with peptide 10 showed no
fibrils similar to the other peptides, supporting the idea that the slight increase in the fluorescence
intensity after 12.5 hours is a false positive that can attributed to the binding of ThT to bacteria or
amorphous aggregates seen in the TEM image as random structures.143, 229, 230
The NFGAILSS sequence has previously been shown to increase amyloid formation by
full-hIAPP1-37.49 It is interesting to speculate how the non-aggregating electron rich peptides exert
their effect on full-length amylin. The 5-20 region of monomeric hIAPP1-37 transiently exists in the
-helical conformation. While several models of hIAPP1-37 aggregation exist, Wiltzius and coworkers have proposed that during self-assembly, helical intermediates associate to bring the
amyloidogenic C-terminal sequence of monomers into close proximity of each other thereby
driving intermolecular β-sheet formation.231 This is believed to be mediated through amylin dimers
which orient themselves in an antiparallel fashion (Figure 4.11).
The 20-29 region of hIAPP has been shown to be particularly important in controlling the
aggregation kinetics and amyloidogenic propensity of the native protein.232 Structural models
indicate that hIAPP fibrils are composed of U-shaped monomers that assemble into parallel βsheets.178, 179, 233 Strikingly, the majority of the residues encompassing the 20-29 region in these
models are not part of a β-sheet but form a partially ordered loop that connects the two β-stands of
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each U-shaped monomer. This loop structure is believed to form early in the aggregation
process.234 In stark contrast, short peptides derived from the 20-29 region competently form βsheet rich amyloid structures.

Figure 4.11. Potential mechanism of inhibition of amylin aggregation by electron rich
hIAPP22-29 peptides. A) Assembly in the absence of inhibitory peptides based on the model of
Wiltzius et al.49 illustrating the formation of two layers of cross-β structure (top layer is
shown in color). The 5-20 region of hIAPP1-37 transiently forms α-helices which associate to
bring C-terminal amyloidogenic sequences into proximity of each other. Amylin dimers
associate in a head to tail fashion followed by local β -sheet formation. Residues contained in
the red strands interdigitate to form the steric zipper interface. This β -sheet formation
propagates the collapse of polypeptide chains into the characteristic U-shaped structures
comprising the cross- β motif. Portions of the 20-29 region encompass a loop which connects
each β-strand. Residues encompassing β-strands are based on the solid-state NMR model of
Lucas et al.51 The cross-β motif is depicted from above with the long axis of the fibril coming
out of the plane of the page. B) Inhibition by electron rich hIAPP22-29 peptides. Electron rich
peptides (solid black lines) bind to full-length amylin and enforce localized β-sheet structure
in the 20-29 region. This localized structure limits flexibility and prevents the formation of the
loop required for the conversion to U-shaped monomers.
One may envision an inhibition mechanism by which the recognition and binding of the
20-29 region of full-length hIAPP1-37 by EDG and electron rich peptides enforces an ordered βsheet secondary structure that limits the flexibility of this region and impedes the formation of Ushaped monomers (Figure 4.11). Aromatic-aromatic interactions between the electron rich
aromatic rings of hIAPP22-29 peptides and the benzene ring of Phe-23 in amylin would serve to
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strengthen peptide-amylin interactions. This type of inhibition may lead to the build-up or
persistence of helical intermediates and is particularly in keeping with the CD spectra of amylin in
the presence of peptide 10 which shows a consistent degree of α-helical secondary structure present
over the course of the experiment (Figure 4.8). These CD data strongly suggest that peptide 10 is
particularly effective at stabilizing helical intermediates along the aggregation pathway.
It is important to note that other possible mechanisms of inhibition by electron rich
hIAPP22-29 peptides may exist. However, the proposed mode of inhibition is consistent with
mutations that demonstrate the importance of flexibility in the 20-29 region of full-length hIAPP137.

A Ser-20 to Gly substitution in full-length amylin is known to enhance amyloidogenic

propensity and is associated with a rare mutation found among Chinese and Japanese populations
that increases the risk for developing type II diabetes.186, 235
It has been speculated that it is the increased flexibility in the 20-29 region due to the
presence of Gly that is responsible for accelerated amyloid formation.231 Furthermore, rat IAPP137,

which is not amyloidogenic, contains several substitutions in the 20-29 region which include a

leucine residue at position 23 along with proline substitutions at positions 25, 28 and 29. The only
other difference between rat and hIAPP1-37 is a His-18 to Arg substitution.136, 182 The Pro residues
in the 20-29 sequence preclude the formation of any ordered structure in the 20-29 region
effectively eliminating the possibility of adopting a loop type conformation. Taken together, these
observations support the necessity of flexibility in the 20-29 region in amyloid formation.
In the case of EDG peptides 4 and 10, it is clear that an additional component is at play in
the inhibitory efficacy of these compounds as the amino and amide functionalities appear to confer
an additional ability of these constructs to interact with full-length amylin. Theoretically, such
interactions should increase lag time, slow the aggregation rate and diminish the amount of soluble
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amylin converted to amyloid. We observe all these features when native amylin is treated with
peptides 4 and 10. Further investigations are underway to determine the exact mechanism of action
of these peptides.

4.5. Conclusions
In the present study, an array of peptides based on hIAPP22-29 containing phenylalanine
analogs with electron donating or withdrawing groups along with heteroaromatic surrogates with
electron poor or rich aromatic rings have been employed to probe the effect of π-electron
distribution on amyloid formation. Our findings indicate that electron rich aromatic systems
consistently inhibit and prevent the self-assembly of peptides derived from hIAPP22-29. In contrast,
peptides containing electron deficient aromatic systems universally self-assemble to form
aggregates. These observations illustrate the importance of aromatic interactions in amyloid
formation by hIAPP22-29 as well as to how electron density can be used to alter and tune the selfassembly process. This has resulted in the identification of several novel peptides with drastically
different amyloidogenic properties than the native NFGAILSS sequence.
How the geometry of various aromatic substituents effects peptide self-assembly has also
been clarified. Comparison of hIAPP22-29 peptides containing electron donating and electron
withdrawing groups of the same geometry indicates that it is the electron releasing character of the
aryl substituent and not its steric hindrance associated with the functional groups geometry which
is responsible for the inhibition of fibril formation.
Finally, through screening the ability of peptides containing electron rich phenylalanine
analogs and surrogates to inhibit the self-assembly of full-length hIAPP, we identified two novel
peptides capable of significantly inhibiting fibril formation by amylin. These single substitution,
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p-amino and p-formamido phenylalanine peptides are more potent inhibitors of amylin selfassembly than the previously reported NYGAILSS sequence. The identification of the p-amino
and p-formamido moieties may serve to further advance the design and development of future
potential aggregation inhibitors.
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5. Peptide Conjugates of Benzene Carboxylic Acids as Agonists and
Antagonists of Amylin Aggregation

Profit, A. A., Vedad, J., and Desamero, R. Z. (2017) Peptide Conjugates of Benzene Carboxylic Acids as
Agonists and Antagonists of Amylin Aggregation, Bioconjugate chemistry 28, 666-677.

5.1. Abstract
Human islet amyloid polypeptide (hIAPP), also known as amylin, is a 37-residue peptide
hormone that is stored and co-secreted with insulin. hIAPP plays a pivotal role in type 2 diabetes
and is the major component of amyloid deposits found in the pancreas of patients afflicted with
the disease. The self-assembly of hIAPP and the formation of amyloid is linked to the death of
insulin producing

-cells. Recent findings suggest soluble hIAPP oligomers are the cytotoxic

species responsible for

-cell loss whereas amyloid fibrils themselves may indeed be innocuous.

Potential avenues of therapeutic intervention include the development of compounds that prevent
hIAPP self-assembly as well as those that reduce or eliminate lag time and rapidly accelerate the
formation of amyloid fibrils. Both of these approaches minimize temporal exposure to soluble
cytotoxic hIAPP oligomers. Towards this end our laboratory has pursued an electrostatic repulsion
approach to the development of potential inhibitors and modulators of hIAPP self-assembly.
Peptide conjugates were constructed in which benzene carboxylic acids of varying charge were
employed as electrostatic disrupting elements and appended to the N-terminal of the hIAPP22-29

96

(NFGAILSS) self-recognition sequence. The self-assembly kinetics of conjugates were
characterized by turbidity measurements and the structure of aggregates probed by Raman and CD
spectroscopy while the morphology was assessed using transmission electron microscopy. Several
benzene carboxylic acid peptide conjugates failed to self-assemble and some were found to inhibit
the aggregation of full-length amylin while others served to enhance the rate of amyloid formation
and/or increase the yield of amyloid produced. Studies reveal that the geometric display of free
carboxylates on the benzene ring of the conjugates plays an important role in the activity of
conjugates. In addition, a number of free benzene carboxylic acids were found to modulate amylin
self-assembly on their own. The results of these investigations confirm the viability of the
electrostatic repulsion approach to the modulation of amyloid formation and may aid the design
and development of potential therapeutic agents.

5.2. Introduction
Human islet amyloid polypeptide (hIAPP) is a 37-residue hormone that is co-stored and
co-secreted with insulin in pancreatic β-cells. The polypeptide functions in maintaining glucose
homeostasis and appetite satiation.236, 237 hIAPP also plays a pivotal role in the development and
progression of adult onset diabetes (type 2 diabetes or diabetes mellitus).238-242 Type 2 diabetes is
characterized by a loss of β-cell mass which is correlated with the appearance of amyloid deposits
in the pancreas. Indeed, post-mortem analysis has revealed that approximately 95% of type 2
diabetes patients have pancreatic amyloid deposits.185, 243 The depletion of insulin producing βcells ultimately leads to the hyperglycemia associated with type 2 diabetes and is a major
contributor to the pathology of the disease.
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Human islet amyloid polypeptide is the major protein component of amyloid fibrils in type
2 diabetes. In these insoluble fibers, the polypeptide exists in a structure known as the cross β motif
in which extended polypeptide chains run perpendicular to the long axis of the fibril in a parallel
β-sheet conformation. While initial investigations regarded hIAPP derived amyloid deposits as
being culpable for the polypeptides cytotoxicity, more recent findings illustrate that soluble hIAPP
oligomers are responsible for inducing β-cell death.244 A significant and growing body of evidence
indicates that the cytotoxic effects of hIAPP stems from the polypeptides ability to induce
membrane damage.245, 246 In keeping with this, negatively charged phospholipids have been shown
to promote and enhance the aggregation of hIAPP while dye leakage studies have confirmed the
ability of hIAPP to disrupt model membranes.37, 247, 248 It is hypothesized that the phospholipid
surface may serve to increase the local concentration of hIAPP thereby promoting interactions
between hIAPP molecules or inducing conformational changes that drive fibril assembly. The
effect of anionic phospholipids on amylin aggregation is further supported by the observation that
heparin can also promote hIAPP aggregation.249, 250
The membrane disrupting ability of hIAPP has been mapped to the N-terminal region of
the polypeptide. Residues 1-19 are responsible for facilitating the interaction of hIAPP with
phospholipids and model membranes.251 This observation is consistent with the fact that all
positively charged amino acids in the hIAPP sequence reside in the 1-19 region.
The mechanism of membrane disruption by hIAPP is believed to occur through a two stage
process and displays biphasic kinetics.252, 253 The first stage is characterized by the formation of
pores in the membrane followed by oligomer growth on the membrane surface leading to further
membrane damage. Loss of ion homeostasis, in particular Ca2+, along with the activation of various
stress signaling pathways culminate with cell death.
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Other mechanisms of hIAPP cytotoxicity have also been proposed including oxidative and
ER stress as well as the activation of death receptors and apoptotic signaling pathways.253 In
reality, it is very likely that multiple mechanisms of hIAPP toxicity are at work in vivo including
the disruption of cell and organelle membranes. What is consistent between these various cytotoxic
mechanisms is that they appear to be initiated by exposure to soluble oligomers of hIAPP.
Possible therapeutic approaches to the treatment of type 2 diabetes include circumventing
the buildup of cytotoxic soluble oligomers responsible for β-cell death. This can be achieved in
one of two ways. The first approach is the development of novel chemical entities that can inhibit
amylin aggregation. A second approach is to develop compounds capable of hastening the
formation of insoluble amyloid fibrils. By rapidly driving the formation of amyloid, the temporal
buildup of soluble oligomers can be avoided. Such an approach may avert the damage done by
cytotoxic soluble oligomers by minimizing exposure times.
Small peptide fragments derived from Aβ and hIAPP have been shown to serve as
inhibitors of amyloid formation. The self-recognition ability of these peptides directs them to
corresponding regions of the target protein where they can exert their inhibitory effects. For
example the peptide KLVFF is known to inhibit Aβ aggregation.254 Scorcchi et al. have identified
a number of peptide amylin aggregation inhibitors derived from the hIAPP sequence.255 Porat and
co-workers discovered that replacement of Phe in the hIAPP22-29 sequence (NFGAILSS) resulted
in a peptide that failed to self-assemble like the native sequence.256, 257 The NYGAILSS peptide
was also found to inhibit amyloid formation by full-length hIAPP.257 Likewise, Nilsson et al.
identified a non-aggregating peptide based on the hIAPP20-29 sequence containing a Phe-23 to Trp
substitution which inhibits amylin self-assembly.258 More recently, our laboratory identified
several non-aggregating peptides that are effective inhibitors of amylin aggregation.259 These
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peptides are believed to bind to the 22-29 region of full-length hIAPP and enforce local secondary
structure in an otherwise flexible region of full-length hIAPP and thereby hindering formation of
the characteristic U-shaped monomers of amyloid fibrils.
The use of self-recognition element (SRE) peptide sequences derived from amyloidogenic
proteins has been exploited to deliver bulky groups and/or secondary structural elements to specific
sites within the target protein to prevent aggregation. For example Findies and co-workers
appended cholic acid to the LVFF sequence of Aβ to produce a peptide conjugate that was able to
inhibit self-assembly of Aβ due to steric repulsion.260 Likewise, peptide sequences containing βsheet breaking residue such as Pro and 2-amino isobutyric acid (Aib) have also lead to compounds
capable of inhibiting amyloid formation.261-263
Charge repulsion has been employed to disrupt and modulate amyloid formation. Murphy
et al. synthesized and evaluated peptide constructs based on the Aβ 16-20 recognition sequence
that contained charged amino acid residues appended to the N- or C-terminal as potential Aβ
amyloid inhibitors.264, 265 The peptides KLVFFKKKK and KLVFFEEEE were found to alter the
kinetics of Aβ aggregation by enhancing amyloid formation and providing protection against Aβ
cellular toxicity. Thus, changing the kinetic pathway of fibril formation and driving oligomers to
the state of insoluble deposits minimizes the buildup of soluble oligomers and their membrane
damaging cytotoxic effects.
We were interested in applying the approach of Murphy et al. towards the modulation
and/or inhibition of amylin self-assembly. However, the increased molecular mass associated with
appending several amino acid residues to the N- or C-terminal of a recognition sequence was of
some concern as we wished to keep the potential inhibitor as compact as possible. A smaller
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molecule would more readily facilitate the future development of peptide mimetic compounds. On
the basis of this, we contemplated appending more “charge dense” moieties on the terminal region
of a peptide self-recognition element. Toward this end we chose to conjugate various benzene
carboxylic acids to the N-terminal of the hIAPP22-29 recognition sequence. The benzene carboxylic
acids vary in charge and should serve as potential disrupting elements of amylin aggregation. We
now report the amyloidogenic propensity and biophysical characteristics of these novel peptide
conjugates and describe how they affect the self-assembly of the full-length amylin.

5.3. Results and Discussion
5.3.1. Conjugate Design and Synthesis
Peptide conjugates were designed to prevent self-assembly through a charge repulsion
mechanism. We chose the 22-29 region of hIAPP (NFGAILSS) as the SRE because this peptide
fragment is well studied and characterized. The native hIAPP22-29 sequence forms aggregates on
its own while specific point mutations at Phe-23 have led to the acquisition of non-aggregating
inhibitors of amylin self-assembly.257-259 NFGAILSS has also has been used to seed full-length
amylin to drive fibril production.255
For charged disrupting elements we chose inexpensive, commercially available benzene
carboxylic acid derivatives that contain varying numbers of carboxyl groups (Figure 5.1). These
include benzene-1,4-dicarboxylic acid (terephthalic acid) (1), benzene-1,3,5-tricarboxylic acid
(trimesic acid) (2), benzene-1,2,4,5-tetracarboxylic acid, (pyromellitic acid) benzene-1,2,4,5tetracarboxylic acid, (pyromellitic acid) (5), benzene-1,2,3,4,5,6-hexacarboxylic acid (mellitic
acid) (6) and 5-sulfosalicylic acid (7). Benzene-1,2,4-tricarboxylic-1,2-anhydride-4-chloride (3)
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and benzene-1,2,4-tricarboxylic acid anhydride (4) were employed to prepare isomeric versions of
the trimesic acid (2) containing conjugate that varied in the display of carboxylates on the aromatic
ring.
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Figure 5.1. Structures of benzene carboxylic and cinnamic acid derivatives employed to
prepare peptide conjugates.
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Figure 5.2. Structure and activity of benzene carboxylic acid peptide conjugates.
The peptide conjugates synthesized as potential inhibitors of amylin aggregation are
illustrated in Figure 5.2. Conjugates are identified by the prefix “C” followed by the number of
the corresponding free benzene carboxylic acid from which they are derived. For ease of synthesis,
benzene carboxylic acids were conjugated to the N-terminal of the hIAPP22-29 SRE through an
amide bond linkage. After conjugation, each benzene carboxylic acid moiety has n-1 (where n =
the total number of carboxyls) carboxyl groups available to function as charged disrupting
elements. At physiological pH each carboxyl group should be ionized and provide the benzoic acid
moieties with net negative charges ranging from -1 to -5. Intense charge repulsion between the N103

termini of adjacent peptide strands should prevent self-association to form the characteristic
parallel β-sheet structure described for NFGAILSS.259 The ability of the conjugates to adopt an
alternative anti-parallel β-sheet structure should also be hindered as this arrangement would bring
the negatively charged free C-terminal of one peptide strand into proximity with the highly
negatively charged benzene carboxylic acid moiety of an adjacent strand. Systematic variation in
the number of carboxyl groups on the benzene carboxylic acids should facilitate the ability to
discern the minimum charge requirements necessary to inhibit conjugate self-assembly.
While conjugates containing terephthalic (1) and sulfosalicylic (7) acid moieties both
possess a N-terminal with a single negative charge at pH 7.2, it was contemplated that the sulfonic
acid may lead to some enhanced interactions with full-length amylin. This is due to the observation
that amyloid binding compounds such as Congo red, phenolsulfothalien and acid fuchsin contain
sulfonic acid moieties.266-268 In addition, sulfonated molecules such as 3-amino-1-propanesulfonic
acid and 1,3-propanedisulfonic acid have been shown to be effective inhibitors of Aβ and serum
amyloid A aggregation respectively.269, 270
Benzene-1,2,4-tricarboxylic 1,2-anhydride 4-chloride (3) and benzene-1,2,4-tricarboxylic
anhydride (4) and were employed to prepare isomers of C2 in an effort to elucidate if the
substitution pattern of carboxylates on the aromatic ring influences the amyloidogenic propensity
of individual conjugates and their interaction with full-length amylin. C3, with a 3,4-substitution
pattern, was synthesized by preferential reaction of the N-terminal amino group of NFGAILSS
peptidyl resin with the acid chloride functionality of benzene-1,2,4-tricarboxylic 1,2-anhydride 4chloride.
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Reaction of the peptidyl resin with benzene-1,2,4-tricarboxylic acid anhydride (4) yielded
a single isomer as the major product (C4). Equal attack of the amine at the C-1 and C-2 carbonyls
of the anhydride moiety was initially anticipated to provide two discrete products. However,
resonance in benzene-1,2,4-tricarboxylic acid anhydride indicates that the C-1 carbonyl should be
the most electrophilic and therefore the primary site of attack. On the basis of this, we rationalized
that conjugate C4 contains a 1,3-carboxylic acid substitution pattern. The isomeric conjugates C2,
C3 and C4 displayed individual reverse phase analytical HPLC retention times of 31.01, 32.09
and 30.76 minutes respectively each with a molecular mass of 999.53 in agreement with the
calculated value of 999.42. Co-injection of C2, C3 and C4 reveals three closely eluting peaks
confirming these compounds are distinct isomeric conjugates (Figure 5.11).
Peptide conjugates C8 and C9, which are derived from α-cyano-3-hydroxycinnamic acid
and α-cyano-4-hydroxycinnamic respectively (Figure 5.1), were also investigated as molecules
potentially capable of influencing amylin aggregation. α-Cyano-4-hydroxycinnamic acid readily
self-associates and is well known for its use as a matrix in MALDI-TOF mass spectrometry.271
However its isomer, α-cyano-3-hydroxycinnamic acid, does not self-associate which has excluded
its use as a matrix material. On the basis of this, we rationalized that it might be possible to exploit
the different self-association properties of these isomeric hydroxycinnamic acids to prevent
peptide aggregation by appending α-cyano-3-hydroxycinnamic acid to the N-terminal of the
hIAPP22-29 SRE. Hence, we anticipated that the 3- and 4-hydroxycinnamic acid peptide conjugates
C8 and C9 might display significantly different amyloidogenic propensities. Finally, the charged
amyloid disrupting peptide, EEEENFGAILS (P10), was also prepared to compare and contrast the
behavior of the charged peptide conjugates.
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Peptides and conjugates were synthesized manually on Fmoc-Ser(OtBu)-Wang resin using
a standard Fmoc solid phase synthesis protocol. Low substitution resin was chosen to minimize
potential cross linking between adjacent peptide chains during conjugation of the benzene
carboxylic acids. With the exceptions of compounds C3 and C4, carboxylic acids were conjugated
to the N-terminal of the peptidyl resin using HBTU, HOBT and DIEA in DMF as described in the
experimental section. The use of DIEA proved to be critical for coupling of higher substituted
benzene carboxylic acids as their corresponding N-methylmorpholine salts were insoluble in DMF
at the concentrations employed. Conjugates were purified by reverse phase HPLC and their
structures confirmed by MALDI-TOF mass spectrometry.
5.3.2. Self-assembly of hIAPP22-29 Conjugates

Figure 5.3. Changes in optical density at 405 nm monitored over time for 1 mM solutions of
conjugates C1 – C9 and P10 in tris-HCl buffer (pH 7.2). NFGAILSS turbidity plot is included
for comparison and was taken from reference 39.
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Turbidity (light scattering) was employed to determine the amyloidogenic propensity of
individual peptide conjugates. The use of turbidity is a well-established method for monitoring the
self-assembly of short peptide sequences such as NFGAILSS. The results of turbidity
measurements for the conjugates, P10 and NFGAILSS are presented in Figure 3. From the data it
can be seen that conjugates C1, C8 and C9 containing the terephthalic acid and cyanohydroxycinnamic acid moieties readily form aggregates which then begin to settle out of solution.
Conjugates C2 – C7 fail to aggregate as does the amyloid disrupting peptide EEEENFGAILSS
(P10). Interestingly, the hydroxycinnamic acid conjugates are both capable of undergoing selfassembly. This behavior does not reflect the different propensities of the individual free acids to
self-associate. Although both conjugates form amyloid, the α-cyano-4-hydroxycinnamic acid
derivative appears to produce a higher amount of total amyloid than the 3-hydroxy isomer.

Figure 5.4. TEM of aggregated conjugates C1, C8 and C9 from turbidity samples.

From the turbidity data it cannot be definitively stated what the minimum charge
requirements are to prevent peptide self-assembly, although, it does appear that an N-terminal
charge greater than -1 is needed. However, there is still ambiguity. For example, conjugates C1
and C7 which contain the terephthalic and sulfosalycylic acid moieties respectively display
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drastically different amyloidogenic propensities despite both compounds having a single negative
charge associated with the benzene carboxylic acid functionality. The finding that the terephthalic
acid derivative self-assembles while the sulfosalycyclic acid compound does not implies that the
sulfonic acid group provides additional interactions other than charge that effectively inhibits
peptide aggregation. It is possible that the more polar sulpho group, in addition to the phenolic
hydroxyl, may serve to confer enhanced water solubility on C7 making it less prone to aggregation.
While it cannot definitively be stated what the minimum charge requirements are to inhibit selfassembly of the conjugates, it is clear that charge does play a role as more highly charged
conjugates fail to self-assemble.
TEM analysis confirms the findings of turbidity measurements that compounds C2 – C7
as well as P10 do not self-assemble. No evidence of fibrils was observed in aged samples of these
conjugates upon microscopic examination. In contrast TEM images of C1, C8 and C9 reveals a
dense field of amyloid fibrils (Figure 5.4).
Raman and IR spectroscopic analyses of the aggregating conjugates indicate that these
samples exhibit similar characteristics as the hIAAP22-29 peptide mutants studied by our group and
others.257, 259, 272, 273 Regardless of the net ionic charge on the N-terminal, the aggregates yielded a
similar parallel β-sheet configuration. Our group has previously established two particular Raman
markers that interrogate the configuration of the aggregated structures, the Amide I mode at ca.
1674 cm-1 and some ring modes at ca. 1200 – 1210 cm-1.259 Aggregates exhibiting parallel β-sheet
configuration display a single Amide I mode at 1674 cm-1 and a doublet peak in the vicinity of the
1200 cm-1 region. The latter indicating π-π interaction of the rings stacked upon one another. If the
aggregates on the other hand, form an anti-parallel configuration the Amide I mode at 1674 cm-1
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plus a shoulder at around 1689 cm-1 is observed while the ring mode displays a single peak at
approximately 1214 cm-1.
Table 5.1. Raman and IR peaks observed from aggregates of C1, C8 and C9 along with the
apparent beta-sheet orientation. (Raman and IR spectra on Figures S2 and S3, respectively).
Raman Shift (cm-1)

IR Shift (cm-1)

Beta-sheet
orientation

Conjugate
Ring mode

Amide I mode

Amide I mode

1204

1665

1631

C1

Parallel
1211

-

-

1202

1672

1631

C8

Parallel
1215

-

-

1204

1664

1631

C9

Parallel
1217

-

-

A close inspection of Table 5.1 indicates C1, C8 and C9 take on a parallel β-sheet
configuration as aggregates form. Conjugates C1, C8 and C9 all present a single Amide I peak
and two-peak ring modes that are ca. 10 cm-1 apart. The net ionic charge on the N-terminal group
does not influence the resulting configuration.
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5.3.3. Effects of benzene carboxylic acid conjugates and free acids on amylin (hIAPP 1-37)
self-assembly

Figure 5.5. Thioflavin T fluorescence emission plot corresponding to β-sheet formation of
amylin samples upon incubation with non-aggregating peptide constructs.

The self-assembly of hIAPP1-37 is a nucleation dependent event. The kinetics of amyloid
formation is characterized by a sigmoidal curve with three distinct regions representing different
phases of the self-assembly process. The first phase, known as the lag phase, is where hIAPP 1-37
monomers associate to form soluble oligomers. Once a critical number of oligomers have
assembled, nucleation occurs triggering an exponential polymerization of amyloid fibrils. This
rapid polymerization is defined as the growth phase. The final phase of amyloid formation occurs
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when equilibrium is reached between soluble hIAPP1-37 aggregates and insoluble fibers and is
exemplified by a plateau in the kinetic profile. This final stage of amyloid formation is the
saturation phase. Agonists or antagonists of hIAPP1-37 may alter one or more of the kinetic phases
of amyloid assembly.
Previous work from our laboratory, as well as others, has demonstrated that nonaggregating peptides derived from SREs can serve as inhibitors of amylin aggregation. On the
basis of this, we examined the effects of C2 – C7 on hIAPP1-37 fibrillization. Thioflavin T
fluorescence data for amylin aggregation in the absence and presence of conjugates are presented
in Figure 5 (see also Figure S4 for the effect of an aggregating conjugate, C1, on amylin selfassembly). From the data it is clear that the conjugates have a profound effect on the self-assembly
kinetics of full-length amylin. There does not appear to be a direct correlation between the
magnitude of the charge associated with the benzene carboxylic acid moiety and the amyloid
disrupting ability of the peptide conjugates. Conjugates C2, C3, C4, C6 and C7 are all agonists of
amylin self-assembly with distinctly different characteristics. The characterization of C2 – C4
facilitates insight as to how the geometric display of free carboxylates affects the activity of these
compounds.
Conjugates C2 – C4 all possess benzene carboxylic acid moieties with a net charge of -2
yet these compounds exhibit different properties with regards to modulating the amyloidogenic
propensity of hIAPP1-37. Conjugate C2 exhibits a 2,4-substitution pattern of carboxylates whereas
C3 and C4 possess 3,4 and 1,3 displays of carboxyl groups respectively. Both C2 and C3 have
little effect on the lag time of amylin self-assembly. However, C2 significantly increases the total
yield of amyloid produced to over twice that of the amylin control. This observation suggests C2
is capable of shifting the equilibrium between soluble and insoluble hIAPP1-37 aggregates. In
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contrast C3 exhibits a significantly slower growth rate than C2 and produces much less total
amyloid. The overall quantity of amyloid produced in the presence of C3 is less than C2 but
slightly higher than the amylin control.

Figure 5.6. TEM of amylin aggregates formed upon incubation with peptide constructs. Image
A is amylin alone.
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The influence of conjugate C4 on the self-assembly of full-length amylin is markedly
different than that of C2 and C3. Conjugate C4 virtually eliminates the lag time associated with
hIAPP1-37 self-assembly. Full-length amylin begins to aggregate almost immediately in the
presence of C4 but the overall yield of aggregates is much less than the amylin control. Indeed,
C4 produced the lowest amount of amyloid of all the conjugates that enhance amylin selfassembly. However, the rate of fibril growth does not appear to be significantly affected by C4.
The above observations reveal that the presentation of carboxylate groups plays an
important role in determining how conjugates C2 – C4 interact with full-length amylin and exert
their agonistic effects. While thorough SAR studies are needed to parse out the exact structural
requirements for this agonistic behavior it is clear that it is not the magnitude but the spatial
arrangement of charge that is key to the activity of these compounds.
Conjugates C6 and C7 are also agonists of amylin self-assembly. C6 exhibits carboxylates
at positions 1 through 5 and has a charge of -5 associated with the benzene carboxylic acid whereas
C7 contains the sulphosaliciylic acid moiety with a charge of -1. Conjugate C6 is a strong agonist
of amyloid formation. In the presence of C6 lag time is all but abolished, the fibrillation rate is
increased and the total amount of amyloid produced is similar to that of the amylin control. In
juxtaposition to C6, conjugate C7 does not have as dramatic an effect on lag time but significantly
increases the total yield of amyloid to approximately twice that of the control. C7 also induces an
increase in the rate of fibril growth although not to the same degree as C6.
Interestingly the influence of C2 and C7 on amylin aggregation is almost completely
opposite to that of C4 and C6. Both C4 and C6 eliminate lag time but do not produce high yields
of amyloid whereas C2 and C7 have a minimal effect on lag time but produce significantly larger
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quantities of amyloid fibers. TEM data confirms the presence of fibrils formed by hIAPP 1-37
incubated with conjugates C2, C3, C4, C6 and C7 and corroborates the findings of ThT kinetic
assays (Figure 5.6). The TEM data for EEEENFGAILSS (P10) reveals aggregate formation that
was perhaps only minimally registered in the ThT assay. Indeed, if the fluorescence intensity axis
of the ThT plot is expanded (Figure 5.15), a slight increase in signal is observed reflecting the
formation of a small amount of aggregates. Despite this observation P10 is still an effective
inhibitor of amylin at concentration utilized in the assay.
In sharp contrast to C2, C3, C4, C6 and C7 conjugate C5, which is derived from benzene1,2,4,5-tetracarboxylic acid, is a potent antagonist of amylin self-assembly. C5 completely
abolishes the self-assembly of hIAPP1-37 (Figures 5.5 and 5.6). The charge associated with the
benzene carboxylic acid in C5 is -3. CD spectra taken of full-length hIAPP incubated with C5
indicates that the conjugate is able to trap or stabilize the polypeptide in a unique conformation
that is unable to transition to the β-sheet structure (Figure 5.7). The CD spectra appear to only
change in intensity over the time course of the experiment. Transmission electron microscopy
verifies the absence of any amyloid fibrils when hIAPP1-37 is incubated in the presence of C5 and
corroborates CD and ThT data (Figures 5.5 and 5.6). It is also particularly significant that C5
inhibits amylin aggregation more effectively as the designed disrupting peptide P10 while being
lower in molecular mass, size and charge. Likewise, conjugate C5 is able to inhibit amyloid
formation without the use of a large bulky group appended to the N-terminal as in the case of the
Aβ inhibitor cholyl-KLVFF.
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Figure 5.7. Time course of amylin self-assembly in the absence or presence of peptide
constructs as monitored by CD. (A) amylin alone; (B) amylin incubated with C5; and (C)
amylin with P10.
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The ability of P10 to inhibit amylin self-assembly is also strikingly different from what has
been observed with similar peptides designed to disrupt Aβ aggregation. For example, the peptides
KLVFFEEEE and KLVFFKKKK were found to serve as agonists of Aβ aggregation. Neither was
able to prevent Aβ self-assembly although both peptides protected cells against the toxic effects
of amyloid. There is a substantial body of evidence that indicates the toxicity of amyloid,
regardless of the source protein, can be attributed to the membrane disrupting capabilities of
soluble oligomers and not amyloid fibrils themselves. Peptides such as KLVFFEEEE and
KLVFFKKKK presumably exert their protective effects by rapidly driving the formation of
insoluble amyloid fibrils thereby by preventing the buildup of soluble oligomers.

Figure 5.8. Fluorescence emission plot of thioflavin-T upon incubation of amylin with different
benzene carboxylic acid derivatives; terephthalic acid (1); 1,3,5-tricarboxylic acid (2); 1,2,4,5tetra-carboxylic acid (5); mellitic acid (6); sulfosalicylic acid (7); and benzoic acid (11).
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We next investigated the ability of the various benzene carboxylic acids to inhibit amylin
self-assembly on their own. Figure 5.8 illustrates the results of these studies. The data demonstrates
that benzene-1,2,3,4,5,6-carboxylic acid (6) and benzene-1,2,4,5-tetracarboxylic acid (5) strongly
induce amylin aggregation. Benzene-1,2,3,4,5,6-carboxylic (6) acid eliminates the lag phase and
increases the rate of fibril growth while producing similar amounts of amyloid as the control.
Benzene-1,2,4,5-tetracarboxylic acid (5) reduces lag time, increase the rate of fibrillization and
approximately doubles the number of amyloid fibrils produced at equilibrium. Benzene-1,3,5tricarboxylic acid (2) is a significant inhibitor of amyloid formation whereas 5-sulfosalycylic (7),
terephthalic (1) and benzoic acid (C6H5COOH, (11)) all exhibit only minor effects on amylin selfassembly. TEM reveals the presence of amyloid fibrils in the samples of amylin containing the
various benzene carboxylic acids (Figure 5.9).

Figure 5.9. TEM of aggregates formed from mixtures of 40µM free carboxylic acids and 4 µM
amylin in Tris buffer pH 7.21. All samples were incubated for 24 hours before imaging.
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The observation that the more highly charged benzene carboxylic acids such as mellitic
acid (6) and benzene-1,2,4,5-tetracarboxylic acid (5) serve as agonists of hIAPP1-37 self-association
is consistent with previous observations that negatively charged phospholipids catalyze amylin
aggregation. The highly charged benzene carboxylic acids may serve as a nucleation site for
amylin aggregation just as the negatively charged surface of a phospholipid bilayer dose. Studies
have shown that the membrane disrupting ability of full-length hIAPP is indeed due to selfassociation and fibril growth on the membrane surface. Hamilton et al. have recently reported the
synthesis and characterization of negatively charged, oligoamide α-helix mimetics displaying
carboxylates equivalent to the i, i+3/4 and i+7 positions that demonstrate agonist activity toward
amylin self-assembly.274. Likewise, Hassanpour et al. have developed doubly charged carboxylic
acid derivatives of 2,5-diaryl-substituted thiophene helical mimetics that reduced the lag phase and
dramatically increased the total amount of amyloid produced by hIAPP1-37.275 These compounds
are believed to work through a mechanism involving interactions between negatively charged
carboxylates and positively charged residues located in the N-terminal portion of amylin. The
mode of action of negatively charged helical mimetics as well as the influence of phospholipids
are consistent with the effects of the free mellitic and benzene-1,2,4,5-carboxylic acids on the
amyloidogenic propensity of amylin. However, it should be noted that helical mimetics are more
likely to optimally present their carboxylate groups to engage in and exploit specific interactions
between the positively charged residues in amylin due to their conformational and spatial
constraints. For example, terephatlic acid which contains two negatively charged carboxyl groups
has little effect on amylin aggregation whereas thiophene helical mimetics presenting two
carboxylates have been reported to significantly alter the amyloidogenic propensity of amylin.275
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The interaction of 5 and 6 with amylin may only occur through general non-specific electrostatic
interactions.
Comparison of the free benzene carboxylic acids with the conjugates reveals some
significant findings. Conjugate C5 which contains the 1,2,4,5-benzene tetracarboxylic acid moiety
serves to totally abolish amyloid formation whereas the free acid is a strong agonist of amylin
aggregation. This observation implies that there are two distinctly different mechanisms of action
involved with the conjugate and the free acid and suggests that the peptide SRE plays an important
role in how these conjugate functions.
It is perhaps plausible to make the argument that C5 should be more aptly compared to free
1,3,5-benzene carboxylic (2) acid as the benzene carboxylic acid moieties of both these compounds
possess a net -3 charge. While benzene-1,3,5-tricarboxylic acid (2) is an effective inhibitor of
amylin self-assembly it is not as efficacious as C5. Furthermore, the corresponding conjugate that
actually contains the benzene-1,3,5-tricarboxylic acid moiety (C2) is an agonist of amylin selfassembly. Conjugates C2 and C7 also act in a manner contrary to the free benzene carboxylic acids
from which they are derived. Terephthalic and 5-sulfosalycylic acid exhibit little effect on amylin
aggregation yet the corresponding conjugates dramatically enhance the amyloidogenic propensity
of hIAPP1-37 (Figure 5.5 and 5.14). These observations again support an important role for the
peptide SRE in the mechanism of action of the conjugates.
It is intriguing to speculate how C5 and peptide P10 exert their inhibitory effect on fulllength amylin. The 5-20 region of monomeric hIAPP1-37 transiently exists in a helical
conformation. Wiltzius et al. have proposed that during amylin self-assembly, helical
intermediates associate to bring the amyloidogenic C-terminal of monomers into proximity thereby
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driving intermolecular β-sheet formation to produce the characteristic U-shaped monomers of
amyloid fibrils. This process is believed to be mediated through amylin dimers which orient
themselves in an antiparallel fashion. A plausible mechanism for the inhibition of amyloid by C5
and peptide P10 would entail binding of the SRE to monomeric amylin at the 22-29 region. Charge
repulsion between amylin-peptide complexes could prevent the initial dimerization of helical
intermediates necessary to drive amyloid formation (Figure 5.10).
Alternative models of amyloid formation suggest that helical intermediates may actually
be off-pathway species in the amyloidogenic process while others implicate β-hairpins as being
key on-pathway species.276, 277 In the context of these models it may be that C5 and P10 somehow
stabilize off-pathway helical intermediates thereby preventing amyloid formation. In the β-hairpin
model, it is proposed that hIAPP monomers interconvert between α-helix and β-hairpin
conformations. Constructs C5 and P10 may somehow prevent this key transition. This is consistent
with CD data that suggests C5 traps hIAPP1-37 in a unique conformation (Figure 5.7). Clearly
thorough mechanistic investigations are needed to address exactly how the peptide conjugates are
exerting their specific effects on amylin.
The inhibitory action of C5 is likely to be more complex than that of P10 with the
geometric arrangement of carboxylates playing a role. The fact that conjugates of lesser and higher
charges than that of C5 serve as agonists of amylin self-assembly indicates that charge of the
conjugate alone is not sufficient for its inhibitory activity.
The N-terminal region of amylin contains the positively charged residues Lys-1 and Arg11. Depending on the pH of the medium, His-18 may also exhibit a positive charge. It is a
possibility that these conjugates are somehow interacting with Lys-1, Arg-11 or His-18 in a fashion
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that inhibits or enhances the kinetics of fibril formation. Interactions with His-18 may be of
particular importance as the protonation state and presence of this residue has been shown to play
a significant role in amylin self-assembly.278

Figure 5.10. A) Proposed mechanism of amyloid formation based on the model of Wilzius et
al. illustrating the formation of two layers of cross-β structure (top layer is shown in color,
bottom in gray). The 5-20 region of amylin monomers transiently form helical intermediates
that assemble into dimers. Sets of dimers orient themselves in a head to tail fashion which brings
amyloidogenic C-terminal sequences together and drives β-sheet formation to produce the
characteristic U-shaped monomers associated with the cross-β architecture of amyloid fibrils.
The cross-β motif is depicted from above with the long axis of the fibril coming out of the plane
of the page. B) Potential mechanism of amyloid inhibition by C5 and possibly P10. The SRE
binds to the 22-29 region of amylin monomers. Electrostatic repulsion between amylinconjugate complexes prevents the dimerization of amylin monomers blocking further
progression toward the formation of amyloid deposits.

In conjugate C6, the SRE may not serve any critical purpose as its behavior resembles that
of the free benzene carboxylic acid. This demonstrates that the behavior of C6 is most likely
governed by the benzene carboxylic acid moiety with the SRE exerting little to no effect. The
highly charged, amphipathic nature, of 6 may allow it to replicate the behavior of phospholipids
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or detergent micelles in solution with the negatively charged benzene carboxylic acid moieties
resembling lipid “head” groups and the relatively hydrophobic peptide chain mimicking lipid
“tails”. It may be possible that fibril growth can occur on the negatively charged surface of micelles
derived from C6. Turbidity data demonstrating that C6 does not form insoluble amyloid does not
mean the compound fails to undergo self-association. Indeed, C6 may simply form soluble
oligomers that promote amylin nucleation or micelles as previously stated.
To probe the possible effect of micelle formation on aggregation propensity, we measured
the turbidity of 1 mM C6 dissolved in tris-HCl buffer (pH 7.21) in the presence of sodium dodecyl
sulfate (SDS) at concentrations below and above the SDS critical micelle concentration (CMC) of
8.2 mM. After incubating C6 in 2 mM SDS for 15 mins no significant increase in turbidity signal
was observed nor were any fibrils detected. On the other hand, C6 aggregates immediately formed
when they were incubated in 10 mM SDS. Fibrils can be clearly observed soon after mixing and
turbidity signal measured at 405 nm is significant. This, observation is consistent with the data
collected by Sureshbabu et al,279 demonstrating that in the presence of micelles, aggregation
propensity of C6 is enhanced but only at detergent concentrations above CMC. Therefore, at the
conditions of our ThT assay (40 µM conjugate to 4 µM amylin) it is unlikely that the conjugates
exist as micelles that would affect the aggregation of amylin. We can also surmise that the CMC
for the conjugates must be higher than 40 µM because not all aggregated when a 1 mM sample
was incubated in buffer (Figure 5.3).
The sulfonated conjugate C7 may mimic sulfonated compounds such as heparin and the
glycosaminoglycan chains of the heparin sulfate proteoglycan (HSPG) Perlecan known to promote
amyloid self-assembly.280, 281 However, these findings are at odds with the documented inhibition
of amyloid by acid fuschin and other sulfonated small molecules.
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Employing electrostatic repulsion to mitigate amyloid formation may be an effective
strategy for developing potential therapeutic agents. It has been previously demonstrated that small
molecules capable of modulating the net charge of a protein can be used to affect the amyloidgenic
potential. Abdolvahabi and coworkers demonstrated that acylation of Lys residues in SOD1 with
aspirin increases the net negative charge of the polypeptide and slows the rate of aggregation. 282
In a similar fashion, Patil and Alexandrescu have recently applied a charge repulsion approach to
inhibiting amylin self-assembly by preparing “charge-loaded” analogs of full-length amylin.283 In
this study, strings of Arg or Asp residues were strategically incorporated into the native amylin
sequence to produce aggregation inhibitors. These amylin analogs displayed a concentration
dependent inhibition of wild type amylin self-assembly. Under the experimental conditions
employed the amylin analogs greatly reduced amyloid formation. However, none of the
polypeptides was able to completely abolish amylin aggregation even at the highest concentration
used (120 µM). The most potent of the charged-based analogs (termed Arg-1) was also effective
at protecting MIN6 mouse insulinoma cells from the cytotoxic effects of native amylin. In contrast,
to full-length charge-based amylin analogs, the significantly smaller conjugate C5 along with
peptide P10 here are capable of virtually abolishing amylin self-assembly at a concentration of 40
µM in vitro.

5.4. Conclusions
The benzene carboxylic acid conjugates described in this study may serve as a template for
the future design of amyloid inhibitors and further illustrate the viability of using electrostatic
interactions to produce agonist and antagonists of amylin aggregation. These compounds
successfully address two viable strategies for circumventing the buildup of soluble cytotoxic
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oligomers by either rapidly driving the fibrillation process to completion or inhibiting it all
together. The identification of free benzene carboxylic acids that are capable of antagonizing or
promoting amylin aggregation may also aid in the development of small molecule amyloid
inhibitors. Our laboratory is currently pursuing the optimization of several benzene carboxylic acid
conjugates as well as conducting detailed mechanistic studies and cellular assays. The results of
these investigations should enhance our knowledge of how to regulate the amyloidogenic process
and drive the design and development of more efficient amyloid inhibitors.

5.5. Experimental Section
5.5.1. Reagents
Pre-loaded Fmoc-Ser(tBu)-Wang resin was purchased from EMD Chemicals, Inc
(Gibbstown, NJ). All other reagents for peptide synthesis and Fmoc-protected amino acids were
obtained from Advanced ChemTech (Louisville, KY). N,N-dimethylformamide (DMF),
dichloromethane (DCM) and acetonitrile (ACN) were purchased from Pharmco-AAPER
(Brookfield, CT). Terephthalic acid was obtained from Acros Organics (XXXX). All other
reagents were from Sigma-Aldrich Co. (St. Louis, MO)
5.5.2. Peptide Conjugate Synthesis
The resin-bound peptide NFGAILSS was synthesized manually on Fmoc-Ser(tBu)-Wang
resin (substitution level 0.22 mmol/g). Fmoc removal was accomplished using 20% piperidine
(v/v) in DMF for 20 min. Couplings were performed using three equivalents each of Fmocprotected

amino

acid,

N,N,N’,N’-Tetramethyl-O-(1

H-benzotriazol-1-yl)uranium

hexafluorophosphate (HBTU), 1-Hydroxy-benzotriazole (HOBT) and nine equivalents of Nmethylmorpholine (NMM) relative to resin-bound amine. Amino acid couplings and Fmoc
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removal were monitored by Kaiser ninhydrin test.284 After the coupling of Fmoc-Asn-OH, the
peptidyl resin was aliquoted, deprotected and the appropriate benzene carboxylic acid coupled
according to the protocol described for the conjugation of benzene-1,2,4,5-tetracarboxylic acid
unless otherwise specified.
Cleavage of peptides from the resin with simultaneous removal of all side chain protecting
groups was accomplished using a cocktail composed of 95% trifluoroacetic acid, 2.5% water and
2.5% triisopropylsilane (TFA/H2O/TIPS). After concentrating in vacuo, crude peptides were
isolated by precipitation with cold diethylether. Crude peptides were dissolved in 50%
CH3CN/H2O and filtered through a 0.45 mm PDVF filter before being subjected to
chromatography. Peptides were purified by reverse phase HPLC (Varian ProStar, Palo Alto, CA)
on a Vydac C18 protein and peptide column (2.2 × 25 cm) using a linear gradient of CH3CN/H2O
containing 0.1% TFA. Column effluent was monitored at 218 and 254 nm. Appropriate fractions
were pooled and lyophilized. Peptides were characterized by matrix-assisted laser desorption
ionization time of flight (MALDI-TOF) mass spectrometry (Waters Corporation, Milford, MA).
Peptide purity was confirmed by reverse phase analytical HPLC on a Vydac C 18 protein and
peptide column (4.6 × 250 mm).
5.5.3. Conjugation of Benzene-1,2,4,5-tetracarboxylic acid
Five equivalents each of benzene-1,2,4,5-tetracarboxylic acid, HBTU and HOBT relative
to resin bound amine and nine equivalents of DIEA relative to benzene-1,2,4,5-tetracarboxylic
acid were employed to activate the benzene carboxylic acid prior to amide bond formation. The
molar ratio of reagents used favours the activation of a single carboxyl group by ensuring a 4:1
ratio of carboxylate ion to HBTU/HOBT thereby minimizing the likelihood of cross linking
between adjacent polymer bound peptide chains. A similar procedure was used for the coupling of
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the other benzene carboxylic acid derivatives.
5.5.4. Conjugation of benzene-1,2,4-tricarboxylic 1,2-anhydride 4-chloride (trimellitic
anhydride chloride) and benzene-1,2,4-tricarboxylic anhydride (trimellitic anhydride)
Benzene-1,2,4-tricarboxylic 1,2-anhydride 4-chloride or benzene-1,2,4-tricarboxylic
anhydride (five equivalents relative to resin bound amine) along with nine equivalents of DIEA
dissolved in DMF was added to the NFGAILSS peptidyl resin and coupling allowed to proceed.
Turbidity Measurements. Lyophilized peptide conjugates were dissolved in DMSO to prepare
concentrated stock solutions. Stock solutions of the NFGAILSS control were prepared by
dissolving the peptide in 100% HFIP. Stock solutions were sonicated immediately prior to use.
Aliquots of the concentrated stocks were diluted into 10 mM Tris-HCl pH 7.5 to a final peptide
concentration of 1 mM for peptide aggregation studies. The final concentration of DMSO ranged
from 2 to 4%. Turbidity was measured at 405 nm at room temperature as a function of time on a
Jasco V-570 spectrophotometer (Easton, MD).
5.5.5. Thioflavin T (ThT) Fluorescence Assay
To assess the influence of non-aggregating conjugates on the self-assembly of full-length
amylin we performed ThT fluorescence assays.24, 29 For the ThT assay, peptide conjugates were
dissolved in 100 % 1,1,1,3,3,3-HFIP to prepare concentrated stock solutions. Stock solutions were
sonicated immediately prior to use. Aliquots of the concentrated stocks were diluted into 10 mM
Tris-HCl buffer (pH 7.5) containing ThT to a final ThT and peptide conjugate concentration of 3
and 40 µM, respectively. To this mixture amylin (Bachem, Torrance, CA) was added to a final
concentration of 4 µM. The ThT chromophore was excited at 450 nm and the emission monitored
at 482 nm as a function of time on a FluoroMax-4 Spectrofluorimeter (Horiba Jobin Yvon Inc.,
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Edison, NJ). Monochromator slits were set to 2.5 and 10 nm, respectively, for excitation and
emission. Fluorescence was monitored every 30 minutes for at least 20 hours at 25oC.
5.5.6. Raman Spectroscopy
All Raman spectra were obtained on a Jasco NRS-3100 confocal dispersive Raman
spectrometer equipped with a macro-Raman measurement accessory (Easton, MD). Raman
scattering was induced by a 12 mW 488 nm laser and collected on a thermoelectrically cooled
CCD detector. The macro-Raman assembly permitted direct measurements of solution in quartz
cuvettes. Raman spectra were taken of each peptide dissolved in HFIP, before the aggregation
process was initiated, and immediately after aliquots of the concentrated stocks were diluted into
10 mM Tris-HCl. The aggregate forming peptides yielded the Raman spectra of the fibrils formed.
Aggregates were collected, layered unto a quartz slide, and its spectra measured using the confocal
Raman set-up. Aggregates layered unto a slide yielded stronger Raman signals free of interfering
solvent signals. Samples were prepared under the same experimental conditions as described for
the kinetic aggregation assay. Measurements were done at room temperature and solutions were
at 1 mM.
5.5.7. Circular Dichroism Spectroscopy
In conjunction with the ThT assay, changes on the secondary structure of amylin in the
presence of the different peptide conjugates were done using CD spectroscopy on a Jasco J-810
spectrometer (Easton, MD). Similar solutions as with the ThT assay in the absence of thioflavin t
were prepared with the CD spectra taken every 30 minutes for 24 hours. All CD spectra were
subtracted with the CD spectra of a blank containing 40 μM peptide bioconjugate in 10 mM TrisHCl buffer (pH 7.5).
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5.5.8. Transmission Electron Microscopy
TEM images were obtained at Brooklyn College of CUNY. Aliquots of aged peptide
solutions containing aggregates were placed on carbon coated Formvar copper grids and
negatively stained with 2% uranyl acetate.

5.6. Supporting Information
5.6.1. HPLC and MALDI-TOF MS Analysis of peptide 2, 3, and 4
The bioconjugate peptides were purified from crude peptide using reversed phase HPLC
with a C18 Preparative Column (Grace Vydac, Columbia, MD) in a Varian ProStar 210 HPLC
system (Palo Alto, CA) with the solvent program described in Table 5.2.
Purity of the purified bioconjugate peptide were assessed by running an analytical reversed
phase HPLC using an analytical C18 column (Grace Vydac, Columbia, MD) with the solvent
program described in Table 5.3. Elution times for the bioconjugate peptide isomers were as
follows:
Table 5.2. Retention times of the three isomeric peptides 2, 3, and 4.
Peptide
Elution time (min)
2
31.010
3
32.089
4
30.760
Chromatogram of a coinjection of peptide mixture containing all isomers is presented in Figure
5.11.
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Figure 5.11. Chromatogram of the co-injection of the three peptide isomers.

Mass spectrometric analysis of the bioconjugate peptides was performed confirm the
molecular weight and structure. MALDI-TOF MS analysis were performed on HPLPC purified
samples using a MALDI Micro MX, TOF Mass Spectrometer (Waters, Corp., Milford, MA).
Molecular ion (M+H)+ peaks were detected for all conjugates at an m/z value closely matching
the theoretical molecular weight.
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Table 5.3. Calculated and experimental molecular masses of the different constructs (C1 - C9,
P10).

5.6.2. Raman and IR Spectroscopic Analysis of Peptide Aggregates
Peptide samples forming amyloid fibrils were collected and subjected to Raman and IR
analyses. Figure 5.11 summarizes the important Raman modes (~1200 cm-1 ring modes and ~1670
cm-1 amide I mode) and S3 the pertinent IR mode (~1630 cm-1 amide I mode).

Figure 5.12. Raman spectra of peptide 1(1), 9(2) and 10(3) showing the ring modes at ca. 1200
cm-1 (a) and amide I mode at ca. 1670cm-1.
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The infrared spectra of the aggregated samples of peptides are shown in Figure 5.12 with
a peak from the second derivative at 1631 cm-1.

Figure 5.13. Infrared spectra of the aggregated peptides 1, 9, and 10 (broken lines)
superimposed with its second derivative (solid line) for easy identification of peak
positions.
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5.6.3. Amylin Aggregation in the Presence of C1
As a control, we incubated amylin (4 µM) with C1 (40 µM) in tris-HCl buffer (pH 7.2).
C1, an aggregating conjugate, did not drastically change the aggregation profile of amylin. The
final ThT fluorescence of amylin with C1 is slightly higher than just amylin alone.

Figure 5.14. ThT aggregation profiles of amylin with and without C1.

5.6.4. Expanded ThT Assay of P10 and C5 Incubated with Amylin.
Data indicate that there is slight increase (less than a percentile than that of Amylin) in
the ThT intensity for amylin incubated with P10 and but not in the one incubated with C5.
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Figure 5.15. Expanded plot of Figure 5. Thioflavin T fluorescence emission plot corresponding
to β-sheet formation of amylin samples upon incubation with P10 and C5 showing a slight
intensity increase, during the first 5 hour of incubation, for the amylin with P10.

5.6.5. CD Spectra of the Constructs

Figure 5.16. CD spectra of individual constructs C2 -C7 and P10.
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6.1. Abstract
Cation-π interactions between charged amino acids such as Arg and Lys and the aromatic
residues Phe and Trp are common in proteins and play an important role in protein structure and
function. In this paper, we explore the effect of cation-π interactions on the aggregation propensity
of peptides derived from hIAPP using UV resonance Raman and fluorescence spectroscopy. By
employing an analog of hIAPP22-29 in which Phe-23 is replaced with Trp (NWGAILSS), we were
able to demonstrate an increase in the amyloidogenic propensity of this mutant in the presence of
Zn2+ that is attributable to cation-π interactions. In contrast, no cation-π interactions were
observed when the cationic F23R analog of hIAPP22-29 (NRGAILSS) was allowed to interact
with NWGAILSS. From these observations, it was surmised that the dominant interaction between
Arg and Trp in these peptides involves hydrophobic interactions between the -CH2- groups of Arg
134

and the indole ring of Trp and not cation-π interactions. These hydrophobic interactions, coupled
with the hydrotropic effect of the guanidine functionality of Arg, led to a delay in the aggregation
kinetics of NWGAILSS. These unique interactions were further exploited to design a peptidebased inhibitor of full-length amylin self-assembly.

6.2. Introduction
Cation-π interactions within proteins, characterized by favorable electrostatic interactions
between an aromatic π-electron surface and a positively charged species, are thought to play an
important role in maintaining protein stability and function.285-287 A survey of proteins using the
method of Gallivan and Dougherty found a high occurrence of cation-π interactions in proteinprotein interfaces.288, 289 This interaction is also present in protein-ligand binding and catalysis as
well as ion channel mechanisms.287,
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A dominant form of this particular interaction exists

between Arg and the aromatic amino acid residues such as Phe and Trp.288 The most common
cation-π interaction occurs via a parallel orientation rather than perpendicular or T-shaped
orientations.291 The parallel orientation allows Arg to participate in a cation-π interaction with Trp
while simultaneously participating in hydrogen bonding with surrounding solvent water
molecules.292, 293 These simultaneous interactions are not possible with similarly charged, Lys,
which makes Arg a far more common residue to be involved in cation-π interactions with aromatic
residues in proteins and polypeptides.293,
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Arg-Trp cation-π interactions are particularly

ubiquitous and essential in antimicrobial peptide activity where the cationic nature of arginine and
hydrophobic

nature

of

tryptophan

work

hand-in-hand

facilitating peptide-membrane

interactions.295
Craven et al. have recently exploited cation-π interactions to design a 19-residue miniprotein with a distinct β-strand: loop: polyproline type II (PPII) helix tertiary structure stabilized
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by a core network of interactions between Arg and Trp residues.296 This approach has also been
extended to drive the assembly of peptide and peptoid oligomers to form PPII helices.297
The role of ions in the aggregation of proteins has been described in some earlier studies
of amyloidogenic polypeptides. In the case of amyloid-β peptide (Aβ), the key protein in the
pathology of Alzheimer’s disease, the presence of ions, particularly Zn2+, promotes the aggregation
process by forming intermolecular chelates between histidine residues of Aβ peptides. This
interaction, however, is interrupted by the introduction of Cu2+, which competes with the Zn2+ ion
to form intramolecular chelates between a histidine residue and the amide backbone.57, 298 This is
supported by the remarked ion imbalance in Alzheimer’s patient brains, which typically exhibit
enriched Zn2+ and reduced Cu2+ levels compared to unaffected brains.299 The role of ions in the
aggregation of human islet amyloid polypeptide (hIAPP or amylin) has also been studied;
however, the effect has been found to differ depending on the ion concentration. 58, 59 As with the
case for Aβ, the zinc-effect was determined to be due to its interaction with His-18.
Full-length amylin contains three aromatic residues, namely Phe-15, Phe-23 and Tyr-37,
all of which are capable of participating in

-stacking interactions. However,

-stacking

interactions have been shown not to be an absolute requirement for the self-assembly of peptide
fragments derived from hIAPP or for aggregation of the full-length polypeptide although it does
appear that the presence of such residues affects aggregation kinetics and may contribute to the
thermodynamic stability of amyloid fibrils.141,

300-302

Aside from possible stacking with other

phenylalanine residues, Phe is also capable of interacting with Zn2+ via cation-π interaction. We
hypothesized that cation-π interactions between an aromatic residue in an amyloidogenic sequence
and Zn2+ would have an effect similar to that previously observed for His-18 and Zn2+.58, 59
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In order to investigate the effect of cation-π interactions on the behavior of amyloidogenic
peptides, we synthesized a F23W mutant of (hIAPP22-29) to enable us to employ UV resonance
Raman (UVRR) and take advantage of known marker bands for cation-π interactions involving
Trp. Besides probing Trp-zinc ions interactions, we also investigated possible cation-π interactions
between Trp and Arg. Raman and fluorescence spectroscopy, coupled with theoretical simulations,
were utilized to characterize cation-π interactions in short peptide fragments derived from hIAPP2229. The results

of these investigations were exploited to develop a peptide-based inhibitor of amylin

aggregation.

6.3. Materials and Methods
6.3.1. Reagents
Reagents used in peptide synthesis were purchased from Advanced Chemtech (Louisville,
KY). hIAPP1-37 was purchased from Bachem (Torrance, CA). Solvents for high performance liquid
chromatography (HPLC) and peptide synthesis were obtained from Pharmco-AAPER (Brookfield,
CT). All other reagents were purchased from Sigma Aldrich (St. Louis, MO).
6.3.2. Solid Phase Peptide Synthesis
Synthesis of the peptide sequences was performed using standard Fmoc-solid phase peptide
synthesis procedure. Fmoc-Ser(tBu)-Wang resin (substitution level 0.50 mmol/g) was used with
1-hydroxybenzotriazole hydrate (HOBT), O-Benzotriazol-1-yl-N,N,N',N'-tetramethyluronium
hexafluorophosphate (HBTU) and 4-methylmorpholine as activating agents. Fmoc group was
removed by 20 % (v/v) piperidine in dimethylformamide (DMF). Coupling and deprotection steps
were carried out with microwave heating following the protocol developed by Bacsa et al. using a
Mars 6 Microwave Accelerated Reaction System (CEM Corporation, Matthews, NC).303 Cleavage
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from the resin was completed by a 95:2.5:2.5 volume ratio of a mixture of trifluoroacetic acid
(TFA), water, and triisopropylsilane (TIPS) as scavenger. Crude peptide was purified via reversedphase HPLC (Varian Pro-Star, Palo Alto, CA) on a Vydac C18 column (22 x 250 mm2) in a linear
solvent gradient program of water and acetonitrile with 0.1% TFA. Analytical reversed-phase
HPLC on a Vydac C18 (4.6 x 250 mm2) column was employed to assess the efficiency of the
purification process. Matrix assisted laser desorption ionization-time of flight (MALDI-TOF)
mass spectrometry (Waters Corp., Milford, MA) was used to ascertain the molecular weight of the
purified peptide. Peptide stock solutions prepared from lyophilized peptides were prepared in
dimethyl sulfoxide (DMSO).
We prepared three peptide sequences: NWGAILSS as the model amyloidogenic peptide,
NRGAILSS as the cationic peptide, and, as control, an analog to the NRGAILSS peptide with a
citrulline (Cit) amino acid replacing arginine (NCitGAILSS).
6.3.3. Kinetic Turbidity Assay
Aggregate formation of the peptide was monitored by measuring the scattering of light at
250 nm over time using a Jasco V-570 UV-Vis spectrometer (Easton, MD). Measurements were
performed on a 1 mM solution of NWGAILSS in 10 mM Tris-HCl buffer (pH 7.2) from a 100
mM solution of peptide in DMSO which was incubated with twice the concentration of Zn2+,
NRGAILSS and NCitGAILSS.75
6.3.4. Fluorescence Measurements
Fluorescence measurements were done using a Horiba Fluoromax-4 spectrofluorimeter
(Edison, NJ) with excitation wavelength of 280 nm (2.5 mm slit) and emission scan from 290-420
nm (5.0 mm slit) in a 10 mm quartz cuvette. Fluorescence emission of the unaggregated peptide
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samples were performed by removing the aggregated peptides via centrifugation at 10,000 rpm for
30 minutes and testing the clear supernatant solution.
Steady-state fluorescence measurements were also performed for the thioflavin-T (ThT)
assay to monitor β-sheet formation during aggregation. hIAPP solutions were prepared with a
concentration of 4 µM incubated with 40 µM peptide fragment. The ThT binding was measured
by exciting at 450 nm and monitoring the emission at 482 nm with a FluoroMax-4
Spectrofluorimeter (Horiba Jobin Yvon Inc., Edison, NJ). Monochromator slits were set to 2.5 and
10 nm, respectively, for excitation and emission. Fluorescence was monitored every 30 minutes
until the aggregation of the control was complete.
6.3.5. Circular Dichroism (CD) Measurements
CD measurements were performed from the diluted samples previously prepared for the
kinetic aggregation assay. Using a Jasco J-810 spectropolarimeter (Easton, MD), samples were
measured in a short pathlength (2mm) quartz cuvette. Sample spectra were corrected by
subtracting buffer CD spectra from individual sample CD spectra.
6.3.6. Raman Measurements
Raman spectroscopic measurements were performed in a confocal dispersive NRS 3100
Raman spectrometer (Jasco Inc., Easton, MD) equipped with a micro-sampling assembly and a
thermoelectrically cooled charged-coupled device detector (CCD) detector and a 12 mW 488 nm
laser excitation wavelength. Samples were prepared by utilizing drop-coat deposition on a
stainless-steel surface with a thin hydrophobic coating (Tienta SpectRIM, Sigma Aldrich, St. Louis
MO).119, 120 UV Resonance Raman (UVRR) measurements were performed on a Horiba LabRAM
HR Evolution (Edison, NJ) equipped with a 25 mW 244 nm LEXEL Deep UV laser source
(Cambridge Lasers, Freemont, CA) and a thermoelectrically cooled CCD detector. Samples in the
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UVRR experiment were run in solution with consistent mixing to reduce self-quenching and
sample bleaching.
6.3.7. DFT Simulation Studies
To aid understanding of the Raman spectra, density functional theory (DFT) based
simulations were performed in Gaussian 09 (Gaussian, Inc., Wallingford, CT) implementing the
Becke’s three parameter exchange functional in combination with the Lee, Yang and Parr
correlation function (B3LYP).304-306 6-311G ++ (d,p) basis set to account for intermolecular
interactions.307, 308 Input file preparation as well as data analysis were done using GaussView05
(Gaussian Inc., Wallingford, CT) software.309

6.4. Results and Discussion
The aggregation of the octapeptide NFGAILSS has been extensively studied as a model
for the aggregation of the full-length amylin. Evidence of π-stacking as well as hydrophobic
interactions have been presented as contributing forces for the formation of aggregates.
Perturbations applied on these forces proved to be a potential strategy for the development of
aggregation inhibitors.310 Another significant interaction common among aromatic residues in
proteins and polypeptides are cationic-π interactions. These interactions usually occur between
aromatic residues (Trp and Phe) and positively charged residues (Lys and Arg). To investigate
these interactions and their possible effects on the aggregation of hIAPP, we synthesized a F23W
mutant of the amyloidogenic fragment hIAPP22-29, (NWGAILSS). Trp and Phe are similarly
aromatic, so we expected a similar aggregation kinetic profile for NWGAILSS as that of the
unmodified fragment.49, 311, 312 The choice of Trp-23 mutation over the native Phe-23 peptide was
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for ease of monitoring any perturbation to the Trp structure as its electronic transition is more
resonant to the excitation wavelength used.
Turbidity assay measurements of NWGAILSS showed a typical aggregation pattern with
an initial lag phase from t0 to approximately 2,000 seconds until the aggregation increased to the
growth phase which was characterized by a t50 of approximately 2,750 seconds (Figure 1). The
presence of Zn2+ resulted in a shorter lag phase and steeper growth phase with similar asymptotic
maximum as the control. This observation is similar to the earlier reported effect of Zn2+ on
aggregation of the full-length hIAPP; however, the interactions involved are different in the case
of full-length hIAPP because His-18 is the residue involved in the interaction with zinc via
coordination.58, 313
The negative C-terminus in NWGAILSS is the only charged moiety with potential for
electrostatic interaction with Zn2+. The delocalized π-electrons of the Trp residue also have
potential to interact with Zn2+ via cation-π interactions. This type of interaction is therefore a
possible factor in the perturbed aggregation kinetics of NWGAILSS in the presence of Zn 2+.
Cation-π interactions are also possible between aromatic residues and charged amino acids
particularly with Arg residues. In an earlier research publication, Porat et al. demonstrated, using
a membrane binding assay, that a hIAPP22-29 F23R mutation is capable of binding to full-length
hIAPP.49 A clear explanation of this binding was not provided. Other mutations were shown to
bind including aromatic residues such as Tyr, Phe and Trp. The binding of these aromatic residues
has been attributed to π-stacking interactions, evidence of which has been previously published.49,
127, 311

The case for potential interactions between positively charged residues and aromatics, on

the other hand, has been less studied in this system.
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The incubation of NWGAILSS with either NRGAILSS or NCitGAILSS yielded similar
kinetic profiles with delayed aggregation (Figure 6.1). Aggregation was only detected after
extended measurements (data not shown). At the experimental pH of 7.2, the Arg residue possesses
a positive charge making it available for a potential cationic-π interaction with Trp. NCitGAILSS
serves as a control with the urea of the Cit residue replacing the guanidinium group of Arg, thereby
allowing the study of the effect of the Arg charge on NWGAILSS aggregation. Similar effects on
the aggregation kinetics of NWGAILSS mutant by the Arg and Cit analogs suggests that the charge
of Arg is not directly involved in the observed perturbation of aggregation.

Figure 6.1. Kinetic turbidity profile of NWGAILSS in the presence of Zn2+, NRGAILSS and
NCitGAILSS.
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Raman measurements of the NWGAILSS peptide showed typical markers for a peptide in
an aggregated state (Figure 6.2). The distinctive amide I Raman band at ca. 1672 cm-1 indicated a
formation of parallel oriented β-sheets in the formed aggregates.310 Supporting this observation,
the fluorescence emission of the aggregated NWGAILSS showed the characteristic blue-shift of
the Trp emission which indicates a change to a more hydrophobic environment surrounding the
tryptophan residue (Figure 6.3).314, 315 The Fermi doublet (1366 and 1387 cm-1) from the UVRR
spectra, a common marker to assess the surrounding hydrophobicity of tryptophan residues,
indicated a highly hydrophobic environment (Figure 6.4).316,

317

This is consistent with the

expected π-stacking interactions involved in peptide aggregation.127

Figure 6.2. Raman spectra of NWGAILSS peptide aggregates (black) in the presence of Zn 2+
(yellow), NRGAILSS (blue) and NCitGAILSS (red) showing the distinctive amide I band at
1672 cm-1 which is a marker for the β-sheet secondary structure.
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In contrast, in the presence of zinc ions, the Fermi doublet suggests a less hydrophobic
environment with a calculated Fermi doublet ratio (RFD) of 0.75 (compared to RFD = 0.92 in
NWGAILSS). The fluorescence emission of NWGAILSS incubated with Zn2+ is also significantly
less blue-shifted, suggesting a less hydrophobic environment brought about by the charged zinc
ion binding with the Trp residue. This observation supports the data from the UVRR
measurements.

Figure 6.3. Fluorescence emission of NWGAILSS in the absence and presence of NRGAILSS
NCitGAILSS and Zn2+ with solid traces representing the aggregates samples and broken traces
corresponding to unaggregated samples.
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Figure 6.4. UVRR spectra of the NWGAILSS peptide (black) in the presence of NRGAILSS
(blue), NCitGAILSS (red) and Zn2+ (yellow) including that of tryptophan amino acid dissolved
in water (green).

Figure 6.5. Simulated W18 (ca. 780 cm-1) and W16 (ca. 1010 cm-1) Raman modes in the
presence of Zn2+ at different distances to the Trp plane showing the effect of cation-π
interaction to the peak position and intensity of W16 relative to W18.
Aside from the Fermi doublet in the UVRR spectra, the W16 mode is also seen to be
perturbed by the presence of Zn2+ (Figure 6.4). It has been suggested that the intensity of the W16
relative to the W18 mode of Trp residues can be used as indicators of possible cation-π interaction
with a decrease in W16 intensity as a Raman marker for such interaction.318 Using DFT simulations
to predict the effect of Zn2+ on the W16/W18 mode, it was seen that upon peak normalization with
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W18, the W16 mode showed a decrease in peak intensity supporting the experimental observations
from an earlier published work (Figure 6.5).318 DFT simulations showed a slight blue-shift of the
W16 mode which was also evident on the experimental UVRR spectra (1016 cm-1 → 1018 cm-1).
For the case of NWGAILSS incubated with NRGAILSS, the UVRR spectra showed no
signs of cation-π interactions and the Fermi doublet indicated a similarly hydrophobic environment
around the Trp as was the case for NWGAILSS on its own. The hydrophobic Trp environment is
supported by fluorescence emission measurements with a significant blue shift occurring upon
aggregation (Figure 6.3).317 It is important to note, however, that the observed blue shift in
fluorescence emission was less pronounced in the presence of NRGAILSS. This suggests, that
even with a significant increase in hydrophobicity upon aggregation in the presence of
NRGAILSS, the degree of hydrophobicity around Trp is slightly less than without it.317, 319, 320 The
UVRR and fluorescence measurement of the Cit substituted fragment showed similar results as to
that of the Arg containing peptide, thereby suggesting a less prominent role for the charge of Arg
in the process.
These results suggest an indirect role of the charged guanidine group of Arg to the
perturbation of hIAPP fragment aggregation. This implies that the binding of Arg mutant on hIAPP
as observed by Porat et al. is not likely due to cation-π interaction and could rather be driven by
other interactions among side chains as part of the recognition process.49
In the aggregation of a synthetic octapeptide RFRFRFRF, it is reasonable to expect cationπ interactions as a driving force for its aggregation; however, no cation-π interactions were
observed.321 In fact, the beta sheets that were formed were stabilized by π-stacking between Phe
residues and dipole-dipole interactions between the polar guanidine groups of the Arg residues. In
another study, potential cation-π interactions were probed in a helical peptide involving aromatic
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and charged residues (Trp/Phe(i) - Arg(i + 4)) designed for the two resides to be on the same side of
the helix. Cation-π interactions were assessed based on the stability of the helix with the hypothesis
of increased stability brought about by the cation-π interaction. Results showed some degree of
stabilization but this was mostly attributed to hydrophobic packing rather than cation-π
interaction.285 Another relevant study with similar findings showed -CH2- groups on Lys and Arg
residues interacting with aromatic residues rather than cation-π interactions.322, 323
Based on the above, we speculate that the side chain methylene groups of Arg and Cit in
NRGAILSS and NCitGAILSS form hydrophobic contacts with the aromatic ring of NWGAILSS.
This interaction, together with the hydrotropic effect of Arg and Cit, increase the solubility of
NWGAILSS thus delaying aggregation. This increased solubility is, however, later overcome by
hydrophobic packing with other Trp residues as the amyloid matures leading to eventual
aggregation. Evidence of this mechanism is in the fluorescence emission of NWGAILSS
aggregates in the absence and presence of the Arg and Cit peptides. A similar blueshift was
observed in the tryptophan emission in the presence of NRGAILSS and NCitGAILSS indicating
a similar change to a more hydrophobic environment of the tryptophan residue which is a
consequence of the aggregation process. In comparison to aggregates with just the NWGAILSS
peptide, the characteristic shift in the fluorescence emission is slightly less in the presence of the
Arg and Cit peptides indicating that the hydrophobicity is slightly less which can be attributed to
the less hydrophobic nature of the methylene chain of the Arg and Cit residues in a hydrophobic
packing with the much more hydrophobic Trp ring. The guanidinium and urea groups of Arg and
Cit, respectively, also remain available for H-bonding with solvent molecules. These findings
corroborate our earlier observations on the inhibitory effect of NF-(4-amino)GAILSS and NF-(4formamido)GAILSS on the aggregation of amylin.310 The inability of NRGAILSS to completely
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abolish aggregation suggests that the strength of hydrophobic interaction is essential to the
effectivity of inhibitors.49 This also highlights the potential significant role of nitrogen-containing
functional groups in the inhibition mechanism of hIAPP aggregation.

Figure 6.6. The kinetic turbidity profile of the hIAPP20-29 fragment (black) in the presence of
the of other short peptide fragments resulting to the inhibition of aggregation.

Figure 6.7. Kinetic turbidity plots of the different peptide constructs showing no inherent
aggregation propensity on all of the synthesized peptides.
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Figure 6.8. CD spectra SNNFGAILSS (hIAPP20-29) before and after aggregation and in the
presence of the peptide constructs used in the experiment.

Based on the results of the experiments done with NWGAILSS, we attempted to see if the
same effect would be observed with Phe, as is the case for the full-length polypeptide hIAPP
(Figure 6.6). We opted to test the aggregation propensity of the fragment SNNFGAILSS (hIAPP2029) in the presence of the same inhibitory peptides NRGAILSS and NCitGAILSS. We also included

an additional construct introducing the 4-guanidinophenylalanine (Gua) at position 23
(NGuaGAILSS). On their own, these peptides did not show inherent aggregation tendencies in the
kinetic turbidity assay (Figure 6.7). Similar to their effect on the aggregation of NWGAILSS, these
peptides appeared to have inhibited the aggregation of SNNFGAILSS. The CD spectra of
SNNFGAILSS before and after the aggregation process was measured and contrasted with the
presence of the other peptide constructs (Figure 6.8). Results of the CD experiments suggest βsheet secondary structure on the aggregated SNNFGAILSS. The unaggregated SNNFGAILSS in
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the presence of the peptide constructs also showed β-sheet conformation which is believed to be
the consequence of binding between SNNFGAILSS and the peptide fragments, which is key to
their inhibition mechanism. The other possibility is that there could be soluble oligomers of
SNNFGAILSS that have started to form but are not big enough to form detectable fibrils.
To test if these inhibitory effects translate to the full-length hIAPP, a ThT assay was
performed to follow the formation of β-sheets during hIAPP aggregation. The assay showed
strikingly different results from that of the aggregation of the model peptide fragments (Figure
6.9).

Figure 6.9. ThT assay of hIAPP (control) incubated with the different peptide constructs
showing significant inhibition by NGuaGAILSS and GuaNRGAILSS.
Figure 6.9 shows the expected aggregation profile of hIAPP with the characteristic lag
followed by a steep increase in the dye emission, which corresponds to the formation of β-sheets
as the amyloid fibrils begin to mature, and ultimately plateau as the aggregation reaches
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equilibrium. The presence of NRGAILSS did not completely abolish hIAPP aggregation but only
showed a reduced rate of aggregation as well as reduced degree of aggregation with significantly
lower ThT fluorescence emission than that of the amylin control. As expected, the same can be
said of the citrulline analogs. This could be due to the overwhelming hydrophobic interactions that
drive the self-assembly process. In addition, a weaker attraction between the Phe and Arg (or Cit)
as compared to Trp and Arg (or Cit) could account for the underwhelming inhibition of the fulllength hIAPP. Strengthening this interaction could potentially increase the potency of the inhibitor,
as was demonstrated with the NGuaGAILSS peptide construct. This peptide takes advantage of
the π-staking interaction between the aromatic groups of Phe in hIAPP1-37 and the Phe-(4guanidino) residues, which is significantly stronger than that of Phe and the aliphatic carbon chain
of Arg and Cit residues. At the same time, this peptide construct can also take advantage of the
hydrotropic effect of the guanidine functional group. This effect mirrors the same inhibitory effect
of the NF-(4-amino)GAILSS peptide to hIAPP previously reported in an earlier publication.310
Based on our previously proposed model of inhibition an efficient binding to the 22-29 region of
hIAPP of the peptide inhibitor is essential to prevent the region from folding into a β-turn, an
important precursor in the aggregation mechanism of hIAPP.310, 324 In a more recent publication,
we took advantage of this hIAPP binding mechanism and also introduced negatively charged
groups to the N-terminus the peptide inhibitors.324 The presence of the negatively charged groups
provided repulsive forces between hIAPP monomer/inhibitor complexes, thereby providing a
secondary means of inhibiting aggregation in addition to preventing the peptide from forming the
key β-turn intermediate. For the guanidine-based peptide inhibitors (NRGAILSS and
NGuaGAILSS), the same binding motif is exploited, while at the same time utilizing the increased
solubility brought about by the highly hydrotropic guanidine groups.
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Based on our studies with charged peptide conjugate inhibitors, we investigated whether
an additional charge at the N-terminus of NRGAILSS will enhance its inhibitory activity on fulllength hIAAP.324 Therefore, we synthesized the sequences RNRGAILSS and GuaNRGAILSS, the
latter which contains a Phe-(4-guanidino) residue added to the N-terminus. The presence of an
additional Arg residue in RNRGAILSS did not result in any significant decrease in the aggregation
propensity of hIAPP. We had hoped that with the additional Arg in the structure will improve
solubility and thereby increase inhibition of aggregation propensity. On the other hand, the
GuaNRGAILSS peptide construct performed exceptionally well in the ThT assay exhibiting
complete abolition of hIAPP aggregation within the tested time frame. This peptide construct
highlights the multifactorial nature of amyloid formation which appears to be not only dependent
on hydrophobic/π-stacking interactions of Phe residues. The stark contrast in the effect of
RNRGAILSS and GuaNRGAILSS opens up new questions on the role of the Asn residues in the
aggregate formation. In a study conducted by Nguyen et al., it was shown that aggregation was
inhibited when Asn-21 was mutated to Asp-21 in the full-length hIAPP.325 This mutation
introduced a charge at residue-21 of hIAPP which appeared to be significant in the inhibition of
hIAPP self-assembly. The peptide construct GuaNRGAILSS also introduced a charge near
residue-21 with its charged guanidino group. This is likely to be the cause of the reduced
aggregation propensity of amylin. The same charge is introduced by RNRGAILSS but aggregation
propensity does not seem to be affected. This observation merits further investigation on the role
of charged species on this region of the hIAPP polypeptide and can also be used in the future as
basis of the development of novel peptide inhibitors to peptide aggregation.
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6.5. Conclusions
We investigated the potential effects of cation-π interactions on peptide aggregation
utilizing a model peptide based on the hIAPP22-29 sequence with a F23W mutation (NWGAILSS).
Use of the F23W mutant enabled UVRR investigation of perturbations to Trp vibrations. From
these investigations it was revealed that low zinc-peptide ratios result in an increase in aggregation
similar to that previously reported for full-length hIAPP. Using UVRR markers, we were able to
attribute this effect to cation- interactions between Zn2+ ions and Trp. This mechanism is distinct
from the effect of Zn2+ on full-length hIAPP as it does not involve coordination to His-18.
Significantly, the inhibitory mechanism of NRGAILSS on NWGAILSS is disparate to that of Zn2+
and does not involve cation-

interactions. Although it is easy to pinpoint cation-π interaction

between Trp and Arg, spectroscopic measurements point to hydrophobic packing as a more
probable interaction between the two residues. These results present options for future
peptide/peptidomimetic inhibitor design by exploiting such hydrophobic interactions. Indeed,
utilizing this interaction and the increased solubility brought about by the hydrotropic guanidine
functional group of Arg, we were able to design peptide-based inhibitors capable of inhibiting
aggregation of the SNNFGAILSS amyloidogenic fragment of hIAPP. However, the inhibitory
effect did not fully translate to full-length hIAPP. Upon strengthening the interaction between the
inhibitor peptide and the hIAPP by utilizing the Phe-(4-guanidino) amino acid in lieu of Arg,
improved inhibitory properties were observed.
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7.1. Ramifications on the Role of Aromatic and Other Interactions on the
Aggregation of hIAPP22-29
The aggregation of hIAPP1-37 has been key to the pathology of type-II diabetes. In this
dissertation, the amyloidogenic fragment hIAPP22-29 was studied as a model for the full-length
hIAPP. In line with the specific aims of this dissertation, we investigated the effects of perturbing
the aromaticity and π-electron distribution of Phe-23 in the aggregation of hIAPP22-29. We also
looked at the effects of conjugating benzene carboxylic acids to the N-terminal of hIAPP22-29 to
examine electrostatic repulsion as a basis of inhibiting aggregate formation. In addition to these,
cation-π interactions were also studied as a potential interaction that can be exploited in the design
of potential inhibitors to aggregation. We utilized Raman and IR spectroscopic markers to
investigate the polypeptide secondary structure, particularly that of β-sheet structures that are
predominant in amyloid fibrils. We also used vibrational spectroscopy in conjunction with other
spectroscopic techniques to assess intermolecular interactions involved in the aggregation process.
From these investigations, it is apparent that the π-electron distribution of Phe-23, a key
residue in the aggregation mechanism of hIAPP, can be perturbed to change the aggregation
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propensity of the hIAPP22-29 peptide fragment. Consistently, fragments with electron-rich aromatic
systems inhibited from forming aggregates which is in contrast with fragments with electron-poor
aromatic systems that consistently formed aggregates. These observations illustrate the importance
of aromatic interactions in the aggregation mechanism of hIAPP.127
It is also apparent that the addition of charged groups in the form on the N-terminal of the
hIAPP22-29 fragment to provide electrostatic repulsion between hIAPP monomers is an efficient
way to prevent the aggregation of hIAPP22-29 fragments.324
Strong evidence suggesting the important role of the aromatic Phe-23 in the aggregation of
hIAPP made us investigate further into other interactions that involve the aromatic π-electrons.
Cation-π interactions, a common interaction found in proteins and polypeptides that has been
found to play roles in stabilizing protein secondary structures, were thus investigated. Based on
the results of our experiments, we observed an agonistic effect of Zn2+ ions to the aggregation of
hIAPP22-29 fragment brought about by cation-π interactions between Zn2+ ions and the aromatic
ring. In the case of Arg, in the form of NRGAILSS peptide fragment, as the source of cationic
charge, the effect is rather opposite with some inhibition observed in the SNNFGAILSS fragment
due to the binding of NRGAILSS stabilized by hydrophobic packing. The hydrotropic nature of
the Arg residue increased the solubility of the amyloidogenic fragment resulting to a delay of the
amyloid formation.
Aside from these interactions, we also investigated purely hydrophobic interactions on
hIAPP22-29 by looking at the aggregation propensities of leucine substituted peptide fragments.
Replacement of the aromatic Phe-23 of hIAPP22-29 with Leu-23 and its isomers resulted to a lower
aggregation rate compared to that of the native Phe-23 peptide construct (Figure 7.1). All samples
formed amyloid fibrils after extended measurements (data not shown).
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Figure 7.1. Turbidity plots of the different leucine substituted hIAPP22-29 peptide fragments.
The peptide with a tert-leucine substitution (yellow) exhibited the greatest aggregation. The
isoleucine substituted peptide (blue) also showed some aggregation while the norleucine
(black) and leucine (red) remained flat during the duration of the turbidity run.

Figure 7.2. Raman (left) and IR (right) spectra of the formed amyloid fibrils suggesting
parallel oriented β-sheets among all variants of the leucine substituted peptide fragments
tested.
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Raman and IR measurements of the aggregates that formed during the aggregation process
suggest parallel oriented β-sheets among the amyloid fibrils (Figure 7.2). The distinctive single
peak at 1670 cm-1 in the Raman spectra and the 1629 cm-1 band in the IR spectra are both
characteristic markers for parallel oriented β-sheets.
When these peptides were incubated with the full length hIAPP, no effect on the rate of
aggregation (Figure 7.3). This may suggest the lack of interaction between the peptide fragments
and the full length hIAPP.

Figure 7.3. Raman (left) and IR (right) spectra of the formed amyloid fibrils suggesting
parallel oriented β-sheets among all variants of the leucine substituted peptide fragments
tested.

Based on all the ThT assays performed on the inherently non-aggregating peptides in this
dissertation, the peptide fragments NF(4-amino)GAILSS, NF(4-formamido)GAILSS and
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NGuaGAILSS showed some significant inhibition of hIAPP amyloid formation at 1:10 ratio of
hIAPP and peptide inhibitor while complete inhibition was observed with the fragment
GuaNRGAILSS. The degree of inhibition is most likely dependent on the peptide-amylin ratio and
thus requires further studies on the concentration dependence of the inhibitory properties of these
peptides towards amyloid formation.

7.2. Future Directions
Results of these studies open up new avenues for further research. Peptides that showed
successful inhibition of hIAPP aggregation can further be investigated for the concentration
dependence of their inhibitory effect. In-vivo measurements can also be done on these peptides
to test their effectivity on a cellular environment.
Among the greatest weakness of peptide-based therapeutics are their susceptibility for
protease catabolism. To improve the resistance of these peptide inhibitors against digestion,
modifications on the structure involving peptidomimetic chemistry can be done.326, 327
Another avenue for further research is the application of the findings from these
experiments on the development of peptide-based inhibitors targeting other amyloidogenic
regions of hIAPP that also involve aromatic residues.300, 328 It may be worthwhile to study if the
effectivity of these peptide-based inhibitors will be improved if they are designed to target more
than one amyloidogenic region of hIAPP.
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